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Abstract 
After traumatic brain injury (TBI) astrocytes perform various beneficial tasks like the 
reorganisation and support of the blood-brain barrier (BBB), the remodelling of synapses and 
neural circuits and controlling inflammation. They do this by becoming reactive under these 
conditions. Astrocyte reactivity includes, but is not limited to hypertrophy, polarization, the 
upregulation of glial fibrillary acidic protein (GFAP) in astrocytic processes as well as 
proliferation of astrocytes surrounding the lesion site. In the somatosensory cortex of mice 
juxtavascular astrocytes, which have their soma directly adjacent to blood vessels are more 
prone to proliferate in response to TBI, whereas non-juxtavascular astrocytes with the cell 
soma further away from the vasculature are less likely to do so. Nevertheless, the underlying 
mechanism of this selective proliferation is still not well understood. It is known that ion 
channels play an important role in cell cycle progression in different cell types and at different 
developmental stages. Especially potassium (K+) channels have been shown to be key players. 
To determine whether there are differences present between the two astrocyte subtypes per se, 
in this study K+ channel expression patterns and electrophysiological properties were 
characterized in juxtavascular astrocytes and compared with the ones of non-juxtavascular 
astrocytes in the unlesioned somatosensory cortex of Aldh1l1-eGFP mice. Furthermore, ion 
channel expression patterns were compared five days after astrocyte reactivity was induced by 
a stab wound lesion. 
Whole-cell patch-clamp recordings in somatosensory cortex slices of healthy Aldh1l1-eGFP 
mice revealed great heterogeneity in the resting membrane potential (Vr), the resting membrane 
conductance (Gr) and the input resistance (Rin) of different astrocytes. 70% of non-
juxtavascular and 81% of juxtavascular control astrocytes displayed typical Ohmic passive 
current patterns with linear IV-curves. Blocking of inwardly rectifying Kir4.1 ion channels in 
electrophysiological recordings as well as immunohistochemical stainings revealed a 
homogeneous expression of Kir4.1 channels in astrocytes across all cortical layers. 
Heterogeneous expression of Kir6.2 and Kv4.3 channels in somatosensory cortex astrocytes 
was revealed by means of immunohistochemistry. Moreover, heterogeneous expression of 
hyperpolarization-activated cyclic nucleotide-gated 1 (HCN1) channels in somatosensory 





not be confirmed in electrophysiological recordings. All dissimilarities mentioned above could 
not be related to whether an astrocyte is non-juxtavascular or juxtavascular in nature. 
A stab wound lesion and the subsequent reactive astrogliosis triggered a downregulation of 
Kir4.1 in proliferating reactive astrocytes as well as the upregulation of Kv4.3 channels on 
polarized astrocytic processes. This was accompanied by a shift especially in juxtavascular 
astrocytes towards non-passive current response patterns. This proposed an important role of 
these two K+ channel subtypes in astrocyte proliferation suggesting that these reactive 
astrocytes might resemble immature astrocytes with proliferative potential. Astrocyte 
reactivity and proliferation had no impact on Kir6.2 and HCN1 channel expression. HCN2 
channels, which were absent in astrocytes in control conditions were upregulated on processes 
of a subset of reactive polarizing astrocytes independently of non-juxtavascular and 
juxtavascular position as well as proliferative behaviour. These finding are of great interest for 
therapeutic approaches since there is increasing evidence that astrocyte proliferation positively 
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1 Introduction 
1.1 Glia cells 
1.1.1 Evolution of glia cells 
At some point in life history on earth and especially with the evolution of bilateral body 
organization centralized brains appeared in combination with condensed ganglia that were 
more complex than the so far present nerve nets of the radial symmetric phyla Cnidaria and 
Ctenophora: This allowed animals to react to more advanced external stimuli and complex 
environments. In addition, a new cell type arose, the so called glia cells (Bullock & Horridge, 
1965; Hartline, 2011). The most likely scenario is that glia cells evolved parallel to the 
appearance of sensory systems. For example in Planarians and Polychaeta larvae light 
detecting neurons are accompanied by supporting pigment cells (Gehring & Ikeo, 1999), which 
might already resemble a form of glia cells. During evolution, the amount of glial cells in the 
brain increased. In invertebrate species like Drosophila and Caenorhabditis around 10 % of 
cells in the central nervous system are glia cells (Pereanu et al., 2005; Beckervordersandforth 
et al., 2008; von Hilchen et al., 2008; Oikonomou & Shaham, 2011) whereas the amount of 
glia cells appears to increase with brain complexity. The general opinion is, that the bigger the 
brain, the higher the ratio of glia cells to neurons (Reichenbach, 1989). And indeed, studies 
have shown, that there is a dominance of glia cells in comparison to neurons in larger brains 
(Ransom et al., 2003). For a long time it has been thought, that in the highly advanced and 
large human brains, glia cells outnumber neurons up to ten times (Kandel et al., 2000; Ullian 
et al., 2001; Doetsch, 2003; Nishiyama et al., 2005; Noctor et al., 2007). But newer studies 
show, that the human brain bears nearly the same number of neurons and non-neuronal cells, 
with the latter being comprised of glia cells, mesenchymal cells as well as endothelial cells and 
that the ratios in humans resemble the ones in other primates (Azevedo et al., 2009). The ratio 
of non-neuronal cells to neurons differs immensely for different brain regions. For example in 
the cerebral cortex the ratio is 0.99 non-neuronal cells/neurons, whereas in the cerebellar cortex 
the ratio is only 0.23. In the rest of the brain, non-neuronal cells outnumber neurons by an 
astonishing ratio of 11.35 (Azevedo et al., 2009). This is in line with other studies in the human 
brain, where it has been shown that in subcortical areas like the thalamus, the glia to neuron 





ratio of glial cells to neurons depends on neuronal density and not on brain size (Herculano-
Houzel, 2014). 
1.1.2 Historic background of neuroglia 
The concept of glia cells was established in 1856 by the German scientist Rudolf Virchow. He 
named these cells after the greek word “glia” referring in this case to "putty", due to him 
believing that these neuroglia cells were an acellular mass that functions as connective brain 
tissue, the so called “Nervenkitt” or “Zwischenmasse” in which the neurons of the brain are 
embedded (Virchow, 1856, 1858). The first glia cell type was identified namely the Müller 
glia cells in the retina (Müller, 1851) followed by the discovery of cerebellar Bergmann glia 
in 1857 (Bergmann, 1857). In 1865 white and grey matter stellate glia cells were described by 
Otto Deiters (Deiters, 1865). Later, using his silver-chromate impregnation technique, Camillo 
Golgi described grey matter glia cells as cells with a round soma and a high amount of fine 
stellate processes. Moreover, he defined glia as a distinct cellular population that stays in close 
contact to blood vessels and he showed the existence of heterogeneous glia cell populations 
throughout the brain, as well as glial networks and radial fibres now known as radial glia cells 
(Golgi, 1870). In 1920, Cajal implemented the astrocyte-specific gold chloride-sublimate 
staining and described a variety of astrocyte types (Ramon y Cajal, 1920). Also 
oligodendrocytes and microglia were identified and described around that time (Del Rio-
Hortega, 1919, 1920). Another type of neuroglia, the NG2 glia cells are a much more recent 
discovery (Stallcup, 1981). 
1.1.3 Definition of glia cells 
All non-neuronal cells of the nervous system, except cells that are part of the vasculature, are 
pooled under the umbrella term neuroglia. In contrast to neurons, which are defined as cells 
that generate action potentials, it is quite difficult to find a simple and universally applicable 
definition to define a glia cell. They are often said to be non-excitable, delineating them from 
excitable neurons, but exceptions to this rule are present. Newer approaches define glia 
according to their functions as homeostasis-maintaining cells that show high amounts of 
heterogeneity regarding their origin, structure and especially their function (Parpura & 





with neurons and they separate neuronal compartments from the mesoderm. They arise from 
ectodermal layers and are named macroglia (Bullock & Horridge, 1965; Radojcic & Pentreath, 
1979; Hartline, 2011; Parpura & Verkhratsky, 2014). Studies in Drosophila have shown that 
these macroglia cells can be subdivided into different classes and perform various functions 
like constituting the blood-brain barrier (BBB), enwrapping axons, ensuring the proper 
layering of neurons during development, the maintenance of neurons, axon guidance and many 
more (Hartenstein, 2011). In invertebrates macroglia cells also function as brain macrophages. 
In contrast, vertebrate brain immune cells, the so called microglia cells originate from the 
mesoderm and migrate into the central nervous system (CNS) during embryogenesis (Saijo & 
Glass, 2011). In the mammalian nervous system, glial cells are classified in peripheral nervous 
system (PNS) glia originating from the neural crest and CNS glia with neuroectodermal origin 
(Parpura & Verkhratsky, 2014; Prasad & Charney, 2019). PNS glia comprises satellite glial 
cells that ensheathe neuronal cell bodies in sympathetic, parasympathetic and sensory ganglia 
(Hanani, 2005, 2010), olfactory ensheathing cells that enwrap non-myelinated neurons in the 
olfactory nervous system (Ramón-Cueto & Avila, 1998) as well as enteric glia which is present 
in the nervous system of the gastrointestinal tract and has stunning similarities to astrocytes in 
the CNS (Coelho-Aguiar et al., 2015). Non-myelinating Remak Schwann cells that enwrap 
small axons in Remak fibres are crucial for the proper development and function of the PNS 
as well as regeneration after peripheral nerve damage (Harty & Monk, 2017). One more type 
of non-myelinating Schwann cells are perisynaptic Schwann cells, that enwrap the 
neuromuscular junction (Ko & Robitaille, 2015). Myelinating Schwann cells, that are the 
counterpart of oligodendrocytes in the CNS, form the myelin sheath of sensory and motor 
neurons to enable saltatory conduction along the nodes of Ranvier (Kidd et al., 2013). In the 
CNS also several types of glia cells are present (Allen & Barres, 2009) that can be divided into 
macroglia cells with neuroectodermal origin and microglia cells that stem from the mesoderm 









1.2 Glia cell types 
1.2.1 Microglia 
New studies show, that microglia progenitor cells are derived from CD-45 c-kit positive 
erythromyeloid precursors in the extra-embryonic yolk sac, the first site where haematopoiesis 
takes place and are generated in mice during early embryogenesis (Kierdorf et al., 2013). These 
cells subsequently invade the CNS and colonize all regions via tangential and radial migration 
(Mosser et al., 2017), where they differentiate into microglia cells in a transforming growth 
factor (TGF)-β-dependent process (Butovsky et al., 2014). Microglia cells (Figure 1) function 
as the resident immune cells of the brain (Allen & Barres, 2009). In humans, depending on the 
studies, they are estimated to provide 5 to 10 % or even up to 15 % of glia cells (Mittelbronn 
et al., 2001; Pelvig et al., 2008). Microglia cells can transform into different states depending 
on the functional need. Ramified microglia cells are present throughout the healthy CNS in a 
resting state, non-phagocytic and phagocytic activated microglia appear in the pathological 
CNS and dystrophic microglia cells are present in the aging brain (Gehrmann et al., 1995; 
Angelova & Brown, 2018). Microglia cells are organised in distinct non-overlapping domains 
(Kreutzberg, 1995) forming a massive network constantly scanning the surrounding neural 
tissue with their thin processes throughout an organisms` lifetime (Lawson et al., 1990). They 
use this scanning mechanism to sense damage, infectious agents and debris from dead cells, as 
well as to conduct housekeeping tasks (Hickman et al., 2018). Their roles in housekeeping 
mechanisms comprise the remodelling of synapses during development and neurodegeneration 
(Zhan et al., 2014; Lui et al., 2016; Vasek et al., 2016), maintaining myelin homeostasis (Healy 
et al., 2016), as well as reacting to lesions and cell death by migrating towards debris and 
phagocytosing it (Fuhrmann et al., 2010). Another important function of microglia cells is the 
protection against damaging events. They do this by mediating defence mechanisms against 
pathogens, detrimental self-proteins and tumours. This is mediated by pathogen sensing 
receptors and the according receptor mediated pathways. Upon activation, neuroinflammatory 
responses are triggered in microglia cells, as well as the upregulation of antigen presenting 
complexes like the major histocompatibility complex (MHC) II to interact with T-lymphocytes 





essential for brain development and function and when disrupted has detrimental effects on the 
CNS (Parpura & Verkhratsky, 2014). 
 
  
Figure 1: Schematic illustration of the main glial cell types in the central nervous system 
Astrocytes (green) are in contact with the brain vasculature via endfeet. Microglia cells (blue), the immune cells 
of the brain, constantly scan their surrounding via small processes in the ramified resting state. Oligodendrocytes 






During the development of the CNS, neurons are generated first in a process called 
neurogenesis which is followed by gliogenesis where macroglia cells are made (Deneen et al., 
2006; Kang et al., 2012). Gliogenesis takes place from late embryonic to even postnatal stages 
(Goldman, 2004). The switch from neurogenesis to gliogenesis occurs at embryonic day 12.5 
in the spinal cord and around embryonic day 16-18 in the cerebral cortex of mice under the 
control of the transcription factors Sox9 and NFIA (Stolt et al., 2003; Deneen et al., 2006; 
Kang et al., 2012). Moreover, other factors like Notch-signalling pathways, histone 
methylation, the methylase Dntm1 and N-CoR, which is a repressor of transcription, play direct 
and indirect roles in the switch to gliogenesis (Molofsky and Deneen, 2015). 
1.2.2 NG2 glia 
NG2 glia cells are a subtype of macroglia cells that are positive for the nerve/glia antigen 
(NG2), which is a chondroitin sulphate proteoglycan. They are present in white and grey matter 
regions of the developing and adult brain (Nishiyama et al., 2009), as well as in neurogenic 
niches like the dentate gyrus and subventricular zone (Aguirre, 2004; Aguirre et al., 2004; 
Passlick et al., 2013). Studies in mice have shown, that during brain development NG2 glia 
cells appear in three different waves originating from different neural precursors. The first 
wave emerges around E11.5 in the ventral forebrain from Nkx2.1 precursors in the medial 
ganglionic eminence (MGE). The second wave has its origin in the lateral and caudal 
ganglionic eminences (LGE; CGE) around E15 and are generated by Gsh2 precursors. The 
NG2 glia cells generated during the first two waves populate the embryonic telencephalon and 
cerebral cortex. The third wave arises postnatally in the cerebral cortex from Emx1 precursors 
(Kessaris et al., 2006). During development and even during adulthood NG2 glia cells generate 
oligodendrocytes and hence make up the greatest population of resident progenitor cells in the 
adult brain (Dimou & Gallo, 2015). They have a highly branched morphology and are capable 
to react to injury by repopulating lesioned areas (Aguirre et al., 2007; Simon et al., 2011; 
Whittaker et al., 2012; Filous et al., 2014; Scafidi et al., 2014). NG2 glia cells are the only glia 
cells that receive direct inhibitory and excitatory input from neuronal synapses. This 
neurotransmitter-mediated signalling might mediate NG2 differentiation into oligodendrocytes 





they have the capacity to give rise to astrocytes or persist self-renewing NG2 glia cells 
dependent on the brain region they reside in and their developmental stage (Zhu et al., 2007; 
Zhu et al., 2008; Simon et al., 2011; Zhu et al., 2011). 
1.2.3 Oligodendrocytes 
Oligodendrocytes (Figure1) are characterized as neuroglia cells, with only few processes 
radiating from their soma (Pérez-Cerdá et al., 2015). They originate from NG2 glia cells that 
differentiate first into premyelinating oligodendrocytes and later become mature myelinating 
oligodendrocytes (Emery, 2010). Oligodendrocytes are only present in the CNS and their 
analogues in the PNS are Schwann cells (Kidd et al., 2013). Oligodendrocytes are smaller than 
astrocytes and lack cytoplasmic glycogen granules and intermediate filaments. Moreover, they 
have a high density in their cytoplasm and nuclei with densely packed chromatin and their 
processes have a high amount of microtubules (Afifi, 1991; Lunn et al., 1997). Myelinating 
oligodendrocytes extend 1 to 40 processes (depending on the CNS region) that contact axons 
of different neurons and enwrap them to form the myelin sheath which is needed for fast action 
potential propagation as well as axon protection and trophic support  (Bunge et al., 1961; 
Bunge et al., 1962; Bunge, 1968; Afifi, 1991; Fünfschilling et al., 2012; Saab et al., 2016). 
Additionally, satellite or also called perineuronal oligodendrocytes exist. Satellite 
oligodendrocytes are primarily non-myelinating cells present predominantly in the grey matter 
(Ludwin, 1979; Takasaki et al., 2010; Szuchet et al., 2011). They are located at the somal base 
close to the axon initial segment which is the action potential initiation site of a neuron (Kole 
& Stuart, 2012; Pérez-Cerdá et al., 2015). These cells are proposed to remyelinate axons after 
injuries (Ludwin, 1979), guard neurons from apoptosis (Taniike et al., 2002) and give them 
metabolic support (Takasaki et al., 2010). Moreover, it has been shown that satellite 
oligodendrocytes are integrated into a glial-syncytium with oligodendrocytes and astrocytes 








Astrocytes were named in 1895 by Michael von Lenhossék after the Greek words astron = star 
and kytos = cavity or cell meaning star like cell (Lenhossék, 1895). Later, Santiago Ramón y 
Cajal introduced the gold and mercury chloride-sublimate staining technique, which 
specifically stains glial fibrillary acidic protein (GFAP) of astrocytes and led him to confirm 
that astrocytes originate from radial glia cells (García-Marín et al., 2007). Already in the late 
19th and early 20th century scientists assumed that astrocytes perform a plethora of different 
functions apart from just being a filler between neurons (Verkhratsky & Nedergaard, 2018). 
Nowadays it is known that astrocytes are a very heterogeneous group of cells with many 
different subtypes and an incredible amount of different functions they exert in the nervous 
system. The following paragraphs will exclusively discuss astrocytes in the mammalian brain. 
1.3.1 Astrocyte definition 
Astrocytes are extremely heterogeneous and as already discussed earlier, not only important in 
the mature brain but also play important roles during the development of the CNS by providing 
migratory pathways for neurons and supporting neuronal growth. They also serve as 
progenitors for neurons and other neural cells and play a critical role in synapse formation and 
development (Ransom et al., 2003). Therefore astrocytes drastically change their functions and 
properties over the course of development (Kimelberg, 2010) and it is hard to find general 
applicable criteria that define an astrocyte. Nevertheless, several criteria have been established 
(Barres, 2003; Ransom et al., 2003; Kimelberg, 2004c, b, a; Barres, 2008; Wang & Bordey, 
2008; Kimelberg, 2009, 2010). Astrocytes are defined as non-excitable cells in the CNS with 
a high amount of potassium (K+) channels in the cell membrane and hence have a resting 
membrane potential (Vr ) close to the equilibrium potential for K
+ (EK). They possess a large 
amount of intermediate filaments which are the origin of the astrocyte specific GFAP protein 
and many of the astrocytic processes are in close contact with synapses and surround them. 
Moreover, astrocytic endfeet contact the vasculature and they bare glycogen granules. They 
are able to take up the neurotransmitters glutamate and gamma-aminobutyric acid (GABA) via 
astrocyte-specific transporters and are highly coupled with other astrocytes by gap-junctions 
made of connexin 43 and 30. All of the criteria mentioned above can individually or in some 





is what identifies a neural cell as an astrocyte (Wang & Bordey, 2008; Kimelberg, 2010; 
Verkhratsky & Nedergaard, 2018). 
1.3.2 Astrocyte origin and development 
Radial glia cells in the embryonic ventricular zone operate as neural progenitor cells that 
produce neurons at earlier stages and when neuronal migration along their radial fibres is 
finished around birth, they morph into protoplasmic astrocytes (Schmechel & Rakic, 1979; 
Voigt, 1989; Malatesta et al., 2000; Noctor et al., 2001; DeAzevedo et al., 2003; Malatesta et 
al., 2003). Radial glia cells in the subventricular zone of the neonatal CNS are generating 
intermediate glial progenitor cells via asymmetric division that migrate into the cortex and 
develop into grey matter astrocytes and oligodendrocytes. Additionally, they have the potential 
to become white matter astrocytes (Levison et al., 1993; Levison & Goldman, 1993, 1997; 
Ganat et al., 2006). NG2 glia cells in the ventral forebrain are also capable of generating 
protoplasmic astrocytes that do not migrate to other brain areas but remain residential in the 
ventral forebrain. This generation of astrocytes starts prenatally around E17.5 most likely from 
the Emx1positive NG2 glia cells mentioned in paragraph 1.2.2 (Kessaris et al., 2006; Zhu et 
al., 2007; Zhu et al., 2011). Another type of neural progenitors which reside in the marginal 
zone of the embryonic and neonatal cortex give rise to astrocytes of cortical layer I-IV as well 
as to neurons and oligodendrocytes. This might explain differences that are present between 
astrocytes of superficial and deeper layers (Costa et al., 2007; Breunig et al., 2012). 
Nevertheless the main source of astrocytes generated in the postnatal brain is through 
symmetric proliferation of mature astrocytes throughout the CNS (Ge et al., 2012). 










1.4 Astrocyte types 
As previously mentioned astrocytes comprise a highly heterogeneous group of glial cells with 
many subpopulations of different morphology and functions (Kimelberg, 2004c). Based on 
morphology, astrocytes are proposed to make up 20 to 40 % glia of the human brain (Pelvig et 
al., 2008). In this paragraph the main astrocyte subpopulations in the various regions of CNS 
are introduced.  
1.4.1 Protoplasmic astrocytes 
Protoplasmic astrocytes (Figure 1) are present in the grey matter of the CNS and have a very 
specific morphology with a small (approximately 10 µm) cell soma with radially extending 
processes that bare a massive amount of fine lamellar arborisations that occupy a more or less 
spheroid volume and make up for a high surface-to-volume ratio of up to 25 µm-1 and a surface 
area of 80.000 µm2 (Bushong et al., 2002; Ogata & Kosaka, 2002; Kimelberg, 2004c, 2010; 
Reichenbach et al., 2010; Verkhratsky & Nedergaard, 2018). They are highly abundant with 
between 10.000 to up to 30.000 cells per mm3 (Bushong et al., 2002; Ogata & Kosaka, 2002; 
Reichenbach et al., 2010). Moreover, they are greatly coupled through gap-junctions with other 
surrounding astrocytes via their smallest arborisations and occupy non-overlapping domains 
that resemble a syncytium like structure (Giaume & McCarthy, 1996; Bushong et al., 2002; 
Houades et al., 2008). In the cortex of rodents, protoplasmic astrocytes are in contact with up 
to 8 neurons and cover a plethora of synapses in addition to surrounding neuronal dendrites 
(Bushong et al., 2002; Halassa et al., 2007). Human astrocytes are the most complex ones in 
the mammalian kingdom. They are 2.55 fold larger in diameter and occupy a greater volume 
than their rodent counterparts. Hence, they are capable of covering way more synapses within 
a single astrocytic domain (Oberheim et al., 2006; 2009). Protoplasmic astrocytes have a 
tremendous heterogeneity in morphological features between and within different nuclei 
(Kimelberg, 2004c, 2010; Verkhratsky & Nedergaard, 2018). In addition to the morphological 
differences, protoplasmic astrocytes have a high amount of heterogeneity regarding 
functionality as well as physiological properties (Kimelberg, 2004c, 2010; Parpura & 






1.4.2 Fibrous astrocytes 
In mammals astrocytes that are present in the white matter tracts, the retinal nerve fibre layer 
and the optic nerve, are named fibrous astrocytes and they differ drastically from grey matter 
astrocytes regarding their morphology (Waxman, 1986; Butt et al., 1994). They have small cell 
somata that lay in rows between axon bundles in the white matter and are characterised by an 
elongated appearance due to their up to 100 µm long protruding processes that span radially 
along myelinated fibres (Lundgaard et al., 2014). Other morphological characteristics of 
fibrous astrocytes are overlapping domains with other astrocytes. They establish perinodal 
processes that contact the nodes of Ranvier and have endfeet associated with the vasculature 
and the pia (Verkhratsky & Nedergaard, 2015). In addition to the morphological differences to 
protoplasmic astrocytes; fibrous astrocytes differ in protein expression patterns as well. The 
hyaluronic acid receptor cluster of differentiation 44 (CD44) as well as the intermediate 
filament proteins vimentin and GFAP are predominantly and highly expressed in fibrous 
astrocytes (Kaaijk et al., 1997; Goursaud et al., 2009) compared to very little amounts being 
present in protoplasmic ones. Therefore, they are thought to play an important role for 
structural integrity among myelinated axon bundles. In contrast to protoplasmic astrocytes, 
where gap-junctional coupling is happening on average between 94 astrocytes, in fibrous 
astrocytes the degree of gap junctional coupling varies immensely between different brain 
regions from no to a few coupled astrocytes in the corpus callosum to up to 91 % of fibrous 
astrocytes forming a network in the optic nerve (Lee et al., 1994; Haas et al., 2006).  
1.4.3 Müller glia  
Müller glia cells, which were discovered and named by Heinrich Müller in 1851 are retinal 
cells that combine the characteristics of radial glia cells and protoplasmic astrocytes (Müller, 
1851; Reichenbach & Bringmann, 2017). Their cell somata lie in the inner nuclear layer of the 
retina and they extend main processes that bare microvilli to the subretinal space and main 
processes that contain multivesicular bodies that project to the vitreal space. Smaller processes 
that emanate from the sides of the cell enwrap and contact neurons but also form endfeet that 
associate with blood vessels (Bringmann et al., 2006; Reichenbach & Bringmann, 2017). In 





Müller glia cells - due to their elongated shape - have a higher refractive index and are therefore 
able to provide a low scattering passage for light through the retina (Franze et al., 2007).  
1.4.4 Bergmann glia 
Bergmann glia cells support young granule cell migration from the external granular layer of 
the cerebellum comparable to radial glia cells in cortical development (Rakic, 1971; Gregory 
et al., 1988; Hatten, 1990; Hartmann et al., 1998). They have small somata located in the 
Purkinje cell layer of the cerebellum and extend radially aligned processes that span the 
molecular layer of most vertebrates, also known as Bergmann fibres (Grosche et al., 2002). 
Around 8 Bergmann glia cells surround one Purkinje neuron. They are responsible for proper 
functioning and the survival of neurons by exerting homeostatic functions as well as glutamate 
uptake (Chaudhry et al., 1995; Müller & Kettenmann, 1995; Reichenbach et al., 1995; Ruiz & 
Ortega, 1995; Cui et al., 2001; Grosche et al., 2002). The 3 to 6 Bergmann fibres that emanate 
from a Bergmann glia cell branch of complex side processes with a high surface-to-volume 
ratio which allow them to contact and ensheathe up to 8000 synapses (Grosche et al., 1999). 
1.4.5 Radial glia 
In mammals, radial glia cells are the glia of the developing brain. Their cell somata are located 
in the ventricular zone of the embryonic neural tube. They have a bipolar morphology with one 
process extending to the basal surface under the meninges and one reaching the apical surface, 
where they are in contact with the lumen of the ventricle (Cameron & Rakic, 1991; Bentivoglio 
& Mazzarello, 1999). They are connected among each other by adherent junctions (Shoukimas 
& Hinds, 1978; Møllgård et al., 1987; Aaku-Saraste et al., 1996). Moreover, radial glia cells 
bear glycogen granules, as also seen in adult astrocytes (Götz et al., 2002). Radial glia cells 
start developing from neuroepithelial cells depending on the basic helix-loop-helix Hes 
transcription factor at the embryonic stage E9.5 (Hatakeyama, 2004). Radial glia cells occupy 
a lot of different functions. On the one hand they support the migratory process of postmitotic 
neurons from the ventricular zone to their positions in basal parts of the neural tube (Rakic, 
1988) by working as a scaffold for neurons to move along. On the other hand they make up the 
majority of precursor cells in the developing brain and start to divide during the neurogenic 





(Malatesta et al., 2000; Hartfuss et al., 2001; Noctor et al., 2002; Malatesta et al., 2003). The 
generation of astrocytes by radial glia cells has already been shown by Voigt (1989), who used 
DiI tracer labelling of radial glia cell endfeet at the pial surface in the ferret cortex. This way 
he was able to follow labelled radial glia cells throughout development and shows that they 
become astrocytes later on (Voigt, 1989). Moreover it has been shown that radial glia cells also 
generate multiciliated ependymal cells which are present in the wall of the lateral ventricle 
(Spassky, 2005). 
1.4.6 Other astrocyte types 
Many other types of astrocytes can be found in the CNS. There is the subpopulation of surface-
associated astrocytes that form the glia limitans in the posterior piriform cortex (Feig & 
Haberly, 2011). Tanycytes, which are bipolar astrocytes, form a bridge between the ventricular 
wall and the portal capillaries. They play a key role in brain-endocrine interactions (Rodríguez 
et al., 2005). Velate astrocytes are present in the granular layer of the cerebellum and in the 
olfactory bulb where small neurons are packed very densely (Chan-Palay & Palay, 1972; 
Valverde & Lopez‐Mascaraque, 1991). Pituicytes in the neurohypophysis actively engage in 
controlling the ionic microenvironment (Hatton, 1999). Marginal and perivascular astrocytes 
form several layers of endfeet plates with blood vessels that are located close to the pia mater 
and therefore form the pial and perivascular glia limitans barrier (Liu et al., 2013). Moreover 
ependymocytes, choroid plexus cells and retinal pigment epithelial cells exist that line the 
ventricles and subretinal space. They are responsible for the production of the cerebrospinal 
fluid as well as its flow (Reichenbach & Bringmann, 2017). In the primate and human brain 
astrocyte types can be found that do not exist in other animals. First off, human protoplasmic 
astrocytes have much more complex arborisations and therefore occupy significantly larger 
domains than in rodents (Oberheim et al., 2006; Oberheim et al., 2009) . In primates, polarized 
astrocytes exist that have their cell somata located close to the corpus callosum and extend 
long processes into superficial cortical layers (Oberheim et al., 2009). Vice versa interlaminar 
astrocytes exist in old world monkeys, apes and humans that have a small cell soma located in 
cortical layer I that project up to two very long process into cortical layer IV and several smaller 
processes into cortical layer II to IV (Oberheim et al., 2009). Being an exclusive feature in 





project long unbranched processes in all directions through the deeper cortical layers that bare 
























1.5 Astrocyte functions in the healthy brain  
During the development of the nervous system astrocytes already play important roles in 
synaptogenesis by providing regulatory factors and structural components in the perinatal brain 
(Eroglu & Barres, 2010; Pfrieger, 2010; Clarke & Barres, 2013; Verkhratsky & Nedergaard, 
2018). In the adult brain specialised astrocytes exist in neurogenic niches that function as adult 
stem cells capable of neurogenesis (Ihrie & Alvarez-Buylla, 2008; Kriegstein & Alvarez-
Buylla, 2009). 
During late embryogenesis protoplasmic astrocytes start to divide the grey matter into non-
overlapping parcels in a process called tiling. This generates micro-anatomical domains that 
are restricted by the reach of the astrocytic processes. The processes are in contact with 
multiple neurons and their respective synapses and connect them to the vasculature in said 
domain hence creating the so called neurovascular unit (Iadecola & Nedergaard, 2007). These 
astrocyte domains are connected with each other via gap-junctional coupling forming astroglial 
syncytia that are segregated themselves within anatomical structures like for example the 
barrels of the somatosensory cortex (Houades et al., 2008).  
1.5.1 Homeostatic functions 
When neurons are active, depolarisation leads to an accumulation of K+ ions in the surrounding 
extracellular space. If K+ is not removed it would have detrimental effects like continuous 
neuronal depolarisation, hyperexcitability and seizures (Wang & Bordey, 2008). Astrocytes 
are capable of taking up the excess K+ from the extracellular space via inwardly rectifying 
potassium channels (Kir), as well as Na
+/K+ and K+/Cl- transporters and distribute it through 
the gap-junctional syncytium where it is subsequently released at sites with lower extracellular 
K+ concentration (Ballanyi et al., 1987; Karwoski et al., 1989). This mechanism is called K+ 
spatial buffering (Figure 2c) (Kuffler & Nicholls, 1966). In addition to K+ spatial buffering 
astrocytes also execute homeostatic functions by regulating the extracellular chloride (Cl-) 
concentrations (Kettenmann et al., 1987; Egawa et al., 2013), calcium (Ca2+) concentrations 
(Zanotti & Charles, 1997) as well as the pH by hydrogen (H+) removal from and hydrogen 
carbonate (HCO3
-) release into the extracellular space (Rose & Ransom, 1996; Deitmer & 





brain (Winkler et al., 1994; Desagher et al., 1996; Dringen et al., 1999; Rice, 2000). They 
regulate the volume of and the water flow in the extracellular space via aquaporin 4 channels 
(Amiry-Moghaddam & Ottersen, 2003; Yao et al., 2008; Haj-Yasein et al., 2011; Nagelhus & 
Ottersen, 2013). Astrocytes are also performing transmitter homeostasis (Figure 2a) to prevent 
excitotoxicity (Verkhratsky & Nedergaard, 2018). They take up glutamate from the synaptic 
cleft via the excitatory amino acid transporters (EAAT1/2) glutamate aspartate transporter 
(GLAST) and glutamate transporter 1 (GLT-1) (Danbolt, 2001; Hertz & Zielke, 2004; Hertz 
et al., 2007). The glutamate that has been cleared by astrocytes from the synaptic cleft is 
enzymatically broken down to glutamine via glutamine-synthetase (GS) and then released to 
be subsequently taken up by neurons that transform it back to glutamate and GABA 
(Westergaard et al., 1995; Sonnewald et al., 1998). In addition, astrocytes express equilibrating 
and concentrating transporters that allow them to accumulate adenosine internally where it is 
phosphorylated by the adenosine kinase (ADK) (Boison, 2008). Moreover, astrocytes have 
high affinity GABA transporters (GABA transporter 1 and 3 (GAT-1 and GAT-3) located in 
the cellular membrane close to the synaptic cleft and take up GABA, likely to control 
transmitter spillover. The internalised GABA can subsequently be released through GAT 
transporters depending on internal sodium (Na+) concentration and depolarization of the cell 
(Gallo et al., 1991; Yee et al., 1998; Barakat & Bordey, 2002). 
1.5.2 The tripartite synapse 
Astrocytes enwrap synapses in the brain to different extent depending on the brain region, with 
up to 90 % of synapses in layer IV of the somatosensory cortex being ensheathed by astrocytic 
processes (Bernardinelli et al., 2014). Together with the endterminal of the presynaptic neuron 
and the postsynaptic neuron astrocytes form the so called tripartite synapse (Figure 2b) (Allen 
& Barres, 2009). Glutamate (Glu) that is released from the presynaptic neuron binds to 
astrocytic metabotropic glutamate receptors (mGluR) which results in intracellular Ca2+ 
elevation. Ca2+ subsequently triggers vesicular release of neuromodulators and 
neurotransmitters from the astrocyte. These neuromodulators and neurotransmitters interact 
with presynaptic and postsynaptic receptors of neurons which results in the modification of 






Figure 2: Astrocyte functions in the healthy brain 
A: Astrocytes perform transmitter homeostasis.They take up glutamate (Glu) from the synaptic cleft via glutamate 
transporters GLAST and GLT-1. Glutamate is then broken down enzymatically via glutamine-synthetase (GS) 
into glutamine (Gln) which is released and subsequently taken up by neurons. B: Astrocytes enwrap synapses in 
the brain and together with the endterminal of the presynaptic neuron and the postsynaptic neuron they form the 
so called tripartite synapse. Glutamate (Glu) that is released from the presynaptic neuron binds to astrocytic 
metabotropic glutamate receptors (mGluR). Subsequently vesicular release of neuromodulators and 
neurotransmitters from the astrocyte is triggered to interact with presynaptic and postsynaptic receptors of 
neurons. C: Astrocytes perform K+ spatial buffering by taking up excess K+ from the extracellular space vir Kir 
(lilac), as well as Na+/K+ and K+/Cl- transporters (red). Subsequently they distribute it via gap-junctions (long 






synapses (Verkhratsky et al., 2012; Parpura & Verkhratsky, 2014; Verkhratsky & Nedergaard, 
2018). They are able to release neuromodulators and neurotransmitters (e.g. Glutamate, 
GABA, adenosine triphosphate (ATP)) through several different mechanisms in a more 
spatially diffuse and much slower manner than neurons do hence modifying and regulating 
neuronal networks, mechanism and activity (Verkhratsky et al., 2012; Parpura & Verkhratsky, 
2014). Furthermore, astrocytes play a role in synaptic pruning, the maintenance of synapses, 
regulation of synaptic plasticity as well as the integration of synaptic fields (Nedergaard & 
Verkhratsky, 2012; Schafer & Stevens, 2013). Thus, they are key players in higher brain 
functions like memory and learning, sleep, circadian rhythm and they are part of the glymphatic 
system that clears the brain from waste and toxins (Verkhratsky & Nedergaard, 2018). 
1.5.3 Maintenance of the blood-brain barrier 
Astrocytes play important roles in the formation, as well as the maintenance of the BBB (Figure 
3). Their endfeet are in contact with the vasculature of the CNS and form the parenchymal part 
of the BBB (Abbott et al., 2010). They also regulate the tight-junctions that are formed between 
blood vessel endothelial cells (Abbott et al., 2006). Astrocytes release vasodilators and 
vasoconstrictors and therefore actively regulate blood flow (MacVicar & Newman, 2015). Due 
to their association with the brain vasculature astrocytes locally provide metabolic support to 
neurons (Figure 3). According to the astrocyte neuron lactate shuttle hypothesis they take up 
glucose from the blood stream and convert it into lactate, which is subsequently released from 
the astrocytes and taken up by neurons and fed into their tricarboxylic acid (TCA) cycle 
(Pellerin & Magistretti, 1994, 2012). In addition, studies in rats have shown that astrocytes are 
able to take up lactate from the extracellular space (Genda et al., 2011). Another way of 
metabolic support for neurons is the storage of glycogen by astrocytic glycogen granules. The 










Figure 3: Astrocytes provide metabolic support for neurons 
Astrocytes take up glucose from the blood stream. The glucose subsequently is converted during the glycolysis 
into pyruvate. Pyruvate is converted into lactate by the lactate dehydrogenase. Lactate is then transported from 
the astrocytes via the monocarboxylate transporter (MCT) to neurons. The glucose that is taken up by astrocytes 
can also be converted into glycogen and is stored in astrocytic glycogen granules. During phases of high neuronal 






1.6 Astrocytes in the injured brain: Reactive astrogliosis 
One major function of astrocytes is, that they are capable to react to neurological disorders, 
brain disease and injury with a multistage and graded process called reactive astrogliosis, 
which is still not fully understood (Pekny & Pekna, 2014). 
Together with microglia cells astrocytes are important for the tissue response triggered by non-
physiological and pathological changes in the brain environment (Pekny & Nilsson, 2005; 
Sofroniew, 2009; Buffo et al., 2010; Sofroniew & Vinters, 2010; Pekny & Pekna, 2014, 2016; 
Pekny et al., 2016; Pekny et al., 2018). So what exactly is reactive astrogliosis and what 
changes do astrocytes undergo after they become reactive? What triggers their activation and 
what are the effects, positive as well as negative, of this reactivity?  
1.6.1 Astrocyte reactivity and reactive astrogliosis 
Reactive astrogliosis in mammals is a multistep process, which is still not completely 
understood but the following definition has been proposed by Michael V. Sofroniew (2009): 
First, reactive astrogliosis can be considered as a series of functional and cellular changes in 
response to different intensities and forms of pathological events and insults to the CNS tissue. 
Second, the extent of these changes depends on the severity of the initiating events. Third, the 
changes undergone by reactive astrocytes are highly regulated by signalling molecules and 
fourth, these changes are accompanied either by loss or gain of functions that have either 
positive or negative effects on the surrounding tissue and cells (Sofroniew, 2009; Sofroniew 
& Vinters, 2010). It is important to keep in mind, that the reactive astrogliosis is a highly 
complex and graded process that proceeds continuously with different stages that blend into 
each other (Sofroniew & Vinters, 2010). First of all, mild to moderate reactive astrogliosis 
happens in response to either diffuse innate immune activation caused by bacterial or viral 
infection, mild trauma or in regions more distant to a bigger lesion. In these cases astrogliosis 
can be reversed after the underlying cause disappeared because no reorganization of tissue 
architecture takes place (Sofroniew & Vinters, 2010). In response to severe lesions, 
neurodegenerative stimuli and more serious infections, severe and diffuse astrogliosis kicks in 
accompanied by the loss of astrocytic domains and astrocyte proliferation. Lastly, severe 





contusive trauma, invasive infections or even abscesses, stroke, chronic neurodegeneration and 
tumours (Sofroniew & Vinters, 2010). Glial scar formation (Figure 4) is a process that also 
involves other neural cells apart from reactive astrocytes (Bundesen et al., 2003; Herrmann et 
al., 2008) where extracellular matrix collagens get deposited to form a molecular clue 
containing scar that inhibits cell migration as well as axonal growth (Silver & Miller, 2004). 
This is accompanied by pronounced and long lasting tissue reorganisation (Sofroniew & 
Vinters, 2010).  
Reactive astrocytes can be triggered by many different molecular mediators excreted by other 
astrocytes and a variety of other cell types including leukocytes, oligodendrocytes, microglial 
cells, endothelial cells and also neurons (Sofroniew, 2009). Amongst these molecular triggers 
are different cytokines and growth factors (John et al., 2003; Di Giorgio et al., 2007), bacterial 
lipopolysaccharides (LPS) and toll-like receptor (TLR) ligands that are part of the innate 
immune response (Farina et al., 2007), molecules that get released by injured cells like ATP 
(Neary et al., 2003), ROS as well as glucose deprivation and hypoxia (Swanson et al., 2004), 
neurotransmitters and neuromodulators (Bekar et al., 2008), NH4
+, which is a product of 
systemic metabolic toxicity (Norenberg et al., 2009), and also by factors that are associated 
with neurodegenerative diseases (Simpson et al., 2010). The mechanisms underlying the 
activation are equally diverse (for more information see (Sofroniew, 2009)). It has been shown 
in mouse models, that candidate pathways mediating astrocyte activation are the STAT3 
pathway (Sriram et al., 2004), the deactivation of β1-integrin in astrocytes (Robel et al., 2009) 
as well as Ca2+-dependent N-cadherin upregulation (Kanemaru et al., 2013). Moreover in rats, 
the activation of the epidermal growth factor receptor (EGFR) is important for the transition 
from non-reactive to reactive astrocytes (Planas et al., 1998; Erschbamer et al., 2007). 
Traumatic brain injury (TBI), which can be caused by many different stimuli like brain 
contusion and penetrating injuries, has different levels of severity (Graham et al., 2000) and is 
a special form of brain insult where mechanical forces are involved (Burda et al., 2016). In 
addition to the previously mentioned activation stimuli, in TBI astrocytes are also activated by 
the mechanical forces that result in tissue distortion and perforation and subsequently in strain. 
In rat cultures, this activates mechanotransducing and stretch-activated ion channels in the 





allows rapid influx of extracellular Ca2+ and Na+ (Rzigalinski et al., 1997; Rzigalinski et al., 
1998; Floyd et al., 2005). 
There are different morphological and molecular features which define an astrocyte as a 
reactive one. First and foremost, they upregulate their expression of GFAP enormously. Even 
astrocytes in the cerebral cortex that do show only minimal or no GFAP positivity in the 
healthy brain upregulate this main element of intermediate filaments upon activation (Eng et 
al., 2000). One more characteristic of reactive astrocytes is the swelling of the cell soma and 
processes, an event called hypertrophy. In mild astrogliosis this happens within their distinct 
domains. Extension, overlap as well as disruption of different astrocytic domains occur in 
severe astrogliosis (Wilhelmsson et al., 2006; Sofroniew, 2009; Sofroniew & Vinters, 2010). 
Moreover, astrocytic process can be seen to polarize towards an injury site depending on the 
Rho guanosine triphosphate hydrolase enzyme (GTPase) cell division control protein 42 
(Cdc42) of rodents in-vivo and in-vitro (Höltje et al., 2005; Etienne-Manneville, 2006; Robel 
et al., 2011a; Bardehle et al., 2013). In addition, Cdc42-dependent migration of astrocyte 
towards the site of injury has been shown in scratch wound assays in-vitro (Etienne-










Figure 4: Reactive astrogliosis after traumatic brain injury 
Glial scar formation is a process that also involves various neural cells where extracellular matrix collagens get 
deposited to form a molecular clue containing scar that inhibits cell migration as well as axonal growth. Astrocytes 
surrounding the lesion in a radius of 300µm upregulate GFAP and become reactive (dark green). Most of the 
reactive astrocytes also become hypertrophic and a subset of them polarizes towards the lesion site. A fraction of 
astrocytes surrounding the lesion start to proliferate. Proliferating astrocytes (dark green; pink nucleus) generate 
two closely associated daughter cells. Proliferation is mainly happening juxtavascular astrocytes. Also activated 
microglia cells (blue) are present at the lesion site in excessive amounts. Also monocytes (white) can be found 





1.6.2 Astrocyte proliferation after injury in-vivo 
As previously mentioned, one key component of astrogliosis is that a proportion of astrocytes 
proliferate (Figure 4) in response to invasive and traumatic brain injury like stab wounds or 
stroke which causes an increase in astrocyte numbers surrounding a lesion (Sofroniew, 2009; 
Buffo et al., 2010; Robel et al., 2011b). Isolation and subsequent in-vitro culturing of rodent 
astrocytes showed that a subset of these cells form neurospheres containing self-renewing and 
multipotent cells with neural stem cell potential (Lang et al., 2004; Buffo et al., 2008). A study 
in mice has shown, that the stem cell response pattern of astrocytes is triggered by sonic 
hedgehog (shh) from the plasma and cerebrospinal fluid (Sirko et al., 2013).  
Because astrocyte migration and proliferation towards and surrounding an injury site has not 
been investigated in-vivo until then, Bardehle et al. in 2013 , used in-vivo 2pLSM (2 photon 
laser scanning microscope) live imaging techniques to observe the response behaviour of 
astrocytes to a traumatic brain injury in the mouse cortex (Bardehle et al., 2013). They found, 
that reactive astrocytes show great functional heterogeneity in their response patterns to a stab 
wound lesion, which can be interpreted as some kind of differentiation of labour. Via in-vivo 
monitoring they analysed the behaviour of the exact same astrocytes over the course of weeks. 
In response to a stab wound lesion, astrocytes surrounding the lesion in a radius of 300 µm 
upregulated GFAP and therefore became activated. Around 86 % of these reactive astrocytes 
were becoming hypertrophic. Polarization of astrocytic processes towards the lesion with a 
positive correlation between the amounts of polarization to the size of the lesion occurred in 
45 % of astrocytes between 3 to 5 days post injury (dpi). This polarization of astrocytic 
processes is also seen in the epileptic mouse brain (Oberheim et al., 2008). Most important 
Bardehle et al. (2013) could show, that in stark contrast to what can be observed in in-vitro 
scratch wound assays in rodents, where astrocytes are moving towards the wound (Höltje et 
al., 2005; Etienne-Manneville, 2006; Robel et al., 2011a) that this is not the case in-vivo 
(Bardehle et al., 2013). In the cerebral cortex of mice astrocytes remain stationary even up to 
weeks after TBI (Bardehle et al., 2013). A very crucial observation they made, was that 14 % 
of astrocytes surrounding the lesion started to proliferate within the first 7 days post injury. 
Therefore, they concluded that the 20 % increase in astrocyte numbers surrounding a lesion in 





Proliferating astrocytes in the cortex generate two closely associated daughter cells and it is 
important to note that proliferation is mainly happening in astrocytes that have their cell soma 
directly adjacent to blood vessels in the brain parenchyma proper. This subset of cells is 
therefore called juxtavascular astrocytes (Bardehle et al., 2013). This lead to the conclusion, 
that the small subset of reactive astrocytes that undergo cell division after a traumatic brain 
injury, the so called juxtavascular astrocytes are especially important because they are the only 
source to increase astrocyte numbers in the grey matter of the somatosensory cortex in mice 
(Bardehle et al., 2013). In addition, selective ablation experiments, performed in the same 
study, suggested that this class of proliferating juxtavascular astrocytes plays a role in limiting 
leucocyte invasion into the injured brain (Bardehle et al., 2013). It has also been shown that 
astrocyte proliferation is common in response to a variety of pathological brain events in 
humans and especially to abscesses and demyelinating lesions like multiple sclerosis. 
However, a much smaller portion of astrocytes proliferate compared to their rodent 








1.7 Positive and negative effects of astrogliosis 
Reactive astrocytes perform various functions in response to CNS insults which will be 
discussed in the following paragraph. For long it has been assumed that due to the inhibition 
of neuronal regeneration beyond the glia scar, reactive astrocytes only play detrimental roles 
after brain insults and even that inhibition of reactive astrogliosis would be a valuable 
therapeutic strategy (Ramon y Cajal, 1928). Indeed, the inhibition of neuronal regeneration, 
especially if not resolved during the acute injury phase, can lead to negative effects (Rolls et 
al., 2009). Moreover in rat astrocyte cultures have shown, that astrocytic pattern recognition 
receptor induced NFκB (nuclear factor kappa-light-chain-enhancer of activated B cells) 
signalling leads to the swelling of cells and subsequently to cytotoxic oedema that are 
responsible for detrimental brain swelling after traumatic insults (Jayakumar et al., 2014). In 
the traumatically injured CNS of rodents proteins that constitute the perineuronal net, the 
chondroitin sulphate proteoglycans (CSPGs) aggrecan, versican and neurocan become 
upregulated in reactive astrocytes directly surrounding the lesion core which might impact 
synapse regeneration and neuronal sprouting in a negative way by thickening of the 
perineuronal net (Busch & Silver, 2007; Harris et al., 2009; Harris et al., 2010; Yi et al., 2012). 
Moreover, reactive astrocytes might be involved in the generation of seizures (Jansen et al., 
2005; Tian et al., 2005), the production of excessive amounts of neurotoxic ROS (Swanson et 
al., 2004; Hamby et al., 2006) and trigger an intense inflammatory reaction by producing 
cytokines (Brambilla et al., 2005; Brambilla et al., 2009).  
Nevertheless, other scientific research elucidates that reactive astrogliosis has a variety of 
positive effects on the injured brain (Sofroniew, 2009). Amongst these beneficial effects is the 
regulation and repair of the BBB, the separation of the damaged tissue to protect healthy 
surrounding tissue, the regeneration of neuronal circuits and synapse remodelling as well as 
controlling inflammatory processes (Burda et al., 2016), which will be discussed in detail in 








1.7.1 Support and reorganization of the blood-brain barrier 
It is known that newly proliferated astrocytes are crucial for the repair of the BBB in mice 
(Bush et al., 1999). They do so by releasing molecules like sonic hedgehog (shh) and retinoic 
acid that act on endothelial cells of the BBB to reduce its permeability and induce its repair 
(Alvarez et al., 2011; Alvarez et al., 2013; Mizee et al., 2014). Moreover, in early stages of 
reactive gliosis the ATP release from astrocytes and subsequent activation of microglia cells 
play a role in maintaining the BBB (Roth et al., 2014). Reactive astrocytes release vasoactive 
endothelial growth factor (VEGF) and apolipoprotein E (APOE) which leads to an increase in 
the permeability of the BBB boosting pro-inflammatory mechanisms and leucocyte infiltration 
in mice (Argaw et al., 2009; Argaw et al., 2012; Bell et al., 2012). Reactive astrocytes alter the 
expression pattern of aquaporin 4 (AQP4) channels on processes that are in contact with 
endothelial cells, which influences fluid homeostasis (Papadopoulos & Verkman, 2013). 
Moreover, reactive astrocytes release danger-associated molecular pattern (DAMP) molecules 
like the high-mobility group box 1 (HMGB1) that act on endothelial cells and promote the 
repair and remodelling of the BBB and vasculature in the lesioned brain of rodents (Hayakawa 
et al., 2012; Hayakawa et al., 2013). 
1.7.2 Synapse and circuit remodelling  
Reactive astrocytes regulate injury-induced remodelling of synapses by polarizing their 
processes towards traumatized neurons, which is beneficial for survival and promotes synapse 
recovery depending on STAT3 mediated thrombospondin-1 signalling in mice (Tyzack et al., 
2014). Thrombospondin-1/2 becomes upregulated in murine astrocytes after stroke and 
promotes axonal sprouting (Liauw et al., 2008). After traumatic brain injury reactive astrocytes 
respond to a decrease in excitatory input from neighbouring neurons by releasing the cytokine 
tumour necrosis factor (TNF) α, which subsequently induces excitatory synaptic scaling in said 
neurons by increasing AMPA receptor density in synapses of rodents (Turrigiano et al., 1998; 
Beattie et al., 2002; Stellwagen & Malenka, 2006; Turrigiano, 2006). In addition, a study in an 
entorhinal denervation in-vitro model has shown that astrocytic TNFα release after injury leads 
to an increase in excitatory synaptic strength, which might be important to preserve neuronal 
excitability while the disturbed neuronal networks reorganize (Becker et al., 2015). Another 





production of extracellular matrix molecules that form and modify the perineuronal net that is 
important for synapse stabilization (Wang & Fawcett, 2012). As previously mentioned, 
proteins that constitute the perineuronal net become upregulated after CNS insults (Busch & 
Silver, 2007; Burda et al., 2016). Conflicting data exists which shows that the upregulation of 
the extracellular matrix protein neurocan that is highly expressed by reactive astrocytes, 
inhibits axon development in-vitro (Friedlander et al., 1994) but is present in regions of 
excessive axonal sprouting in-vivo after TBI in the entorhinal cortex of rats (Haas et al., 1999). 
The same is true regarding tenascin-C, which inhibits axon outgrowth of olfactory sensory 
neurons of mice in-vitro but is present in regions with pronounced axonal sprouting after brain 
damage in the rat dentate gyrus (Deller et al., 1997; Treloar et al., 2009). This might be 
explained by the expression of α9 integrin in sprouting neurons after TBI, which is capable of 
increasing neurite outgrowth on tenascin-C rich substrates in cultures of rat dorsal root 
ganglion neurons (Andrews et al., 2009). In rats, the CSPGs aggrecan, versican and neurocan 
are upregulated in reactive astrocytes surrounding a lesion and are downregulated further away 
(Harris et al., 2009). This suggests a spatiotemporal regulation of these CPSGs; on the one 
hand to prevent the formation of unwanted synaptic connections with deleterious targets and 
on the other hand to promote axonal outgrowth towards constructive ones. This is influencing 
post-traumatic remodelling of neuronal circuits (Burda et al., 2016). 
1.7.3 Control of inflammation 
After focal tissue damage or extent inflammation, reactive astrocytes are able to segregate the 
injured tissue from healthy adjacent neural tissue by forming scars comprised of newly 
proliferated astrocytes that limit spreading of inflammation and mediate wound repair 
(Sofroniew & Vinters, 2010; Wanner et al., 2013; Burda & Sofroniew, 2014; Sofroniew, 2014). 
After traumatic brain injury in mice dying cells in the damaged region release ATP (Kim & 
Dustin, 2006). This ATP-release triggers Ca2+ waves in astrocytes that subsequently triggers 
astrocytes to release ATP themselves through connexin-hemichannels. Extracellular ATP 
signalling in rodents was shown to be crucial for the rapid recruitment of microglial cells and 
neutrophils as well as inducing astrocyte reactivity in-vitro and in-vivo (Guthrie et al., 1999; 
Verderio & Matteoli, 2001; Davalos et al., 2005; Huang et al., 2012; Roth et al., 2014). 





is crucial for the survival of meningeal and parenchymal cells (Roth et al., 2014). Reactive 
astrocytes are also capable of releasing and reacting to inflammatory molecules like danger-
associated molecular patterns (DAMP) and alarmins as well as immunomodulatory molecules 
like chemokines and cytokines. These signalling molecules limit and decrease the 
inflammatory response and encourage clearance of cytotoxic debris (Pedrazzi et al., 2010; 
Burda & Sofroniew, 2014). In addition, it has been shown in mouse astrocytes cultures that 
they also express TLRs and receptor for advanced glycation end products (RAGE) that are 
typically present in cells with immune functions like macrophages and microglia (Ponath et 
al., 2007; Gorina et al., 2011). It has been shown in rat glia cell cultures, that the activation of 
astrocytic RAGE by amyloid-beta results in astrocytes taking over phagocytic functions (Jones 
et al., 2013). The activation of astrocytic pattern recognition receptors by bacterial LPS leads 
to the expression of immunomodulatory and proinflammatory molecules, which is believed to 
increase pro-inflammatory signalling pathways resulting in recruitment of immune cells into 
the CNS (Lenz et al., 2007; Hoarau et al., 2011; Hamby et al., 2012). Experiments with cultured 
rat astrocytes have shown, that opposed to the deleterious effects that astrocytic pattern 
recognition receptor induced NFκB signalling can have after TBI, it can also be beneficial by 
resulting in the release of glio- and neuroprotective growth factors (Zaheer et al., 2001; 
Jayakumar et al., 2014). 
Other beneficial functions of reactive astrocytes are the protection of neurons from ammonia 
toxicity being present in hepatic encephalopathy, Reye’s syndrome, urea cycle disorders and 
other neurological conditions (Rao et al., 2005). In rodents reactive astrocytes produce 
glutathione to protect the tissue from oxidative stress (Chen et al., 2001; Shih et al., 2003; 
Swanson et al., 2004; Vargas et al., 2008), take up excess glutamate, which could otherwise be 
excitotoxic (Rothstein et al., 1996; Bush et al., 1999; Swanson et al., 2004) and they release 
ATP which leads to an accumulation of its catabolic neuroprotective product adenosine in the 







1.8 Underlying cause of astrocyte proliferation  
It has been shown via clonal Star Track analysis in mice that the heterogeneous reaction of 
reactive astrocytes is related to their developmental origin (Martín-López et al., 2013). As 
previously mentioned, astrocyte proliferation mainly occurs in lesions that affect the BBB, 
which led to the identification of several factors that are involved in the regulatory processes 
leading to proliferation like shh, endothelin-1, and fibroblast growth factor (FGF) signalling in 
rodents in-vivo and in–vitro as well as in human tissue (Gadea et al., 2008; Kamphuis et al., 
2012; Zamanian et al., 2012; Behrendt et al., 2013; Götz & Sirko, 2013; Sirko et al., 2013; 
Dimou & Götz, 2014; Kang et al., 2014). Genome wide expression pattern analysis of murine 
grey matter proliferative reactive astrocytes shows that this subset of astrocytes upregulates 
the expression of genes comparable to neural stem cells extracted from the subependymal zone 
(Sirko et al., 2015). Amongst these are the two lectins galectin 1 and galectin 3 that are known 
to be highly expressed in neural stem cells as well as reactive astrocytes of rodents and 
upregulated after smaller injuries and in cancer (Camby et al., 2006; Sakaguchi et al., 2006; 
Kajitani et al., 2009; Yan et al., 2009; Beckervordersandforth et al., 2010; Le Mercier et al., 
2010; Di Lella et al., 2011; Newlaczyl & Yu, 2011; Qu et al., 2011; Zamanian et al., 2012; 
Young et al., 2014; Sirko et al., 2015). Sirko et al. (2015) showed that these two lectins are 
expressed in a small subset of reactive astrocytes (25 %) after traumatic brain injury in the grey 
matter of mice with galectin 3 specifically labelling proliferating ones. These findings were 
further supported by experiments performed in Lgals1-/- (Lectin, Galactoside-Binding, Soluble, 
1) and Lgals3-/- (Lectin, Galactoside-Binding, Soluble, 3) mice where they could show that 
reactive astrocyte proliferation, neurosphere formation and GFAP positivity was reduced in 
response to an insult (Sirko et al., 2015). All of the above could be fully rescued by 
supplementing galectin 3 in-vitro, indicating galectin 3 as a key player in promoting astrocyte 
proliferation after an injury (Sirko et al., 2015). Another factor that might influence the 
proliferation of juxtavascular astrocytes is a cross-regulation happening between astrocytes 
and invading monocytes. After a stab wound injury in mice that lack monocyte invasion, 
increased proliferation of astrocytes was observed (Frik et al., 2018). In addition, a reduced 
glial scar with less extracellular matrix deposition can be observed, which also led to higher 





amount of proliferating astrocytes, less GFAP positive cells were observed at the lesion site 
(Frik et al., 2018). 
1.9 Ion channels in cell cycle progression  
Cell division is a process by which the DNA (deoxyribonucleic acid) has to be distributed 
between two daughter cells. In order to do so, the cell has to pass through the cell cycle that 
consists of a long interphase followed by a mitosis (M)-phase that comprises the mitosis itself, 
in which the replicated genome is separated into two new nuclei and the cytokinesis where the 
cytoplasm is duplicated. The interphase consists of the gap (G) 1-phase, during which the cell 
grows and prepares for the cell division. This is followed by the synthesis (S)-phase where 
DNA is synthesized and chromosomes are replicated. Finally, the G2-phase is reached in which 
the cell continues to grow and synthesizes proteins to form new organelles before it 
subsequently enters into the mitotic cell division phase (M-phase). After the M-phase, each 
daughter cell can either re-enter into the G1-phase of a new cell cycle or into a quiescent G0-
state that for some cells lasts for the rest of their life, the so called end-differentiated ones 
(Campbell & Reece, 2008). To guarantee smooth proceeding of the cell cycle and prevent 
genetic inaccuracies from being propagated certain cell cycle checkpoints have to be hit 
throughout the proliferation process. Most importantly, a sensor to supervise that a task has 
been completed properly is needed before downstream events are initiated (Hartwell & 
Weinert, 1989). A malfunction of cell cycle checkpoints results in uncontrolled division of 
cells and can lead to a lot of health defects including cancer (Blackiston et al., 2009).  
For instance, mitosis cannot start if DNA replication was unsuccessful during the S-phase. 
Also cell segregation cannot happen before all chromosomes are aligned properly on the 
mitotic spindle (Murray, 1992). Hence, cell cycle checkpoints are functioning as feedback 
control mechanisms for cell cycle divisors between G1- and S-phase, G2- and M-phase, as 
well as the transition from the M-phase either into a resting state (G0) or a new G1-phase. In 
vertebrates a main player in this downstream regulation are cyclin-dependant kinases (CDK) 
complexes that need to be expressed at certain points in time (Rieder, 2011). Another key 
mechanism that has been shown to influence cell-cycle progression is the transmembrane 





The transmembrane potential is determined by uneven distribution of ions between the 
extracellular fluids and the cytosol and the cells membrane permeability for said ions (Wright, 
2004). Because ions are electrically charged the extracellular and intracellular side of the 
membrane has a distinct potential and the potential difference across the membrane is called 
resting membrane potential (Vr) (Wright, 2004). Ions can cross the hydrophobic lipid bilayer 
through channel proteins that are hydrophilic on the inside and therefore provide a passage, the 
so called channel pore (Hille, 1992). In non-excitable, as well as in excitable cells the Vr is 
mainly regulated by the K+ conductance. Potential changes in excitable neurons are rapid and 
caused by the opening and closing of voltage-dependent ion channels. The potential changes 
that occur during the cell cycle are way slower and smaller and occur in a gradual manner due 
to variations in ion channel expression and activity in proliferative cells (Urrego et al., 2014). 
It has been shown in T lymphocytes that the blocking of K+ channels leads to an arrest of 
proliferative processes (DeCoursey et al., 1984). Moreover, it has been established for a long 
time that K+ channels vary in their expression pattern and activity depending on the cell cycle 
in cultured cells and Xenopus oocytes (Takahashi et al., 1993; Arcangeli et al., 1995; 
Brüggemann et al., 1997; Pardo et al., 1998). 
The first hints that the membrane potential of a cell might be related to cell proliferation came 
in the early 1950s when it became clear that cells with a hyperpolarized resting membrane 
potential, like neurons and muscle cells are nearly never mitotic at all. But the underlying 
mechanism was not clear at that time (Binggeli & Weinstein, 1986). In the following years 
multiple studies highlighted that the Vr decreases in malignant cells as well as in highly 
growing cultured cells (Blackiston et al., 2009). When human endothelial cells are 
hyperpolarized by applying electric fields the cyclin inhibitor p27 gets upregulated in these 
cells accompanied by a downregulation of cyclin E and proliferation is arrested (Wang et al., 
2003). In the 1960s, it has been shown that Vr fluctuates during the cell cycle correlating with 
the transitions from G1- to S-phase as well as G2- to M-phase in (Figure 5) sarcoma cells 
(Cone, 1969). This has been confirmed by changing a cells intracellular ion concentration to 
generate a hyperpolarized Vr resembling the one of non-proliferative neurons. This resulted in 







Alterations in extracellular ion concentrations leads to a depolarisation of the membrane and 
prevents Schwann cells, lymphocytes, fibroblasts and astrocytes from transitioning from the 
G1- into the S-phase (Orr et al., 1972; Canady et al., 1990; Freedman et al., 1992; Wilson & 
Chiu, 1993). Moreover, a continuous depolarization of neurons induced DNA synthesis and 
the following downstream events in otherwise non-proliferative mature neurons (Stillwell et 
Figure 5: The membrane potential changes during the cell cycle 
The membrane potential (Vr) of cells fluctuates throughout the cell cycle. Cells are hyperpolarised during the G1-
phase and at the beginning of the S-phase. DNA synthesis starts when the membrane becomes depolarized. To 
transition from G2-phase to M-phase the cell membrane has to be depolarized to induce mitosis. Cells that are in 
the resting or end differentiated state (G0) tend to have a very negative Vr. Changes in a cells membrane potential 
are accompanied by changes in ion channel expression. In non-excitable, as well as in excitable cells the resting 
membrane potential is mainly regulated by the K+ conductance hence especially K+ conducting channels are 





al., 1973; Cone & Cone, 1976). Inhibition of certain ion channels causes an arrest in the cell 
cycle of B-cell lymphocytes and other cell types, which is reversible (DeCoursey et al., 1984; 
Chiu & Wilson, 1989; Price et al., 1989; Amigorena et al., 1990; Wang et al., 1992). One of 
the main ion channel families that influence cell cycle progression are K+ channels. When they 
are inhibited, some proteins alter their expression pattern including cell cycle relevant proteins 
like interleukin (IL)1/2 and transferrin (DeCoursey et al., 1984; Gelfand et al., 1987; Price et 
al., 1989; Amigorena et al., 1990; Freedman et al., 1992; Lin et al., 1993). Many cell types are 
less likely to proliferate after they are differentiated and the Vr of differentiated cells is much 
more hyperpolarised than in non-specified cells (Blackiston et al., 2009). This suggests a 
correlation between the Vr and the capacity to enter the cell cycle. In quail embryos neural 
crest cells have a depolarized Vr of -35mV in early stages but become more negative (-55mV) 
at later stages. These changes are due to a turnover in K+ channels. In the early stages the main 
K+ channel present in neural crest cells is the human Ether-a-go-go Related Gene (hERG) 
channel, which gets replaced by inwardly rectifying potassium channels (Kir) later in 
development (Bauer & Schwarz, 2001). The same is true for human mesenchymal stem cells 
where artificial depolarization prevents them from entering into a differentiated state while 
hyperpolarisation leads to faster differentiation (Sundelacruz et al., 2008). When using K+ 
channel inhibiting drugs, cultured intestinal epithelial cells enhance wound healing and 
therefore proliferation (Lotz et al., 2004). Also alterations in gap junctional communication is 
crucial for proliferation of adult stem cells in regenerative processes in Planaria (Oviedo & 
Levin, 2007). Not only do ion channels control proliferation via depolarization and 
hyperpolarization of the cell membrane, the cell cycle itself also influences the expression 
pattern of ion channels downstream of cell cycle checkpoints (Blackiston et al., 2009). For 
example, when cells are exposed to mitogens like epidermal growth factors (EGF) or LPS, 
expression and activity of different K+ channels increases (Mummery et al., 1982; Deutsch et 
al., 1986; Enomoto et al., 1986; Decoursey et al., 1987; Magni et al., 1991; Lovisolo et al., 
1992; Grissmer et al., 1993; Partiseti et al., 1993; Wilson & Chiu, 1993). Although the 
underlying mechanism for K+ channel regulation after mitogen exposure are still unclear, an 
involvement of the serine/threonine-protein kinase (Raf), the rat sarcoma GTPase (Ras) as well 
as the cyclin-dependant-kinase inhibitor proteins p21ras has previously been shown (Huang & 





Experiments in embryonic retinal cells have shown that the composition of ion channels 
changes during the G1-phase (Lenzi et al., 1991, 1993). Among the K+ channels that change 
their expression and activity patterns along with the cell cycle are ATP-sensitive K+ channels, 
Ca2+ activated K+ channels and outwardly rectifying K+ channels during the G1- to S-phase 
transition (Woodfork et al., 1995; MacFarlane & Sontheimer, 2000; Ouadid-Ahidouch et al., 
2001; Ouadid-Ahidouch, 2004). Inhibiting as well as blocking and knock down of voltage-
activated Kv1.3 and Kv1.5 channels in rat oligodendrocyte precursor cells leads to a cell cycle 
arrest in the G1-phase and the accumulation of cyclin-dependant-kinase inhibitor proteins 
p27cip1 and p21kip1 (Ghiani et al., 1999; Chittajallu et al., 2002). Hyperpolarization-activated 
cyclic nucleotide-gated (HCN) channels are also known to be involved in the cell cycle 
progression of embryonic stem cells. Blocking of these channels with ZD7288 decreased the 
amounts of cells in G0-state and G1-phase and increased the amount of embryonic stem cells 
in the S-phase suggesting that also HCN currents influence cell cycle progression (Lau et al., 
2011). The depolarization of mouse macrophages induces the S-phase and an upregulation of 
the avian myelocytomatosis viral oncogene homolog (c-myc) and AP-1 transcription factor 
subunit (c-fos) transcription factors that are relevant for proliferative processes (Kong et al., 
1991). Experiments in the breast cancer cell line MCF-17 confirmed that the Vr is 
hyperpolarized at the transition from G1- to S-phase as well as at the G2- and M-phase 
transition while cells are depolarized around the G0-state and G1-phase (Wonderlin et al., 
1995). To transition from G2-phase to M-phase the cell membrane has to be depolarized 
(Blackiston et al., 2009). At this transition ether-à-go-go (r-eag) K+ channel currents (Pardo et 
al., 1998) and voltage-activated Cl- currents are also known to be involved (Valenzuela et al., 






1.10 Ion channels in astrocytes 
It has been elaborated in the previous paragraphs that the underlying cause of why 
juxtavascular astrocytes are more likely to enter the cell cycle compared to non-juxtavascular 
ones in response to TBI is still not completely understood. As already discussed above it is 
known that ion channels play an important role in cell cycle progression in different cell types 
and at different developmental stages and especially K+ ion channels are known to be a key 
player (Blackiston et al., 2009; Urrego et al., 2014). There are several types of K+ channels 
present in astrocytes, some of which are known to be involved in astrocytic proliferation and 
others that change their expression pattern after a traumatic event (MacFarlane & Sontheimer, 
1997, 2000; Rusnakova et al., 2013; Honsa et al., 2014; Verkhratsky & Nedergaard, 2018). 
This makes these channels, if differently expressed between non-juxtavascular and 
juxtavascular astrocytes, a great candidate to explain their distinct proliferative pattern in 
response to TBI. 
1.10.1 The astrocytic membrane potential 
The intracellular ion concentration is defined by the membrane permeability of the cell for 
certain ions, active transport via ion pumps and intracellular cytosolic buffering mechanisms 
for calcium (Verkhratsky & Nedergaard, 2018). In astrocytes, the intracellular ion 
concentrations are 120-140 mM for K+, 15-20 mM for Na+, 50-150 nM Ca+ and around 30-
60 mM Cl- (Hansen, 1985; Jones & Keep, 1987; Bekar & Walz, 2002; Langer & Rose, 2009; 
Unichenko et al., 2012; Zheng et al., 2015; Rose & Verkhratsky, 2016; Verkhratsky & 
Nedergaard, 2018). 
Astrocytes are known for expressing an excessive amount of inwardly rectifying Kir4.1 ion 
channels in the astrocytic membrane which leads to a very hyperpolarized Vr around -80 mV 
close to the K+ equilibrium potential (EK = 98 mV) and a low input resistance between 5-
20 MΩ (Mishima et al., 2007; Mishima & Hirase, 2010; Dallérac et al., 2013). Moreover, the 
high permeability for K+ also shapes astrocytic current to voltage relationships making them 
almost linear. Hence, mainly passive current patterns are visible establishing it as a feature of 
adult astrocytes (Pastor et al., 1995; Isokawa & McKhann, 2005; Djukic et al., 2007; Adermark 





astrocytes are highly coupled with neighbouring astrocytes via gap-junctions, leads to 
isopotentiality in these networks, by equalizing an astrocytes Vr to the ones of neighbouring 
cells (Ma et al., 2016). The very negative astrocytic Vr is the driving force for membrane 
transporters, which is crucial for performing homeostatic functions that are associated with 
astrocytes (Verkhratsky & Nedergaard, 2018).  
1.10.2 Inwardly rectifying potassium channels (Kir) 
Inwardly rectifying K+ channels are ion channels that are able to conduct K+ ions more rapidly 
from the extracellular side to the cytosolic side of the cell membrane than the other way round 
(Doupnik et al., 1995; Reimann & Ashcroft, 1999). The main physiological role of Kir channels 
is the stabilisation of the Vr close to EK in cardiac as well as neural cells and they mediate the 
potassium flow across the cell membrane governed by a strong voltage-dependence of the 
Mg2+ and polyamine channel block (Nichols & Lopatin, 1997; Guo et al., 2003). The family 
of Kir channels is comprised of seven major subfamilies Kir1 to Kir7 (Nichols & Lopatin, 1997). 
Kir2 channels are strongly rectifying while the Kir1, Kir4, Kir5 and Kir7 subfamilies only have 
weakly rectifying properties. Moreover, Kir3 are G-protein-coupled channels and the Kir6 
subfamily form ATP-gated channels by assembling with sulfonylurea receptors (Nichols & 
Lopatin, 1997; Roeper & Liss, 2001).  
As mentioned above Kir4.1 channels are the main type of K
+ channels expressed by astrocytes 
and responsible for maintaining their very negative Vr (Mishima et al., 2007; Mishima & 
Hirase, 2010; Dallérac et al., 2013). In the CNS, Kir4 expression is predominantly found in 
astrocytes mainly in the hippocampus, cerebral cortex, Bergmann glia of the cerebellum, 
Müller glia in the retina, the optic nerve, deeper cerebellar nuclei and the ventral horn of the 
spinal cord. This was confirmed by either immunohistochemistry or by the presence of Cs+ 
and Ba+ sensitive currents in rodent astrocytes in-vitro and in-vivo (Nowak et al., 1987; Barres 
et al., 1990; Sontheimer et al., 1992; Tse et al., 1992; Ransom & Sontheimer, 1995; 
Poopalasundaram et al., 2000; Higashi et al., 2001; Kalsi et al., 2004; Olsen et al., 2007). The 
astrocytic Kir4.1 channels are predominantly expressed in the processes and endfeet of 
astrocytes especially the ones that are perivascular or perisynaptic (Higashi et al., 2001) and in 
rats there is a developmentally regulated shift from somatic expression towards the processes 





accompanied by an increase in Kir4.1 channel density (Seifert et al., 2009). In addition, it has 
been shown that higher levels in Kir4.1 channel expression in mature astrocytes are strongly 
linked to end-differentiation and a loss of proliferative potential (Sontheimer, 1994; Roy & 
Sontheimer, 1995; Bordey & Sontheimer, 1997; MacFarlane & Sontheimer, 1997; 
Higashimori & Sontheimer, 2007). Moreover, several studies have described the 
downregulation of Kir4.1 in reactive astrocytes after a lesion in rodents in-vitro and in-vivo 
(MacFarlane & Sontheimer, 1997; Olsen et al., 2010; Gupta & Prasad, 2013) and could even 
link said downregulation to the proliferating astrocytes in spinal cord cultures of rats 
(MacFarlane & Sontheimer, 1997). This makes Kir4.1 channels, if differently expressed 
between non-juxtavascular and juxtavascular astrocytes, a great candidate to explain their 
distinct proliferative pattern in response to TBI in-vivo.  
The Kir6 ion channel subfamily is able to assemble with the ATP-binding cassette transporter 
sub-family C (SUR) 1/2 to form ATP sensitive channels that open in response to a decrease in 
ATP concentration. Theses ATP-sensitive channels are known to be present in astrocytes and 
are speculated to play a role in the cells protection after metabolic stress as well as the 
regulation of gap junctional permeability (Thomzig et al., 2001; Wu et al., 2011). This makes 
them perfect candidates to be involved in the astrocytic reaction following an injury. In healthy 
rats, Kir6.1 is present in astrocytes in the hippocampus, cerebellum and cortex as well as in 
Bergman glia (Thomzig et al., 2001). It has been shown, that Kir6.1 mRNA is expressed in 
retinal Müller glia and the brainstem whereas Kir6.2 mRNA is present in Müller glia, astrocytes 
in the cerebellar white matter and in the corpus callosum (Thomzig et al., 2001; Raap et al., 
2002; Zhou et al., 2002): 
1.10.3 Voltage-activated K+ channels (Kv) 
Voltage-activated K+ (Kv) channels are represented by 12 subfamilies (Kv1-12) that are 
responsible for a plethora of different functions like electrical excitability in neurons and 
muscle cells, action potential frequency regulation, transmitter release, establishing the resting 
membrane potential as well as the rhythm of the heart and endocrine secretion (Pongs, 1999). 
Astrocytes show rapidly inactivating and activating A-type currents that are elicited at 
depolarized membrane potentials (-70 to-50 mV), but these A-type currents are most of the 





Seifert et al., 2009). In cultured rat hippocampal astrocytes, pharmacological experiments 
showed that around 70 % of A-type currents in these cells underlie the Kv4 channel subfamily, 
approximately 10 % originate from the Kv3 subfamily and the smallest amount, under 5 %, 
arise from the Kv1 subfamily (Bekar, 2004). Kv3.4 ion channels are predominantly localized 
on astrocytic processes while Kv4.3 channels are located in more somal regions, which might 
enable astrocytes to respond to high-frequency incoming signals from neurons with rapid 
membrane voltage oscillations to synchronize their function with neuronal activity (Bekar, 
2004). In addition to A-type currents, astrocytes in the cerebellum, cortex, hippocampus and 
spinal cord of rats show delayed rectifying K+ currents that are activated at around -20 mV 
(Bordey & Sontheimer, 2000). In young, immature rodent astrocytes, that are either still mitotic 
or have proliferative potential, the dominant currents are delayed rectifying (Id) and transient 
(IA) currents caused by voltage-activated K
+ channel (Kv) subfamilies (Bordey & Sontheimer, 
1997; MacFarlane & Sontheimer, 2000; Seifert et al., 2009).  
1.10.4 Hyperpolarization-activated cyclic nucleotide-gated channels (HCN) 
HCN channels are encoded by four genes, the Hcn1-4 genes and their proteins form hetero- 
and homotetrameric channels that are permeable for K+ and Na+ ions in a 4:1 ratio (Marx et 
al., 1999; Wahl-Schott & Biel, 2008). They are primarily present in neurons and are activated 
at a hyperpolarized Vr. HCN2 and 4 channels can be additionally activated by cyclic adenosine 
monophosphate (cAMP). In neurons these channels are responsible for the stabilization of the 
Vr, constraining long term potentiation (LTP), synaptic transmission and dendritic integration. 
Most importantly they mediate oscillation of the membrane potentials in neuronal and cardiac 
cells (Wahl-Schott & Biel, 2008; Lewis & Chetkovich, 2011). HCN channel transcripts are 
known to be present in neurons and have additionally been reported in primary astrocyte 
cultures and post-ischemic astrocytes of rodents and might therefore play a role in nonspecific 
cation influx (Rusnakova et al., 2013; Honsa et al., 2014). According to literature, HCN1 
channels are present in astrocytes of the healthy rodent brain in small amounts. In the post 
ischemic brain reactive astrocytes have highly increased levels of HCN1-4 transcript and 
HCN1-3 channels were detected via immunohistochemistry in these cells (Rusnakova et al., 





1.11 Aim of the study  
One major subclass of glia cells are astrocytes. Astrocytes play a major role after TBI and in 
several neurological diseases by becoming reactive under these conditions. This includes, but 
is not limited to hypertrophy, polarization, the upregulation of GFAP in astrocytic processes 
as well as proliferation of astrocytes surrounding the lesion site (Pekny & Pekna, 2014; Burda 
et al., 2016). Juxtavascular astrocytes, which have their soma directly adjacent to blood vessels 
are more prone to selectively proliferate after TBI in mice, whereas non-juxtavascular 
astrocytes rarely divide (Bardehle et al., 2013). Nevertheless, the underlying cause of this 
selective proliferation is still not well understood and especially why juxtavascular astrocytes 
are more likely to enter the cell cycle compared to non-juxtavascular ones. It is known that ion 
channels play an important role in cell cycle progression in different cell types and at different 
developmental stages. Especially K+ ion channels are known to be key players (Blackiston et 
al., 2009; Urrego et al., 2014). There are several ion channels known to be present in astrocytes, 
which might also play an important role proliferation of astrocytes after a traumatic event.  
Inwardly rectifying Kir4.1 channels, which are mainly present in astrocytic processes and 
endfeet are responsible for maintaining the very negative Vr of astrocytes (Mishima & Hirase, 
2010; Dallérac et al., 2013). Moreover, Kir4.1 ion channel expression is known to be positively 
correlated with end differentiated cells and a downregulation of these potassium channels is 
known to happen in reactive astrocytes (MacFarlane & Sontheimer, 1997, 2000). The Kir6 ion 
channel subfamily are ATP-sensitive channels known to be present in astrocytes and 
speculated to play a role in protecting the cell after metabolic stress as well as the regulation 
of gap junctional permeability (Thomzig et al., 2001). Moreover, it has been shown that 
delayed rectifying (Id) and transient (IA) currents caused by voltage-activated K
+ channel 
subfamilies (Kv ion channels) are dominant in young and immature astrocytes that are either 
still mitotic or have the potential to proliferate (Bordey & Sontheimer, 1997). These currents 
are also dominating in reactive proliferating astrocytes in spinal cord cultures (MacFarlane & 
Sontheimer, 1997). It is known, that HCN channels are involved in the cell cycle progression 
of embryonic stem cells. Blocking of these channels decreased the amount of cells in the G0-
state and the G1-phase and increases the amount of embryonic stem cells in the S-phase 





of HCN channels are present in primary astrocyte cultures and known to be upregulated in 
post-ischemic astrocytes (Rusnakova et al., 2013; Honsa et al., 2014). 
The aim of this doctoral thesis is to analyse if there are differences in ion channel composition 
present between non-juxtavascular and juxtavascular astrocytes that might be responsible for 
their differential behaviour after traumatic events. Therefore, the two astrocyte subtypes are 
characterised regarding their ion channel expression pattern and passive electrophysiological 
properties (resting membrane potential Vr, resting membrane conductance Gr and input 
resistance Rin) in the somatosensory cortex of adult transgenic Aldh1l1-eGFP mice. 
In the first part of this study, it will be assessed by means of immunohistochemistry and 
electrophysiological whole-cell patch-clamp recordings whether there are inherent differences 
present between non-juxtavascular and juxtavascular astrocytes already in the healthy 
unlesioned somatosensory cortex. 
 In the second part, a stab wound lesion will be introduced into the brain to induce reactive 
astrogliosis. Immunohistochemistry and electrophysiological recordings will be used to work 
out whether the lesion induces a difference in the passive electrophysiological properties and 
ion channel expression patterns of non-juxtavascular and juxtavascular astrocytes. If 
dissimilarities are present, this might be the underlying cause for proliferation mainly occurring 
in reactive juxtavascular astrocytes.  
Findings regarding a differential expression of certain subsets of ion channels that might be 
the underlying cause for the diverse proliferative behaviour of juxtavascular and non-
juxtavascular astrocytes in response to traumatic brain injury would be of great interest for 
therapeutic approaches as it is known that astrocyte proliferation positively affects healing 
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2 Materials and Methods 
2.1 Animal rearing and license 
The experimental animals were reared and housed according to the guidelines of the 
Bundesgesetzblatt Nr.37, Anhang A. The animals were housed and bred in the animal facility 
of the Department II of the LMU Biocenter (Martinsried). They were kept in an open Type II 
cage system in groups of no more than 8 animals and were provided with changing enrichment. 
The lighting was provided by an artificial light source and an artificial day and night cycle was 
generated by 12 hours of light and 12 hours without. A light intensity of 45 lux inside the cages 
was never exceeded. The room temperature in the housing facility lay between 20-24 °C and 
humidity was around 50 %. The animals were provided with food and water ad libitum and all 
conditions were in accordance with the RL2010/63/EU. 
All experiments were in accordance with and approved according to the German 
Tierschutzgesetz. 
2.2 Mouse strain 
The BAC Aldh1l1-eGFP mouse line generated by GENSAT was used (provided by Prof. Dr. 
Magdalena Götz; BioMedical Center, Department of Physiological Genomics, Ludwig-
Maximilians-Universität München) , which specifically expresses enhanced green fluorescent 
protein (eGFP) in nearly all astrocytes in the developing and adult CNS (Heintz, 2004). The 
aldehyde dehydrogenase 1 family, member L1 (Aldh1l1) is a highly expressed astrocyte 
specific gene that can be used as a specific marker to identify astrocytes in the CNS. It has high 
amounts of mRNA expression and its resulting proteins are present in the whole cell (Cahoy 
et al., 2008). The protein itself functions as a catalyser in the conversion of water, 10-
formyltetrahydrofolate and nicotinamide adenine dinucleotide phosphate (NADP+) to carbon 
dioxide, tetrahydrofolate and NADPH (Cook et al., 1991). 
 
  





2.3.1 Stab wound lesion 
Surgical procedures were conducted under the Tierversuchsantrag Gz.: 55.2-1-54-2532-76-
2016 (Regierung von Oberbayern). The experimental animals were briefly anesthetized with 
Isoflurane (IsoFlo®, 100% isoflurane; Zoetis Schweiz GmbH) until the righting reflex was lost 
and then put under general MMF anaesthesia with an intraperitoneal injection (i.p.) containing 
0.5 mg/kg Medetomidin (Oreon Pharma; Domitor 1 mg/ml), 5 mg/kg Midazolam (Braun 
GmbH; 5 mg/ml) and 0.05 mg/kg Fentanyl (Jannsen Pharmaceutica; 0.05 mg/ml). 
Subsequently animals were put back into their cage and monitored constantly. The state of 
general anaesthesia was verified by the lack of the reflex to turn around as well as the lack of 
the blinking reflex. To guarantee working analgesia the paw pinch reflex was tested as well. 
When the animal had reached this condition, the eyes were covered with Bepanthen eye and 
nose cream (Bayer AG; active reagent 5 % Dexpanthenol) to prevent the cornea from drying 
out. During the whole procedure the animal was provided with dampened oxygen (Linde Gas 
Therapeutics GmbH; Conoxia ® GO2X) through a breathing mask to facilitate breathing and 
guarantee proper ventilation.  
To allow access to the operating area a small portion of fur was sheared from the animals head 
with an electric shaver. Then it was head fixed in a motorized stereotaxic stereo drive 
(NeuroStar GmbH; Serial#: SD214) and put onto a feedback controlled heating pad (Physitemp 
Instruments; TCAT-2DF controller and F040070504b 12 V/5.3 Ω/ 1408C-01 pad) set to 36°C. 
The skin on the head was opened with small scissors and a drill was used to perform a 
craniotomy in the region of the somatosensory cortex. A small cranial window was removed 
from the skull and kept aside to close the window later. To introduce the micro lesion a lancet 
was inserted 0.6 mm deep into the parietal cortex 1.5-2.5 mm parasagittal to the midline and 
then moved several times 1-1.5 mm caudally through the brain. After removing the lancet from 
the brain, the cranial window was closed with the small piece of skull, which was removed 
earlier in the procedure and a suture on the head was performed with surgical suture material 
(Feuerstein GmbH; Seide Schwarz 45cm USP 4/0 (m 1.5) HS 18) to close the operating area. 
To antagonize the anaesthesia, the animal was injected i.p. with AFB containing 2.5 mg/kg 
Atipamezol (CP Pharma; Revertor 5 mg/ml), 0.5 mg/kg Flumazenil (Hexal AG; 0.5 mg/ml) 




and 0.1 mg/kg Buprenorphin (Bayer AG; Buprenorvet 0.3 mg/ml). Buprenorphin was used for 
post-surgery analgesia.  
2.3.2 Post-surgery treatment 
After the operation the animals were controlled regularly and 8 hours post-surgery they were 
again injected i.p with 0.1 mg/kg Buprenorphin (Bayer AG; Buprenorvet 0.3 mg/ml) to 
counteract wound pain. Consecutively, the animals were controlled daily and a total health 
score was determined every day post-surgery until the end of the experiment which was either 
1, 3 or 5 dpi. The operated animals were housed together with their conspecifics of the same 
sex in a separate room with the same conditions as mentioned above. Solely during the phase 
while they were awakening from the anaesthesia they were housed individually in special 
prepared cages to prevent them from getting harmed by others. The post-surgical observation 
is conducted by the experimenter and, in addition, animals were controlled daily by the animal 
care takers.  
2.4 Immunohistochemistry 
2.4.1 Transcardial perfusion for tissue fixation 
The supplier information of all the chemicals used in this study is listed in the appendix. Prior 
to the perfusion the experimental animals were injected i.p. with a lethal dose of Narcoren 
(400-800 mg/kg; (Merial GmbH; pentobarbital sodium 16 g/ml)). For post-mortem 
transcardial perfusion, the animals´ rib cage was opened and a needle was introduced into the 
bottom part of the left ventricle. Then the right atrium was cut open and perfusion started with 
Ringer solution containing 0.1 % heparin to prevent blood clotting so that the vascular system 
gets completely cleared from the blood. After 5 minutes the ringer solution is replaced with a 
solution containing 4 % PFA in 0.05 M PB (pH 7.4) for 20 minutes for tissue fixation. 
Subsequently the brain was removed from the skull and post-fixated for 2 hours in 4 % PFA 
solution at room temperature on a shaker. 
  




2.4.2 Slice preparation and immunohistochemistry 
 
After post-fixation brains were washed 3 times for 10-15 minutes in 0.02 M PBS on the shaker 
and then embedded in 4 % agar (dissolved in distilled water). 30 µm thick coronal sections of 
the somatosensory cortex were cut with a VT 1200S vibratome (Leica Microsysteme Vertrieb 
GmbH) and rinsed in 0.02 M PBS. Then the slices were transferred onto Thermo 
Scientific™ SuperFrost Ultra Plus™ Adhesion Slides and dried for at least 1 hour. 
Subsequently the slices were first encircled with an ImmEdge Hydrophobic Barrier PAP Pen 
(Vector Laboratories) to prevent spillage of staining solution and then washed for 5 minutes in 
washing tons filled with 0.02 M PBS on the shaker. After washing, the slices were incubated 
for 20 minutes in blocking solution to prevent unspecific antibody binding. Then this solution 
was replaced with new blocking solution that additionally contained the primary antibodies 
and slides were incubated 48 h at 4 °C in a wet chamber. Thereafter, slides were washed three 
times for 15-20 minutes in washing solution on the shaker at room temperature and then 
incubated with the secondary antibodies (diluted in blocking solution) over night at 4 °C in a 
wet chamber. For blood vessel labelling DyLight 649 labelled Lycopersicon Esculentum 
(Tomato) Lectin was added to the secondary antibody solution. The next day, slices were 
washed 3 times for 15-20 minutes in washing solution at room temperature and if nuclear 
labelling was needed stained with DAPI diluted in PBS for 20 minutes at room temperature. 
After thoroughly washing the slices 5 minutes in washing solution, the slides were mounted 
with VECTASHIELD Antifade Mounting Medium (Vector Laboratories) and cover slips and 




PBS 0.02 M: 5 mM KH2PO4, 16 mM Na2HPO4, 150 mM NaCl, 2.7 mM KCl (pH 7.4) 
Washing solution: 1 % Saponin, 0.5 %TritonX100, 0.02 M PBS 
Blocking solution: 1 % Bovine Serum Albumine, 1 % Saponin, 0.5 %TritonX100, 
0.02 M PBS 










Anti- Host Dilution Company Catalogue # 
Kir4.1 rabbit 1:200 Alomone Labs APC-035 
Kir6.1 rabbit 1:200 Alomone Labs APC-105 
Kir6.2 rabbit 1:200 Alomone Labs APC-020 
Kv4.3 rabbit 1:200 Alomone Labs APC-017 
HCN1 rabbit 1:200 Alomone Labs APC-030 
HCN2 rabbit 1:200 Alomone Labs APC-056 
HCN3 rabbit 1:200 Alomone Labs APC-057 
Ki67 rat 1:100 ThermoFisher 14-5698-82 
GFAP mouse 1:500 Sigma G3893 
GFP chicken 1:500 Aves Labs GFP-1020 
 
Secondary antibodies 
Conjugate Anti- Host Dilution Company Catalogue # 
AMCA Mouse Donkey 1:100 Dianova 715-156-150 
Alexa488 Chicken Donkey 1:300 Dianova 703-546-155 
Cy3 Rabbit Donkey 1:400 Dianova 711-165-152 
DyLight594 Rat Donkey 1:200 Dianova 711-516-152 
 
Unspecific markers 
Marker Dilution Company Catalogue # 
DAPI 1:1000 Thermo Fisher 62248 
DyLight 649 labeled Lycopersicon 
Esculentum (Tomato) Lectin 
1:250 Vector Laboratories DL-1178 
 
  






For all electrophysiological recordings of non-lesioned animals the mice were anesthetized 
with Isoflurane (IsoFlo®, 100 % isoflurane; Zoetis Schweiz GmbH) and quickly decapitated 
under anaesthesia. All lesioned animals were first quickly anesthetized with Isoflurane 
(IsoFlo®, 100 % isoflurane; Zoetis Schweiz GmbH) and then put under general anaesthesia 
using MMF i.p. (0.5 mg/kg Medetomidin (Oreon Pharma; Domitor 1 mg/ml), 5 mg/kg 
Midazolam (Braun GmbH; 5 mg/ml) and 0.05 mg/kg Fentanyl (Jannsen Pharmaceutica; 
0.05 mg/ml)). When animals were under general anaesthesia, 50 µl Texas Red® labelled 
dextran (Molecular Probes Inc.; LOT: 1756567; 70000MW; 10 mg/ml in NaCl) was injected 
into the tail vein (i.v.) for blood vessel labelling. After 10-15 minutes incubation the animals 
were decapitated under general anaesthesia. The brains of all experimental animals were 
dissected from the skull and placed in ice cold artificial cerebrospinal fluid (ACSF) slice 
solution where the meninges were removed with very thin forceps. Then 200 µm thick coronal 
brain sections were cut with a Leica VT1200S vibratome (Leica Microsysteme Vertrieb 
GmbH) in ice-cold carbonated ACSF slice solution. The tissue slices were then transferred 
onto a net inside a beaker filled with ACSF patch solution. The beaker is placed into a water 
bath heated to 36 °C and slices were incubated for 45 minutes while being continuously 
bubbled with 95 % O2 and 5 % CO2. Subsequently, the slices were stored at room temperature 
and used for electrophysiological experiments after they had rested for at least 20 minutes. 
To perform electrophysiological recordings the slices were transferred and weighed down with 
a slice anchor into a recording chamber that was mounted onto an Olympus BX51WI 
microscope (Olympus Europa Holding GmbH). The microscope is equipped with a light source 
ACSF slice: 120 mM sucrose, 25 mM NaCl, 25 mM NaHCO3, 2.5 mM KCl, 1.25 mM 
NaH2PO4, 3 mM MgCl2, 0.1 mM CaCl2, 25 mM glucose, 0.4 mM ascorbic acid, 3 mM 
myo-Inositol, 2 mM Na-pyruvate (pH 7.4 by bubbling with 95 % O2 and 5 % CO2) 
ACSF patch: 125 mM NaCl, 25 mM NaHCO3, 2.5 mM KCl, 1.25 mM NaH2PO4, 2 mM 
CaCl2, 1 mM MgCl2, 25 mM glucose, 0.4 mM ascorbic acid, 3 mM myo-Inositol, 2 mM 
Na-pyruvate (pH 7.4 by bubbling with 95 % O2 and 5 % CO2) 
Intracellular solution: 130 mM K-Gluconate, 20 mM Hepes, 10 mM EGTA, 13 mM Na2-
ATP, 1 mM MgCl2 (Osmolarity:290 +/- 2 mOsm; pH 7.25-7.28 that was achieved via 
titration with either 1 M NaOH or 1 M KOH) 




(Olympus TH4-200; Olympus Europa Holding GmbH) and an infrared filter for bright field 
microscopy and a white light source (LEj GmbH) for fluorescent imaging. For visual 
identification of cells an Orca –R2 Digital Camera C10600 with the corresponding Hokawo 
software (Hamamatsu Photonics K.K) was installed and Olympus objectives with a 4x (Plan N 
0.1; Olympus Europa Holding GmbH) and a 60x (PlanFL N 1.0; Olympus Europa Holding 
GmbH) magnification were used. To guarantee the health of the slices, the chamber was 
constantly perfused with freshly carbonated recording solution (ACSF patch) during the whole 
time of the experiments. All the electrophysiological recordings were performed at room 
temperature. For voltage-clamp whole-cell recordings, borosilicate glass capillaries (BM150F-
10P with filaments, 1.5mm OD/0.86mm ID/100mm L; BioMediacal Instruments) were pulled 
using a DMZ Universal Electrode Puller (Zeitz Instrumente Vertriebs GmbH) to achieve a 
resistance between 3.5-5.5 MΩ when filled with intracellular solution. The recordings were 
acquired with a double patch clamp EPC 10 USB amplifier (HEKA Elektronik Dr. Schulz 
GmbH). The patched astrocytes were identified by fluorescent labelling with eGFP and their 
location towards blood vessels was either identified by bright field microscopy or by 
fluorescent blood vessels labelling (see above). For the identification a dual band 
GFP/mCherry ET Filterset was used (F56-019; AHF Analysentechnik AG). The capacitive 
artefact (C-fast) of the recording electrode was compensated in all recordings. All obtained 
data were corrected for a liquid junction potential of -16 mV. Data were acquired with a 
sampling rate of 20 kHz and Bessel filtered at 2.9 kHz and 10 kHz. The recording protocols 
were created with the help of the pulse generator in the PatchMaster software (HEKA 
Elektronik Dr. Schulz GmbH). The astrocytes were clamped to the Vr measured in current-
clamp mode and subsequently injected with 200 ms long voltage steps ranging from -176 mV 
to +174 mV in 10 mV increments to obtain the current response from the patched cell for 
passive electrophysiological parameter identification. For all further analysis only cells that 
showed stable recordings and constant parameters were taken into account.  
For pharmacological identification of Kir4.1 channels astrocytes were clamped to their Vr 
measured in current-clamp mode and subsequently injected with 200 ms long voltage steps 
ranging from -176 mV to +174 mV in 10 mV increments to obtain the current response. 
Afterwards the Kir4.1 channel blocker BaCl2 dihydrate (200 µM) diluted in recording solution 
was washed into the recording chamber for 10 minutes. 




For pharmacological identification of HCN channels in astrocytes the cells were clamped to 
the cells Vr measured in current clamp mode and then subsequently injected with 1 s long 
voltage steps ranging from -176 mV to -16 mV in 10 mV increments. Consecutively a selective 
HCN channel blocker ZD7288 [4-(N-ethyl-N-phenylamino)-1.2-dimethyl-6-(methylamino) 
pyrimidinium chloride] (50µM) diluted in recording solution was washed into the recording 
chamber for 10 minutes.  
2.6 Microscopy 
For a first evaluation of the immunohistochemical stainings a fluorescent microscope (Nikon 
Eclipse 80i; Nikon Instruments Inc.) equipped with Nikon Plan Fluor 109/0.3 (10x) and a Plan 
Fluor 209/0.50 (20x) objective was used. All final images shown here were then acquired with 
a Leica TCS SP-5 confocal laser scanning microscope (Leica Microsystems Vertrieb GmbH) 
using either a HCX PL APO Lambda Blue 20x 0.7 immersion objective or a HCX PL APO 
Lambda Blue 63x 1.4 oil immersion objective. The virtual slices were set constantly to 0.5 µm 
z-step size and an image size of 512x512 pixels. The bidirectional scanning mode was chosen 
and laser scanning frequency varied between 400 and 1000 Hz depending on the zoom factor 
for the corresponding picture. The line average was calculated from three subsequent line scans 
and the size of the pinhole was automatically adjusted by the software. The microscope used 
the following lasers: a diode laser (405 nm; 25 mW), an argon laser (458 nm, 467 nm, 488 nm, 
514 nm; 5 mW), a DPSS laser (561 nm; 10 mW), a HeNe laser (594 nm; 2.5 mW) and another 
HeNe laser (633 nm; 10 mW) to visualise the different fluorescence labels. Before scanning, 
the laser power and the gain were adjusted to ensure an optimal fluorescence signal.  
2.7 Data analysis 
Igor 
Electrophysiological data (*.dat files) acquired with the PatchMaster software (HEKA 
Elektronik Dr. Schulz GmbH) was loaded into the IGOR PRO 6.35A software (WaveMetrics 
Inc.) with the help of the Patchers Power Tools 2.19 extension (Dr. Francisco Mendez and 
Frank Würrihausen; Max-Planck-Institut für biophysikalische Chemie Göttingen). The raw 
current traces were further analysed with custom written IGOR PRO procedures.  




GraphPad prism 5 
GrapPad Prism 5 (GraphPad Software) was used to further process data, to perform statistical 
analysis on electrophysiological data, cell counting analysis and for graph design. For all data-
sets non-Gaussian distribution was assumed and the results were presented as the median. For 
comparison of passive electrophysiological properties, statistical significance was determined 
by Kruskal-Wallis-tests or Mann-Whitney-tests depending on the datasets. To check for 
differences in the number of astrocytes that possess certain features with the help of 
contingency analysis either a two-sided Fisher´s exact test or a two-sided Chi-square test was 
used. For analyses of experiments with more than two groups, a Kruskal-Wallis test was 
performed to clarify if there is a difference between all respective groups. If the Kruskal-Wallis 
test was significant, a Mann-Whitney test was used for further testing of groups that were of 
interest. In these cases a Bonferroni-Correction was applied to determine the adequate p value. 
In case of experiments, in which a cells´ parameters were compared before and after 
application of an ion channel blocker, the Wilcoxon matched pairs test was used.  
To analyse the expression pattern of ion channels in the healthy somatosensory cortex, 
astrocytes in cortex slices of adult mice were counted in the according cortical layers and the 
mean percentage of ion channel expressing non-juxtavascular and juxtavascular astrocytes for 
each animal was plotted in a bar chart. Then the median percentage of the different animals 
was determined for each layer. The criteria for a homogenous expression pattern was met, if 
the median percentage did not diverge more than 5 % from a complete homogeneity. 
Homogeneity was defined as 100% of the counted astrocytes being positive for the ion 
channels marker. A Kruskal-Wallis test was used to check for differences in ion channel 
expression between different cortical layers and between the two astrocyte subtypes. 









2.8 Image processing 
ImageJ 
All images acquired with the Leica TCS SP-5 confocal laser scanning microscope (Leica 
Microsysteme Vertrieb GmbH) were further processed and analysed with ImageJ software 
(Wayan Rasband, National Institutes of Health, USA). Image Stacks were corrected for a z 
chromatic shift between colour channels. For cell counting, the ImageJ manual counting tool 
was used and all optical sections of one stack were analysed individually. Images were 
produced by making z-stack maximum projections of a certain number of optical sections and 
brightness and contrast was adjusted for optimal signal to noise ratio.  
Figures 
All multi-panel figures and drawings in this study were produced with the help of the vector 







3.1 Characterization of non-juxtavascular and juxtavascular astrocytes 
in the somatosensory cortex of the healthy brain 
Juxtavascular astrocytes with their soma directly adjacent to blood vessels are prone to 
selectively proliferate after TBI in the somatosensory cortex of mice, whereas non-
juxtavascular astrocytes are less likely to divide (Bardehle et al., 2013). It is known, that ion 
channels and especially K+ channels play important roles in cell cycle progression and 
therefore division (Blackiston et al., 2009; Urrego et al., 2014). Hence it was of great interest 
to assess, whether there is an inherent difference between non-juxtavascular and juxtavascular 
astrocytes regarding their electrophysiological properties, as well as their ion channel 
composition in the healthy, unlesioned brain present. 
3.1.1 Electrophysiological characterization of astrocytes in the healthy 
somatosensory cortex 
In order to characterize non-juxtavascular and juxtavascular astrocytes regarding their passive 
properties in the healthy brain, electrophysiological voltage-clamp experiments were 
performed on somatosensory cortex slices of 25 adult BAC Aldh1l1-eGFP transgenic mice at 
ages between p24 and p48. Astrocytes were identified by the green fluorescence of the 
intracellularly expressed Aldh1l1-eGFP as seen in Figure 6a and a´. To distinguish non-
juxtavascular from juxtavascular astrocytes the blood vessels were identified either by green 
fluorescence, which was due to astrocytic processes enwrapping larger blood vessels 
excessively (Figure 6a, red arrows), or with the help of bright field microscopy (Figure 6a). 
Juxtavascular astrocytes were defined by direct opposition of their somata to the blood vessel 
(Figure 6a, cyan arrow), whereas the somata of non-juxtavascular astrocytes were not directly 
adjacent to the vasculature (Figure 6a, white arrow). After identification, astrocytes were 
patched with a borosilicate glass electrode filled with intracellular solution, which also 
contained Alexa568® hydrazide sodium salt to label patched astrocytes with red fluorescence 
(Figure 6a´). In total, for unlesioned control animals, 74 astrocytes have been analysed of 






Figure 6: Electrophysiological characterization of non-juxtavascular and juxtavascular astrocytes in the 
somatosensory cortex 
a: Example pictures of fluorescent Aldh1l1-eGFP positive astrocytes (left pictures) and corresponding bright field 
(BF) images (right pictures) in 200 µm thick somatosensory cortex coronal sections. White arrows mark non-
juxtavascular astrocytes. Red arrows point to blood vessels identified either via eGFP fluorescence resulting from 
astrocytic processes excessively enwrapping them or in the BF picture mode. Cyan arrows point to juxtavascular 
astrocytes. Scale bar 23µm a`: Close up picture of a non-juxtavascular astrocytes (BF picture 1, Aldh1l1-eGFP 
fluorescence picture 2) patched with a borosilicate glass electrode. The electrode was filled with intracellular 
solution and Alexa568 fluorescent dye for cell visualisation (Alexa 568 picture 3). Pictures four and five show 
overlays of the different single channels to proof that the patched cell is really the eGFP positive astrocyte 
(yellow). Scale bar 45µm. b: Distribution of patched astrocytes in the somatosensory cortex of healthy animals. 
c: Current response of an example astrocyte (upper picture) clamped to its Vr and injected with 200 ms long 
voltage steps ranging from -176 mV to +174 mV in 10 mV increments in voltage-clamp mode (small insert). 
Lower picture shows the corresponding IV-relationship. Gr of astrocytes can be calculated from a linear fit (green 
line) performed over five data points, around Vr. d: Passive electrophysiological properties of non-juxtavascular 
(black circles; n = 43) and juxtavascular (green squares; n = 31) astrocytes (total n = 74) of the healthy 
somatosensory cortex were compared. Left graph shows that the median Vr of non-juxtavascular astrocytes 
(median = -83 mV) and juxtavascular astrocytes (median = -87 mV) does not differ significantly (Mann-Whitney 
test: p = 0.6529). Middle graph depicts Gr measured at the steady state and shows no significant difference 
between non-juxtavascular (median = 70 nS) and juxtavascular (median = 85 nS) astrocytes (Mann-Whitney test: 
p = 0.0681). Rin, shown in the right graph, does also not differ significantly between non-juxtavascular 





Astrocytes were clamped to their resting membrane potential (Vr), measured in current-clamp 
mode and subsequently injected with 200 ms long voltage steps ranging from -176 mV to 
+174 mV in 10 mV  increments (Figure 6c, small insert). From the current response traces the 
corresponding current-voltage relationship (IV-curve) was calculated at the steady state, as the 
mean current of each trace over a certain time period, and then plotted against the injected 
voltages (Figure 6c, bottom). The Vr was taken from the intersection of the IV-curve with the 
x-axis. For all of the following analyses non-Gaussian distribution was assumed (because not 
all our results follow Gaussian distribution) and the median of the values was compared. The 
Vr of somatosensory cortex astrocytes showed a high level of heterogeneity ranging from 
- 100 mV up to -62 mV, but median Vr of non-juxtavascular astrocytes (black dots) and 
juxtavascular astrocytes (green squares) did not differ significantly (Figure 6d, left (Mann-
Whitney Test: p = 0.6529)). Because the IV-curves showed a liner relationship around Vr, the 
resting membrane conductance (Gr) of astrocytes could be calculated from a linear fit 
performed over five data points around Vr (Figure 6c, bottom, green line). Since the 
conductance G is the reciprocal of R, G can be derived from Ohm´s law R = V/I (where R is 
the resistance in Ohm, I is the current in Ampere and V is the voltage in Volt) hence G = 1/R 
or G = I/V. Because the slope m of the linear fit is defined as m = Δy/Δx which in our case 
relates to m = ΔI/ΔV, this leads to the formula for the conductance namely 
G[S] = ΔI[A]/ΔV[V]. The Gr determined at the steady state of astrocytic currents was 
heterogeneous with values ranging from 24 nS to 145 nS (Figure 6d; middle) with no 
significant difference between non-juxtavascular astrocytes and juxtavascular astrocytes 
(Mann-Whitney Test: p = 0.0681). As mentioned before, there is a relationship between the 
input resistance (Rin) of a cell and the Gr with G = 1/R. Hence the conductance Gr was used to 
calculate Rin = 1/Gr, which resulted in heterogeneous Rin ranging from 6.62 MΩ to 41.67 MΩ 
for somatosensory cortex astrocytes (Figure 6d, right) with no significant difference between 
the non-juxtavascular and juxtavascular astrocytes (Mann-Whitney Test: p = 0.0681).  
From these results, it was concluded, that somatosensory astrocytes show a high level of 
heterogeneity regarding their passive electrophysiological properties but no significant 
difference was observed between non-juxtavascular and juxtavascular astrocytes present in the 





3.1.2 The main current of somatosensory cortex astrocytes is carried by 
Kir4.1 channels 
The main current of astrocytes in many brain regions is carried by Kir4.1 channels (Mishima 
et al., 2007; Mishima & Hirase, 2010; Dallérac et al., 2013). Hence, it was studied whether 
astrocytes residing in the somatosensory cortex vary in their Kir4.1 current amplitudes 
dependent on their location relative to blood vessels (non-juxtavascular or juxtavascular). To 
test this, electrophysiological recordings on 6 non-juxtavascular and 4 juxtavascular astrocytes 
of 6 different animals (p24-p38) were performed under control conditions and after the wash-
in of the Kir4.1 channel blocker BaCl2 (200 µM). Vr and Gr were measured based on steady 
state IV-relationships and changes were analysed 10 minutes after Ba2+ wash-in. Figure 7a 
shows whole-cell currents of a representative juxtavascular astrocyte under control conditions 
(upper left), after the wash-in of 200 µM Ba2+ (upper right) and the effective Kir4.1 (lower left) 
current pattern, which was obtained by subtracting the current trace where Ba2+ was present 
from the control condition of the same cell. In the lower right graph corresponding IV-
relationships of all three conditions are shown. By blocking Kir4.1 channels in non-
juxtavascular astrocytes, five out of six cells changed to a significantly more positive Vr 
(Figure 7b left; Wilcoxon matched pairs test: p = 0.0469) and three out of four juxtavascular 
astrocytes showed a similar trend (Figure 7b middle; Wilcoxon matched pairs test: p = 0.2500). 
The median effective change in Vr was not different for non-juxtavascular 
(median dVr = 14 mV) and juxtavascular astrocytes (median dVr = 12mV) (Figure 7b right; 
Mann-Whitney test: p = 0.9273). Considering Gr in non-juxtavascular astrocytes, changes 
were very pronounced, with decreases up to 51 nS for one cell (Figure 7c left; Wilcoxon 
matched pairs test: p = 0.0313). The same three out of four juxtavascular astrocytes that 
showed changes for Vr also decreased in Gr. Despite being rather strong, in some cells even up 
to 38 nS, changes were not significant but showed a strong trend (Figure 7c middle; Wilcoxon 
matched pairs test: p = 0.2500). Similar to changes in Vr, there was no significant difference in 
the median change of Gr between non-juxtavascular (median dGr = 21nS) and juxtavascular 
astrocytes (median dGr = 26.5nS) detectable (Figure 7c right; Mann-Whitney test: p = 1). From 
these findings it was concluded that most of the measured astrocytes in the somatosensory 







Figure 7: Astrocytic currents in somatosensory cortex are mainly carried by the Ba2+ sensitive Kir4.1 
a: Current responses of a representative juxtavascular astrocyte are shown under control conditions (upper left), 
and after the wash in of 200 µM Ba2+ (upper right). The effective Kir4.1 current (lower left) was obtained by 
subtracting the current trace with Ba2+ from the control ones in the same cell. The graph on the lower right shows 
the IV-curves at the steady state of the three conditions: Control condition (black), Ba2+ blocked condition (green) 
and effective Kir4.1 current (blue). b: The Vr of 4 out of 6 non-juxtavascular astrocytes (left; Wilcoxon matched 
pairs test: p = 0.0469) and 3 out of 4 juxtavascular astrocytes (middle; Wilcoxon matched pairs test: p = 0.2500) 
became more positive after Ba2+ application. Comparison of the effective changes in Vr of non-juxtavascular 
astrocytes (median dVr = 14mV) to juxtavascular ones (median dVr = 12mV) showed no significant difference 
(right; Mann-Whitney test: p = 0.9273). c: The Gr of all non-juxtavascular astrocytes (left; Wilcoxon matched 
pairs test: p = 0.0313) and 3 out of 4 juxtavascular astrocytes (middle; Wilcoxon matched pairs test: p = 0.2500) 
decreased significantly after Ba2+ application. Analysis of the effective changes in Gr of non- juxtavascular 
(median dGr = 21nS) and juxtavascular (median dGr = 26.5nS) astrocytes revealed no significant difference 





3.1.3 Astrocytes in the somatosensory cortex express Kir4.1 channels 
homogenously 
To verify the previous electrophysiological findings, immunohistochemistry against the 
inwardly rectifying Kir4.1 channels was performed. Figure 8a shows an overview confocal 
image of a somatosensory cortex slice of an Aldh1l1-eGFP transgenic mouse. To determine 
the location of astrocytes towards blood vessels DyLight 649 labelled Lycopersicon 
esculentum (Tomato) lectin (TL 649) was used. Tomato lectin is known to be a marker for 
endothelial cells of the rodent vasculature as well as microglial cells (Mazzetti et al., 2004). It 
is important to note that no anti-Kir4.1-positive neurons were present throughout all cortical 
layers. At first glance, there seemed to be a difference between astrocytes in layer I, II and III 
compared to layer IV, V and VI in the Kir4.1 expression pattern; with the deeper layers showing 
much higher fluorescence intensity than the upper ones. To determine where this difference 
originated from close up images of astrocytes in different layers were analysed. All Aldh1l1-
eGFP expressing astrocytes (green in overlay) and especially astrocytic processes were 
extensively labelled with anti-Kir4.1 (red in overlay) with non-juxtavascular (white arrows) 
and juxtavascular astrocytes (blue arrows) having been equally positive for the anti-Kir4.1 
staining (Figure 8b). This leads to the conclusion that the difference in the fluorescence 
intensity did not originate from heterogeneous expression of Kir4.1 channels but was due to 
less intensively branched processes in upper layer astrocytes compared to highly branched ones 







Figure 8: Immunohistochemistry indicates homogeneous expression of Kir4.1 channels in astrocytes of the 
somatosensory cortex 
a: Confocal maximum z-projection (optical section 10-44) of an overview of an adult (p51) Aldh1l1-eGFP 
transgenic mouse control hemisphere. Three left pictures show from left to right: the Aldh1l1-eGFP expressing 
astrocytes, the anti-Kir4.1 staining and blood vessels (TL 649). The right image shows an overlay of the three 
single channels with Aldh1l1-eGFP positive astrocytes (green), the anti-Kir4.1 channel staining (red) and the 
blood vessels (blue). Scale bar 215µm. b: Maximum z-projection (optical section 5-30) of a close up of layer 
II/III astrocytes in the same slice as in a. White arrows indicate anti-Kir4.1-positive non-juxtavascular astrocytes 





To confirm the homogeneous expression of Kir4.1 channels, astrocytes of different adult mice 
(n = 3) were counted in the according cortical layers (Figure 9). Then they were analysed 
regarding their positivity for anti-Kir4.1 and whether they were non-juxtavascular or 
juxtavascular in nature. The percentage of anti-Kir4.1 positive non-juxtavascular (Nj, solid bar) 
and juxtavascular (J, chequered bar) astrocytes for each animal was plotted in a bar chart 
(Figure 9b) and the median percentage was determined for each layer. In line with the previous 
assumption, astrocytes in the somatosensory cortex expressed the inwardly rectifying Kir4.1 
channel homogenously (no median diverged more than 5 % from a complete homogeneity; see 
Material and Methods) with no significant difference being present between the medians of 
non-juxtavascular (Nj median = 100 % for all layers) and juxtavascular astrocytes (Layer I, J 
median = 98 %; Layers II/III/IV to VI, J median = 100 %) across all cortical layers (Kruskal-
Wallis test: p = 0.9175). 
 
Figure 9: Counting analysis indicates a homogeneous expression of Kir4.1 in non-juxtavascular and 
juxtavascular astrocytes across all layers of the somatosensory cortex in adult mice 
a: Schematic of a coronal section of a mouse brain at the level of the somatosensory cortex. In the left hemisphere 
the different cortical layers are depicted. In the right hemisphere the somatosensory cortex is indicated. 
Abbreviations: LI: Layer I; LII/III/IV: Layer II, III and IV; LV: Layer V; LVI: Layer VI; S1: primary 
somatosensory cortex; S2: secondary somatosensory cortex; CC: corpus callosum; HIP: hippocampus; VL: 
lateral ventricle; V3: third ventricle; Th: thalamus; Hy: hypothalamus. b: Counting analysis of anti-Kir4.1 
positive astrocytes in 3 adult Aldh1l1-eGFP mice (p40-51). Bar chart shows percentage of anti-Kir4.1 positive 
non-juxtavascular (Nj, solid bars) and juxtavascular (J, chequered bars) astrocytes. Median percentages for each 
astrocyte type were determined. Layer I (yellow): Nj median = 100 %, J median = 98 %. Layer II/III/IV (coral): 
Nj median = 100 %, J median = 100 %; Layer V (orange): Nj median = 100 %, J median = 100 %; Layer VI 
(blue): Nj median =100 %, J median = 100 %. The criteria for a homogenous expression pattern was met if the 
median percentage did not diverge more than 5 % from 100 %. Kir4.1 was homogenously expressed in all 





3.1.4 Astrocytes in the somatosensory cortex express Kir6.2 channels 
heterogeneously 
The alpha subunits Kir6.1 and Kir6.2 represent the pore forming part of the ATP-dependent, 
inwardly rectifying KATP channel. It has previously been reported that Kir6.1 is present in 
astrocytes in the hippocampus, cerebellum and cortex as well as in Bergman glia (Thomzig et 
al., 2001), whereas Kir6.2 mRNA was present in Müller glia, astrocytes in the cerebellar white 
matter and in the corpus callosum (Thomzig et al., 2001; Raap et al., 2002; Zhou et al., 2002). 
In this study, immunohistochemical stainings were performed against the Kir6.1 and Kir6.2 
subunits. In contrast to the literature, the results here showed Kir6.2 expression in astrocytes in 
the somatosensory cortex (Figure 10a) and only little to no Kir6.1 expression (data not shown). 
In layer I less anti- Kir6.2 labelling is detectable than in all other deeper cortical layers, where 
a strong anti-Kir6.2 positivity can be seen in astrocytes as well as neurons. The processes of a 
fraction of cortical Aldh1l1-eGFP astrocytes were intensely labelled with anti-Kir6.2, whereas 
astrocytic somata were labelled very sparsely (Figure 10b, red in overlay). Heterogeneous 
expression of Kir6.2 in both non-juxtavascular (white arrows) and juxtavascular astrocytes 
(blue arrows) was found throughout the somatosensory cortex (Figure 10b). Moreover, there 
were astrocytes that lack anti-Kir6.2 positivity (asterisk) regardless of the location of their 







Figure 10: Immunohistochemistry indicates heterogeneous expression of Kir6.2 channels in somatosensory 
cortex astrocytes 
a: Confocal maximum z-projection (all optical sections) of an overview of an adult (p51) Aldh1l1-eGFP 
transgenic mouse somatosensory cortex control hemisphere. The three left pictures show from left to right: the 
Aldh1l1-eGFP expressing astrocytes, the anti-Kir6.2 staining and blood vessels (TL 649). The right image shows 
an overlay of the three single channels with Aldh1l1-eGFP positive astrocytes (green), the anti-Kir6.2 staining 
(red) and the blood vessels (blue). Scale bar 215µm. b: Maximum z-projection (all optical sections) of a close up 
of layer II/III astrocytes in the same slice as in a. There are non-juxtavascular (white arrows) and juxtavascular 
(blue arrows) astrocytes positive for anti-Kir6.2. Anti-Kir6.2 negative astrocytes are marked with an asterisk. Kir6.2 
is mainly present on astrocytic processes. Heterogeneous expression was observed in cortical astrocytes 





To further analyse the distribution of Kir6.2 channels across non-juxtavascular and 
juxtavascular astrocytes, cells of 4 adult Aldh1l1-eGFP mice were counted in the according 
cortical layers (Figure 11a) and analysed for anti-Kir6.2 labelling. Analysis was performed the 
same way as mentioned in paragraph 3.1.3. Heterogeneity in Kir6.2 channel expression was 
detected throughout all layers of the somatosensory cortex (no median higher than 92 %). 
Nevertheless, despite Kir6.2 being heterogeneously expressed, there was no significant 
difference between different layers as well as between non-juxtavascular (Nj, solid bar) or 
juxtavascular (J, chequered bar) astrocytes detectable (Figure 11b; Kruskal-Wallis test: 
p = 0.8409). The sparse anti-Kir6.2 positivity of layer I (Figure 10a) was not a result of a lower 
percentage of astrocytes expressing said ion channel in comparison to other layers (Figure 
11b), but was rather due to a smaller amount of astrocytes present in layer I as well as the 
absence of anti-Kir6.2 positive neurons (see discussion). 
 
Figure 11: Counting analysis suggests a heterogeneous expression of Kir6.2 in non-juxtavascular and 
juxtavascular astrocytes across all layers of the somatosensory cortex in adult mice 
a: Schematic of a coronal section of a mouse brain at the level of the somatosensory cortex. In the left hemisphere 
the different cortical layers are depicted. In the right hemisphere the somatosensory cortex is indicated. 
Abbreviations: LI: Layer I; LII/III/IV: Layer II, III and IV; LV: Layer V; LVI: Layer VI; S1: primary 
somatosensory cortex; S2: secondary somatosensory cortex; CC: corpus callosum; HIP: hippocampus; VL: 
lateral ventricle; V3: third ventricle; Th: thalamus; Hy: hypothalamus. b: Counting analysis of anti-Kir6.2 
positive astrocytes in 4 adult Aldh1l1-eGFP mice (p36-51). Bar chart shows percentages of anti-Kir6.2 positive 
non-juxtavascular (Nj, solid bars) and juxtavascular (J, chequered bars) astrocytes. Median percentages for each 
astrocyte type were determined. Layer I (yellow): Nj median = 75 %, J median = 78 %; Layer II/III/IV (coral): 
Nj median=92%, J median=85%; Layer V (orange): Nj median=85%, J median=82%; Layer VI (blue): Nj 
median = 82 %, J median = 85 %. The criteria for a homogenous expression pattern was met if the median 
percentage did not diverge more than 5 % from 100 %. Kir6.2 was heterogeneously expressed in somatosensory 
cortex astrocytes. The heterogeneity was not dependent on the position of astrocytes towards blood vessels or on 





3.1.5 Astrocytes in the somatosensory cortex express Kv4.3 channels 
heterogeneously 
Because the Shal Kv4.3 channel subunit is present in cultured hippocampal astrocytes and is 
the main underlying source for inactivating A-type currents (IA) (Bekar, 2004).Therefore, it 
was of interest to see, whether Kv4.3 is present in somatosensory cortex astrocytes and if so, 
whether they are homogeneously or heterogeneously distributed between non-juxtavascular 
and juxtavascular astrocytes. Immunohistochemical stainings against Kv4.3 channels were 
performed in adult Aldh1l1-eGFP mice (Figure 12). Layer I was way more sparsely labelled, 
whereas the other layers showed a high amount of Kv4.3 positivity in astrocytes as well as 
neurons (Figure 12a). Astrocytic processes as well as somata (Figure 12b, green in overlay) 
were labelled by anti-Kv4.3 (Figure 12b, red in overlay). Both, non-juxtavascular (white 
arrows) and juxtavascular astrocytes (blue arrows) expressed Kv4.3. In addition, there were 
also astrocytes that lack Kv4.3 (asterisks). But their absence did not correlate with whether 
astrocytes had their cell soma directly adjacent to a blood vessel or not. Therefore, the presence 


















Figure 12: Immunohistochemistry suggests heterogeneous expression of Kv4.3 channels in astrocytes of the 
somatosensory cortex 
a: Overview confocal maximum z-projection (all optical sections) of an adult (p51) Aldh1l1-eGFP transgenic 
mouse somatosensory cortex control hemisphere. The three left pictures show from left to right: the Aldh1l1-
eGFP expressing astrocytes, the anti-Kv4.3 staining and blood vessels (TL 649). The right image shows an overlay 
of the three single channels with Aldh1l1-eGFP positive astrocytes (green), the Kv4.3 channel staining (red) and 
the blood vessels (blue). Scale bar 215µm. b: Maximum z-projection (optical sections 4-48) of a close up of layer 
II/III astrocytes in the same slice as in a. There are non-juxtavascular (white arrows) and juxtavascular (blue 
arrows) astrocytes present that are positive for anit-Kv4.3. Astrocytes that show no anti-Kv4.3 labelling are marked 
with an asterisk. Kv4.3 was heterogeneously expressed in cortical astrocytes independent of astrocytes position 





To obtain a more detailed picture of how Kv4.3 channels were distributed amongst non-
juxtavascular and juxtavascular astrocytes, cells of 7 different adult animals were counted in 
the according cortical layers as shown in Figure 13a and analysed regarding their positivity for 
anti-Kv4.3. Analysis was performed the same way as mentioned in paragraph 3.1.3. Astrocytes 
expressed Kv4.3 channels heterogeneously (no median higher than 92 %) with the exception 
of non-juxtavascular astrocytes in cortical layer VI where 100 % of astrocytes were positive 
for said ion channel (Figure 13b). Even if Kv4.3 was heterogeneously expressed no significant 
difference was present between different cortical layers. Moreover, positivity for anti-Kv4.3 
could not be related to whether an astrocyte belongs to the non-juxtavascular (Nj, solid bar) or 
juxtavascular (J, chequered bar) subtype (Kruskal-Wallis test: p = 0.5925). The sparse 
labelling by the anti-Kv4.3 antibody that was observed (Figure 12a) could not be explained by 
a lower percentage of astrocytes expressing said ion channel but, was rather due to a smaller 








Figure 13: Counting analysis indicates a heterogeneous expression of Kv4.3 in non-juxtavascular and 
juxtavascular astrocytes across all layers of the somatosensory cortex in adult mice 
a: Schematic of a coronal section of a mouse brain at the level of the somatosensory cortex. In the left hemisphere 
the different cortical layers are depicted. In the right hemisphere the somatosensory cortex is indicated. 
Abbreviations: LI: Layer I; LII/III/IV: Layer II, III and IV; LV: Layer V; LVI: Layer VI; S1: primary 
somatosensory cortex; S2: secondary somatosensory cortex; CC: corpus callosum; HIP: hippocampus; VL: 
lateral ventricle; V3: third ventricle; Th: thalamus; Hy: hypothalamus. b: Counting analysis of anti-Kv4.3 positive 
astrocytes in 7 adult Aldh1l1egfp mice (p36-51). Bar chart shows percentages of Kv4.3 positive non-juxtavascular 
(Nj, solid bars) and juxtavascular (J, chequered bars) astrocytes. Median percentages for each astrocyte type were 
determined. Layer I (yellow): Nj median = 89 %, J median = 75 %; Layer II/III/IV (coral): Nj median = 92 %, J 
median =80 %; Layer V (orange): Nj median = 91 %, J median = 78 %; Layer VI (blue): Nj median = 100%, J 
median = 75 %. The criteria for a homogenous expression pattern would have been met if the median percentage 
did not diverge more than 5 % from 100 %: Kv4.3 was heterogeneously expressed in somatosensory cortex 
astrocytes. Heterogeneity was not depending on the position of astrocytes towards blood vessels or on the cortical 





3.1.6 Astrocytes can be classified into non-passive and passive types 
according to their electrophysiological properties 
As previously described by several groups (Zhou, 2005; Houades et al., 2008; Kafitz et al., 
2008), astrocytes in the barrel cortex and the hippocampus transition during development from 
mainly non-passive astrocytes to mainly passive, ohmic ones whose currents are 
predominantly carried by inwardly rectifying ion channels. To see, whether the same 
predominantly passive current responses were present in the somatosensory cortex of adult 
Aldh1l1-eGFP mice, cells were clamped to the Vr recorded in current clamp mode and 
subsequently 200 ms long voltage steps, ranging from -176 mV to +174 mV (Figure 6b, small 
insert) were injected to obtain the current response (Figure 14a). There were two different types 
of astrocytes present. The majority of astrocytes showed typical ohmic passive current 
responses (Figure 14a, c) with linear IV-curves (Figure 14b). The other 26 % of astrocytes 
showed non-passive current response patterns (Figure 14a, c) with non-linear IV relationships 
(Figure 14b). It has been shown that these two different types of astrocytes are also present in 
the developing mouse lateral superior olive (LSO) of the auditory brainstem, with a decrease 
in the fraction of non-passive cells during development (Stephan & Friauf, 2014). Here, the 
same electrophysiological experiments as in the somatosensory cortex were performed on 
astrocytes in the LSO of Aldh1l1-eGFP mice (p15-p30; n=9). At these ages cells are known to 
be already more likely to be passive (Stephan & Friauf, 2014). Non-passive current patterns 
could be observed in 34 % of these astrocytes (Figure 14a, c) accompanied by non-linear IV-
relationships (Figure 14b) and 66 % of cells showed passive ohmic currents (Figure 14a, c) 
and associated linear IV-curves (Figure 14b). Somatosensory cortex astrocytes did not differ 
from LSO astrocytes regarding the ratio of non-passive to passive cells (Figure 14c; Fisher´s-
exact test: p = 0.2800). When passive properties of somatosensory cortex astrocytes were 
compared to those in the LSO, all three parameters tested were significantly different (Figure 
14d-f). The Vr of LSO astrocytes (Figure 14d; median Vr = -82 mV) was significantly more 
positive (Mann-Whitney test: p = 0.0058) than in cortical ones (median Vr = -85 mV). In 
addition, Gr and Rin differed significantly between the two groups (Figure 14e, f; Mann-
Whitney test: p = 0.0305), with LSO astrocytes having a much higher Gr (median Gr = 93 nS) 






Figure 14: Astrocytes can be classified according to their current response pattern into passive and non-
passive  
a: Example current responses of non-passive and passive somatosensory astrocytes (upper pictures) as well as for 
non-passive and passive LSO astrocytes (lower pictures). b: Corresponding steady state IV-relationships for the 
four astrocytes displayed in a. The IV-curves of non-passive cells are displayed in rose, the passive IV-
relationships are coded in blue. LSO astrocytes are visualised by crosses, data points for somatosensory cortex 
astrocytes by circles. c: Bar plot for the distribution on a percentage basis of non-passive and passive astrocytes 
in the somatosensory cortex and the LSO. Non-passive cells are coded in rose and passive cells in blue. A Fisher´s-
exact test showed no significant difference in the ratio of non-passive to passive cells for both brain regions 
(p = 0.2800). d: Comparing the Vr of somatosensory cortex astrocytes (median Vr = -84.5 mV) and LSO 
astrocytes(median Vr = -82mV), showed a significant difference (Mann-Whitney test: p = 0.0058). e: Regarding 
Gr somatosensory cortex astrocytes (median Gr = 75 nS) differed significantly (Mann-Whitney test: p = 0.0305) 
from LSO astrocytes (median Gr = 93 nS). f: Comparison of the Rin of somatosensory cortex astrocytes (median 
Rin = 13.33 MΩ) and LSO astrocytes (median Rin = 10.75 MΩ) also showed a significant difference (Mann-





Gr = 75 nS; median Rin = 13.33 MΩ). To conclude, astrocytes of the somatosensory cortex 
were comparable to LSO astrocytes regarding their ratio of non-passive and passive current 
patterns which is in line with previously published results from the LSO, the barrel cortex as 
well as the hippocampus (Zhou, 2005; Kafitz et al., 2008; Stephan & Friauf, 2014). However, 
there was a significant difference between their passive properties, which might be due to 
different patterns of expressed ion channels, transporters or receptors. 
3.1.7 Passive and non-passive current patterns in juxtavascular and non-
juxtavascular somatosensory cortex astrocytes 
Next it was assessed if the fractioning into non-passive and passive current patterns of 
astrocytes in the healthy somatosensory cortex was related to whether astrocytes are 
juxtavascular or non-juxtavascular in nature. When the 74 control astrocytes (43 non-
juxtavascular, 31 juxtavascular) from unlesioned brains were sorted according to their current 
pattern, the majority displayed passive properties (70 % of non-juxtavascular, 81 % 
juxtavascular astrocytes) (Figure 15a). Testing for differences between the two subgroups, a 
Fisher´s-exact test showed no significance (p = 0.0996). Next passive properties of non-
juxtavascular and juxtavascular astrocytes were analysed when they were sorted according to 
non-passive and passive current patterns (Figure 15b-d). For all following analysis in this 
thesis, if more than two groups were compared in one graph, a Kruskal-Wallis test was 
performed to clarify if there is a difference between all respective groups. If the Kruskal-Wallis 
test was significant, a Mann-Whitney test was used to perform further testing of groups that 
were of interest and a Bonferroni correction was used to determine the adequate p value (alpha 
corrected). Regarding Vr, there was no difference between the two astrocyte subgroups (Figure 
15b; Kruskal-Wallis test: p = 0.3571). However, Gr did differ significantly between the 
subgroups (Figure 15c; Kruskal-Wallis test: p = 0.0004). Non-juxtavascular passive astrocytes 
had in general a 30 nS higher Gr than the non-juxtavascular non-passive astrocytes (Mann-
Whitney test: p = 0.0003; Bonferroni: alpha corrected = 0.025). The same significant 
difference was found (Kruskal-Wallis test: p = 0.0004) between the median Rin of non-
juxtavascular passive astrocytes (Figure 15d), which was with 13.33 MΩ significantly lower 
than in non-juxtavascular non-passive ones (Mann-Whitney test: p = 0.0003; Bonferroni: alpha 





non-juxtavascular astrocytes differ from their juxtavascular counterparts nor did passive 
astrocytes vary dependent on their localisation (non-juxtavascular vs. juxtavascular) in all 
analysed parameters. This lead to the conclusion, that the positions of the cell somata with 
respect to the vasculature did not play a role in whether astrocytes have passive or-non-passive 
current patterns in the healthy brain.  
  
Figure 15: Comparison of non-juxtavascular and juxtavascular astrocytes regarding non-passive and 
passive current patterns 
a: 74 control astrocytes (43 non-juxtavascular, 31 juxtavascular) were sorted according to their current pattern. 
Non-passive cells are shown in rose; passive ones are coded in blue. 30 % of non-juxtavascular astrocytes 
displayed non-passive current patterns and 70 % passive ones. 19 % of juxtavascular astrocytes displayed non-
passive and 81 % passive current patterns. A Fisher´s-exact test showed no significance (p = 0.0996). b: 
Comparison of the Vr of non-passive (rose) and passive (blue) non-juxtavascular (dots) and juxtavascular 
astrocytes (squares) showed no significant difference (Kruskal-Wallis test: p = 0.3571). c: Comparison of the Gr 
of non-passive (rose) and passive (blue) non-juxtavascular (dots) and juxtavascular (squares) astrocytes showed 
a significant difference (Kruskal-Wallis test: p = 0.0004). The median Gr of non-juxtavascular non-passive 
(45 nS) and non-juxtavascular passive (75 nS) astrocytes differed significantly (Mann-Whitney test: p = 0.0003; 
Bonferroni: alpha corrected = 0.025). d: Comparison of the Rin of non-passive (rose) and passive (blue) non-
juxtavascular (dots) and juxtavascular (squares) astrocytes showed a significant difference (Kruskal-Wallis test: 
p = 0.0004). The median Rin of non-juxtavascular non-passive astrocytes (22.22 MΩ) is significantly different 
from the one of non-juxtavascular passive ones (13.33 MΩ) (Mann-Whitney test: p = 0.0003; Bonferroni: alpha 





3.1.8 Identification of HCN channels in the healthy somatosensory cortex 
It has been shown, that reactive astrocytes after ischemia upregulate the expression of certain 
sets of HCN cation channels that give rise to so called Ih currents (Honsa et al., 2014). 
Furthermore, they found that astrocytes in healthy control brains show no signs of HCN 
channel expression at all. To test whether astrocytes in the somatosensory cortex show HCN 
currents and whether there is a difference in the expressions of said channels between non-
juxtavascular and juxtavascular astrocytes, electrophysiological experiments were performed 
on 10 astrocytes (3 juxtavascular, 7 non-juxtavascular) from different animals (p26-37; n = 6). 
The astrocytes were clamped to the cells membrane potential measured in current clamp mode 
and then subsequently injected with 1 s long voltage steps ranging from -176 mV to -16 mV 
in 10 mV increments (Figure 16a´) to obtain the current responses (Figure 16a). Consecutively, 
the astrocytes were incubated with the selective HCN channel blocker ZD7288 (50 μM) for 10 
minutes before the recordings were repeated in the same cell (Figure 16b). The mean current 
for each trace at around the steady state (0.90 s-0.99 s), the corresponding IV-relationship 
before and after ZD 7288 application as well as the one for the effective current response from 
the difference trace (Figure 16d) were calculated. A reduction in the slope of the IV-curves 
after ZD7288 application was observed. However, the subtraction of the ZD7288-blocked 
current response pattern from the control condition (Figure 16c and d) did not show typical Ih 
characteristics. Furthermore, as the IV-relation of the difference current was linear this effect 
is most likely not related to a blockage of HCN channels by ZD7288 but might rather be due 
to an ion channel rundown (see discussion). This led to the conclusion that functional HCN 







Immunohistochemical stainings against the HCN1, HCN2 and HCN3 cation channels were 
performed. Cortical astrocytes were solely positive for the anti-HCN1 channel staining, 
whereas stainings aimed at the HCN2 (Figure 24a) and HCN3 (data not show) subunits 
produced negative results in the healthy brain. The processes and somata of cortical Aldh1l1-
eGFP astrocytes (Figure 17, green in overlay) were labelled with anti-HCN1 (Figure 17, red 
in overlay). Non-juxtavascular (white arrows) and juxtavascular astrocytes (blue arrows) that 
Figure 16: Identification of hyperpolarisation-activated cyclic nucleotide-gated (HCN) cation channels  
a: Current responses of a non-juxtavascular example astrocyte. a’: Small insert shows the stimulus that was used 
to activate HCN channels. Astrocytes were clamped to the cells Vr measured in current clamp mode and 
subsequently injected with 1s long voltage steps ranging from -176 mV to -16 mV in 10 mV. b: Current response 
of the same astrocyte after 10 minute incubation with the HCN channel blocker ZD7288 (50 μM). c: Effective 
current obtained by the subtraction of the ZD7288 blocked current responses from the control condition is shown 
in the difference trace. d: The mean current for each trace at around the steady state (0.90s-0.99s) was calculated 
and the corresponding IV-relationship before (black squared line) and after ZD7288 application (green squared 





were positive for HCN1 were found. In addition, there were also astrocytes that lack HCN1 
channels (asterisk). But their absence did not correlate with astrocytes having their cell somata 
directly adjacent to a blood vessel or not. Therefore, the presence of the HCN1 subunit 
appeared to be heterogeneously amongst cortical astrocytes. Interestingly, this was in contrast 
to the electrophysiological experiments of this study in which no typical Ih currents were 
observed (see discussion). 
Figure 17: Immunohistochemistry revealed heterogeneous expression of HCN1 channels 
Maximum z-projection (all optical sections) of a close up of layer II/III in a somatosensory cortex slice of an adult 
(p51) Aldh1l1-eGFP mouse. The pictures show: the Aldh1l1-eGFP expressing astrocytes, the anti-HCN1 staining 
and blood vessels (TL 649).The right lower image shows an overlay of the three single channels with Aldh1l1-
eGFP positive astrocytes (green), the HCN1 channel staining (red) and the blood vessels (blue).White arrows 
indicate non-juxtavascular astrocytes and blue arrows point to juxtavascular ones that are positive for anti-HCN1. 
Astrocytes that show no HCN1 labelling are marked with an asterisk. HCN1 was heterogeneously expressed in 
cortical astrocytes but the heterogeneity was not relatable to the astrocytes position towards blood vessels or 





3.2 Characterization of juxtavascular and non-juxtavascular astrocytes 
in the somatosensory cortex of the lesioned brain  
In the healthy brain no differences between non-juxtavascular and juxtavascular astrocytes 
regarding their passive electrophysiological properties as well as their ion channel expression 
patterns were observed. The second possibility how ion channels might be involved in the 
proliferation of astrocytes is their up- or downregulation in a certain subset of astrocytes in 
response to a traumatic event. Hence, in the second part of this thesis it was assessed whether 
a stab wound lesion in the brain, which induces astrocytes to become reactive, would lead to a 
difference in ion channel composition in the two subclasses of reactive astrocytes. 
3.2.1 Electrophysiological characterization of juxtavascular and non-
juxtavascular astrocytes in the somatosensory cortex of the lesioned 
brain 
To identify potential changes in passive properties of non-juxtavascular and juxtavascular 
astrocytes induced by a brain lesion, electrophysiological voltage-clamp experiments on 
somatosensory cortex slices of 7 adult animals (p27-p50) were performed exactly the same 
way as in paragraph 3.1. The animals were injured with a stab wound lesion in the 
somatosensory cortex either 1, 3 or 5 days prior to the patch-clamp experiments. For the lesion, 
a small cranial window was removed from the skull and subsequently a lancet was used to 
introduce a 0.6 mm deep and 1.0 to 1.5 mm long micro lesion into the parietal cortex 
parasagittal to the midline (Figure 18a, lesion marked in red). Astrocytes were identified by 
the green fluorescence of the intracellularly expressed Aldh1l1-eGFP as shown in Figure 18b. 
To distinguish between non- juxtavascular and juxtavascular astrocytes the blood vessels were 
visualized by injecting Texas Red® labelled dextran (50 µl) into the tail vein, 10-15 minutes 
prior to the decapitation of the animals (Figure 18b). Additionally blood vessels were identified 
by the criteria mentioned in paragraph 3.1. The lesion was easily identifiable with bright field 
microscopy as seen in Figure 18b and astrocytes surrounding the lesion within a radius of 25 
to 275 µm were recorded. In total 33 astrocytes (58 % non-juxtavascular, 42 % juxtavascular) 






Figure 18: Electrophysiological characterization of juxtavascular and non-juxtavascular astrocytes in the 
somatosensory cortex after a stab wound lesion  
a: Schematic of a mouse brain with a stab wound lesion in the somatosensory cortex (upper picture). The middle 
picture shows a coronal section through the brain at the level of the lesion. The lower picture depicts a blow up 
of the lesion and the surrounding cortical tissue. Neurons are shown in lilac, astrocytes in green. Astrocytes 
surrounding the lesion become reactive (dark green soma, light green nucleus) hypertrophic and polarize towards 
the lesion. Astrocytes further away from the lesion are not activated (light green soma, dark green nucleus). SC: 
Spinal Cord; Cb: Cerebellum; Ctx: Cortex; OB: Olfactory Bulb; S1: Primary Somatosensory Cortex; S2: 
Secondary Somatosensory Cortex; HIP: Hippocampus; VL: Lateral Ventricle; V3: 3rd Ventricle; Th: Thalamus; 
Hy: Hypothalamus; CC: Corpus Callosum; L: Lesion b: Coronal section of a lesioned brain at the level of the 
somatosensory cortex. Left upper picture shows a bright field (BF) overview (scale bar 504 µm) of the lesion 
(pink dotted line). The other two lines are fibres of the grid. The right BF picture shows the same region magnified 
(scale bar 29µm). Left lower picture shows the corresponding Aldh1l1-eGFP positive astrocytes. Juxtavascular 
astrocytes are marked with cyan arrows, non-juxtavascular ones white arrows. Blood vessels are labelled by Texas 
Red-conjugated dextran (right lower picture red arrows). The patched astrocyte (white asterisk) is filled with 
Alexa 568 dye delivered through the patch pipette. c: In total 33 reactive astrocytes (58 % non-juxtavascular; 
42 % juxtavascular) and 74 control cells (58 % non-juxtavascular; 42 % juxtavascular) were analysed. d: 
Comparison of the median Vr of non-juxtavascular (black) and juxtavascular (green) astrocytes of the healthy 
somatosensory cortex (dots) to astrocytes from lesioned brains (triangles)showed no significant difference 
(Kruskal-Wallis test: p = 0.4634). The same was true or Gr and Rin (middle and right graph); (Kruskal-Wallis test: 





It has been shown that the peak proliferation of astrocytes surrounding the lesion occurs at 5dpi 
(Sirko et al., 2015). However, it is possible that changes in ion channel composition and 
therefore passive electrophysiological properties were already starting prior to induce cell 
cycle progression. Hence, cells at three different time points post injury (1dpi n = 4, 3dpi n = 4, 
5dpi n = 25) were analysed. But, there was no significant difference in the median Vr (Figure 
19a; Kruskal-Wallis test: p = 0.8161), Gr (Figure 19b; Kruskal-Wallis test: p = 0.7403) and Rin 
(Figure 19c; Kruskal-Wallis test: p = 0.7403) detected. 
Therefore, patch-clamp recordings were mainly conducted on mice at 5dpi and all reactive 
astrocytes were pooled together for the following analysis. As juxtavascular astrocytes are 
more prone to proliferate in response to brain injury, it was determined whether the lesion 
induced a difference in the passive properties of non-juxtavascular and juxtavascular 
astrocytes. After a lesion the Vr (Figure 18d, left) of non-juxtavascular (median = -83 mV) and 
juxtavascular astrocytes (median = -88.5 mV) did not differ significantly within the subclasses 
of reactive astrocytes, nor when compared to the values of control astrocytes (non-
juxtavascular: median = -83 mV; juxtavascular: median = - 87 mV) (Kruskal-Wallis test: 
p = 0.4634). Regarding the Gr (Figure 18c, middle) of reactive astrocytes the medians of non-
juxtavascular cells (median = 87 nS) and juxtavascular ones (median = 69 nS) did not 
significantly differ. In addition, no significant variations were detected when compared to non-
juxtavascular (median = 70 nS) and juxtavascular (median = 85 nS) control astrocytes 
(Kruskal-Wallis test: p = 0.2119). As expected, the Rin (Figure 18c, right) of non-juxtavascular 
(lesion: median = 11.49 MΩ; control: median = 14.29 MΩ) and juxtavascular (lesion: 
Figure 19: Comparison of passive electrophysiological properties at different time points after a stab 
wound lesion 
Reactive astrocytes were recorded at three different days post injury (1dpi, n = 4; 3dpi, n = 4; 5dpi, n = 25). The 
comparison shows no significant difference for a: Vr (Kruskal-Wallis test: p = 0.8161) b: Gr (Kruskal-Wallis test: 






median = 14.54 MΩ; control: median = 11.76 MΩ) astrocytes did not vary significantly 
neither in the lesion nor in comparison to control astrocytes (Kruskal-Wallis test: p = 0.2119).  
In conclusion, passive electrophysiological properties of somatosensory cortex astrocytes, 
which became reactive after a stab wound brain lesion, showed a high level of heterogeneity 
comparable to the situation in unlesioned, healthy control animals. However, this heterogeneity 
could not be related to whether an astrocyte was non-juxtavascular or juxtavascular in nature. 
There also was no significant difference in the passive properties of reactive astrocytes 
compared to non-reactive control ones.  
3.2.2 A stab wound lesion in the somatosensory cortex changes the ratio of 
non-passive to passive astrocytes 
Next it was assessed if astrocytes in the lesioned brain also show differences in their passive 
properties (Vr, Gr, Rin) if sorted regarding whether they are non-passive or passive in nature 
like they did in the healthy brain. 14 juxtavascular and 19 non-juxtavascular astrocytes in the 
lesioned brain were analysed and compared to the 74 control astrocytes from healthy animals.  
After a lesion was introduced into the brain, reactive non-juxtavascular and juxtavascular 
astrocytes were much more prone to display non-passive current patterns in contrast to control 
conditions, where most of the astrocytes had passive current patterns (Chi-Square test: 
p < 0.0001). After the stab wound lesion, changes in the ratio of non-passive to passive current 
patterns could be observed in non-juxtavascular astrocytes, with 53 % of cells showing non-
passive current patterns whereas in the control condition only around one third of non-
juxtavascular astrocytes (30 %) were non-passive (Figure 20a). Likewise, 64 % of 
juxtavascular astrocytes were non-passive (Figure 20a) in the lesioned animals. This was in 
great contrast to astrocytes in the healthy brain, where 81 % of cortical juxtavascular astrocytes 
showed passive current patterns (Figure 20a). Considering the Gr and the Rin, there were clear 
differences between the groups of astrocytes present (Figure 20c, d; Kruskal-Wallis test: 
p < 0.0001). Non-juxtavascular non-passive and passive astrocytes differed significantly from 
each other (Mann-Whitney test: p = 0.0003; Bonferroni: alpha corrected = 0.0125). In contrast, 







test: p = 0.3433). Compared to the control condition, in which non-juxtavascular non-passive 
and passive astrocytes were significantly different in respect to the Gr and the Rin (Figure 20c, 
d), these astrocytes seemed to lose their dissimilarity due to the brain lesion.  
Figure 20: Comparison of non-juxtavascular and juxtavascular astrocytes regarding non-passive and 
passive current patterns under control conditions and after a stab wound lesion 
a: 74 control astrocytes (43 non-juxtavascular, 31 juxtavascular astrocytes) and 33 reactive astrocytes (19 non-
juxtavascular, 14 juxtavascular) from lesioned brains were sorted according to their current pattern. Non-passive 
cells are shown in rose; passive ones are coded in blue. In the healthy brain (control) 30 % of non-juxtavascular 
astrocytes displayed non-passive and 70 % passive current patterns. 19 % of juxtavascular astrocytes displayed 
non-passive and 81 % passive current patterns. In lesioned brains 53 % of non-juxtavascular and 64 % of 
juxtavascular astrocytes had non-passive current patterns. 47 % of reactive non-juxtavascular and 36 % reactive 
juxtavascular astrocytes displayed passive current patterns. A Chi-square test showed that the subgroups are 
significantly different (p < 0.0001). b: Comparison of the Vr of non-passive (rose) and passive (blue) non-
juxtavascular (rhombus) and juxtavascular astrocytes (squares) of lesioned and healthy animals showed no 
significant difference in (Kruskal-Wallis test: p = 0.3433). c: Comparison of the Gr of non-passive (rose) and 
passive (blue) non-juxtavascular (rhombus) and juxtavascular (squares) astrocytes of lesioned and healthy 
animals showed a significant difference (Kruskal-Wallis test: p < 0.0001) between non-juxtavascular non-passive 
and passive control astrocytes (Mann-Whitney test: p = 0.0003). d: The Rin of non-passive (rose) and passive 
(blue) non-juxtavascular (rhombus) and juxtavascular (squares) astrocytes in lesioned animals and under control 
conditions was significantly different (Kruskal-Wallis test: p < 0.0001 between non-juxtavascular non-passive 






Summarizing, astrocytes that became reactive after a stab wound lesion were more prone to 
display non-passive current patterns than non-reactive astrocytes in the healthy brain.  
Since no difference in ion channel expression between non-juxtavascular and juxtavascular 
astrocytes was found in the healthy brain it was of great interest to consider whether the stab 
wound lesion induced a difference in ion channel expression in reactive non-juxtavascular and 
juxtavascular somatosensory cortex astrocytes and if a relationship between proliferation and 
ion channel expression could be detected. 
3.2.3 Kir4.1 channels are downregulated in proliferating astrocytes after 
stab wound lesion  
In paragraph 3.1.3 it has been shown that Kir4.1 channels were homogenously expressed in 
astrocytes of the healthy somatosensory cortex and there was no difference in the expression 
pattern between non-juxtavascular and juxtavascular astrocytes. Therefore, the same anti-
Kir4.1 antibody that was previously used in the healthy brain was applied after a stab wound 
lesion was introduced and paired with TL 649 for blood vessels labelling. Additionally, an 
anti-Ki67 antibody that labels proliferating cells in all phases of the cell cycle except for the 
M-phase was applied. Figure 21a shows detailed confocal images of a stab wound lesion in the 
somatosensory cortex of an Aldh1l1-eGFP mouse 5dpi. As TL 649 not only labels the 
vasculature but also rodent microglia cells (Mazzetti et al., 2004), a high amount of activated 
microglia can be seen infiltrating the lesion site (Figure 21a). Many non-proliferating reactive 
astrocytes (both non-juxtavascular and juxtavascular) were positive for anti-Kir4.1 (white 
arrows) comparable to control conditions. Moreover, proliferating (anti-Ki67 positive) non-
juxtavascular and juxtavascular astrocytes were found that were additionally positive for anti-
Kir4.1 (dashed double arrows). There were also proliferating non-juxtavascular and 
juxtavascular astrocytes present, that showed little to no labelling with anti-Kir4.1 (asterisk) 
even up to the point where it looks like “holes” in the tissue in the anti-Kir4.1 staining (dashed 
encircling). Comparing these empty spots to the Aldh1l1-eGFP fluorescence clearly showed 
that these astrocytes were in fact present and occupying their astrocytic domain but had lost 
their positivity for anti-Kir4.1. Moreover there was evidence that proliferating astrocytes vary 






Figure 21: Kir4.1 channels are downregulated in a fraction of proliferating reactive astrocytes 5dpi 
a: Confocal maximum z-projection (optical sections 1-27) of a lesioned hemisphere 5dpi in an adult (p51) 
Aldh1l1-eGFP transgenic mouse. The four upper pictures show the Aldh1l1-eGFP expressing astrocytes, the anti-
Kir4.1 staining, blood vessels and activated microglia (TL 649) and the proliferation marker anti-Ki67. The left 
lower picture shows an overlay of Aldh1l1-eGFP positive astrocytes (green) and the blood vessels and activated 
microglial cells (red). The right overlay shows Aldh1l1-eGFP positive astrocytes (green), the anti-Kir4.1 staining 
(red) and the anti-Ki67 positive proliferating nuclei (blue). Arrows indicate non-juxtavascular and juxtavascular 
non-proliferating astrocytes positive for anti-Kir4.1. Dashed double arrows point to non-juxtavascular and 
juxtavascular astrocytes double positive for anit-Kir4.1 and anti-Ki67. Anti-Kir4.1 negative but anti-Ki67 positive 
astrocytes are marked with an asterisk. Dashed circle highlights the astrocytic domain of two anti-Kir4.1 negative 
proliferating astrocytes. Scale bar 38µm. b: Proliferating anti-Ki67 positive non-juxtavascular and juxtavascular 
astrocytes were counted in two lesioned Aldh1l1-eGFP mice (p51) 5dpi. Out of 80 proliferative cells 64 % were 
positive for anti-Kir4.1. Out of 29 proliferative non-juxtavascular astrocytes 83 % were labelled by anti-Kir4.1. 





For quantification, proliferating anti-Ki67 positive astrocytes (n = 80) were counted in two 
lesioned mice 5dpi and contemplated regarding their anti-Kir4.1 positivity as well as their 
position towards blood vessels. In total 64 % of proliferating (anti-Ki67 positive) astrocytes 
were positive for anti-Kir4.1 (Figure 21b, upper pie chart). When proliferating astrocytes were 
sorted according to whether they were non-juxtavascular or juxtavascular in nature, it became 
clear that the majority (83 %) of proliferating non-juxtavascular astrocytes expressed Kir4.1 
(Figure 21b, middle pie chart). Interestingly, only 53 % of proliferating juxtavascular 
astrocytes were positive for anti-Kir4.1 (Figure 21b, lower pie chart).  
Summarizing, a fraction of proliferating (anti-Ki67 positive) astrocytes downregulated Kir4.1 
of which the majority were juxtavascular ones  
3.2.4 Kir6.2 show the same heterogeneous distribution 5dpi like in control 
conditions 
To determine whether there was a change in Kir6.2 channel expression 5dpi compared to the 
heterogeneity present under control conditions (see paragraph 3.1.4) immunohistochemical 
stainings were performed with anti-Kir6.2 antibodies in somatosensory cortex slices of lesioned 
adult Aldh1l1-eGFP mice (5dpi; Figure 22). The anti-Kir6.2 staining was paired with TL 649 
for blood vessels labelling and the proliferation marker anti-Ki67 was used. Like in Figure 21a 
TL 649 showed extensive labelling of activated microglia infiltrating the lesion site in addition 
to blood vessel labelling (Figure 22). Comparable to the findings under control conditions the 
anti-Kir6.2 positivity was present on non-juxtavascular as well as juxtavascular non–
proliferating astrocytes (Figure 22, arrows). Moreover, there were also non-proliferating anti-
Kir6.2 negative non-juxtavascular and juxtavascular astrocytes (hollow arrows) present 
surrounding the lesion which was in line with the heterogeneous expression found in control 
conditions. Proliferating (anti-Ki67 positive) non-juxtavascular and juxtavascular astrocytes 
that were also labelled by anti-Kir6.2 (dashed double arrows) could be detected. In contrast to 
control conditions where anti-Kir6.2 was predominantly visible on astrocytic processes, the 







Figure 22: The channel Kir6.2 channel show the same heterogeneous distribution 5dpi as in control 
conditions  
Confocal maximum z-projection (optical sections 5-35) of a lesioned hemisphere 5dpi in an adult (p51) Aldh1l1-
eGFP mouse. The four upper pictures show the Aldh1l1-eGFP expressing astrocytes, the anti-Kir6.2 staining, 
blood vessels and activated microglia (TL 649) and the proliferation marker anti-Ki67. The left lower picture 
shows an overlay of Aldh1l1-eGFP positive astrocytes (green) and the blood vessels and activated microglial 
cells (red). The right overlay shows Aldh1l1-eGFP positive astrocytes (green), the anti-Kir6.2 staining (red) and 
anti-Ki67 positive proliferating nuclei (blue). Arrows indicate non-juxtavascular and juxtavascular non-
proliferating astrocytes positive for anti-Kir6.2. Dashed double arrows point to non-juxtavascular and 
juxtavascular astrocytes double positive for anit-Kir6.2and anti-Ki67. Astrocytes that show no Kir6.2 labelling 





Overall the heterogeneity of Kir6.2 in astrocytes was maintained after a stab wound lesion with 
no difference between non-juxtavascular and juxtavascular astrocytes. Also proliferation 
seemed to have no impact on Kir6.2 expression. 
3.2.5 Heterogeneous expression of Kv4.3 channels is preserved in lesioned 
mice 5dpi 
In paragraph 3.1.5 it has been shown that Kv4.3 ion channels are heterogeneously expressed in 
astrocytes of the healthy somatosensory cortex. This heterogeneity was independent of the 
position of astrocytic somata towards the vasculature and the cortical layer they resided in. To 
determine whether the same was true after a stab wound lesion was inflicted into the 
somatosensory cortex immunohistochemistry with anti-Kv4.3 was performed in combination 
with TL 649 for blood vessels labelling and the proliferation marker anti-Ki67 on Aldh1l1-
eGFP mice 5dpi (Figure 23). Again TL 649 showed extensive labelling of activated microglia 
infiltrating the lesion site in addition to blood vessel labelling (Figure 23). Comparable to 
control conditions, non-juxtavascular and juxtavascular non-proliferating astrocytes could be 
found that were labelled with anti-Kv4.3 (Figure 23, arrows) as well as astrocytes that were 
negative for anti-Kv4.3 (hollow arrows). Moreover, there were proliferating anti-Ki67 positive 
non-juxtavascular and juxtavascular astrocytes present that were positive for anti-Kv4.3 
(dashed double arrows) as well as proliferating astrocytes that were negative for anti-Kv4.3 
(asterisk). This was in line with the heterogeneity of Kv4.3 seen under control conditions. 
Interestingly, more intense anti-Kv4.3 labelling was observed in some polarized astrocytic 
processes, which might be due to an upregulation of Kv4.3 in certain astrocytes or be the result 
of hypertrophy in this processes. This observation could neither be related to whether 







Figure 23: The Kv4.3 channel show the same heterogeneous distribution 5dpi as in control conditions  
Confocal maximum z-projection (optical sections 15-51) of a lesioned hemisphere 5dpi in an adult (p51) Aldh1l1-
eGFP mouse. The four upper pictures show the Aldh1l1-eGFP expressing astrocytes, the anti-Kv4.3 staining, the 
blood vessels and activated microglia (TL 649) and the proliferation marker anti-Ki67. The left lower picture 
shows an overlay of Aldh1l1-eGFP positive astrocytes (green) and blood vessels and activated microglial cells 
(red). The right overlay shows Aldh1l1-eGFP positive astrocytes (green), the anti-Kv4.3 staining (red) and the 
anti-Ki67 positive proliferating nuclei (blue). Arrows indicate non-juxtavascular and juxtavascular non-
proliferating astrocytes positive for anti-Kv4.3. Dashed double arrows point to non-juxtavascular and 
juxtavascular astrocytes double positive for anit-Kv4.3 and anti-Ki67. Proliferative astrocytes that are negative 
for Kv4.3 are marked with an asterisk. Astrocytes that show no Kv4.3 labelling and are negative for anti-Ki67 are 





3.2.6 HCN2 becomes upregulated in a subset of astrocytes at 5dpi 
As already mentioned before, it has been shown that reactive astrocytes upregulate the 
expression of certain sets of HCN channels that give rise to so called Ih currents weeks after 
ischemia (Honsa et al., 2014). The previous immunohistochemical findings in this study 
confirmed the presence of the HCN1 channel in healthy control animals (see paragraph 3.1.8.). 
Next it was of great interest to see if a stab wound lesion would induce an upregulation in HCN 
channels already 5dpi. Therefore immunohistochemical stainings for HCN1, HCN2 and HCN3 
channel were done on somatosensory cortex slices of lesioned adult Aldh1l1-eGFP mice 
(5dpi). For the HCN1 channel which was heterogeneously expressed in astrocytes of the 
healthy brain no changes in the expression pattern was found 5dpi (data not shown). The HCN3 
channel was neither expressed in astrocytes under control conditions nor after a stab wound 
lesion (5dpi; data not shown). Regarding the HCN2 channel which was not detectable in 
astrocytes in the healthy somatosensory cortex (Figure 24a, hollow arrows) an upregulation of 
said ion channel in a subset of reactive astrocytes was observed 5dpi (Figure 24b). The HCN2 
staining was paired with TL 649 for blood vessels labelling and the proliferation marker anti-
Ki67. As above TL 649 showed extensive labelling of activated microglia infiltrating the lesion 
site in addition to blood vessel labelling. In stark, contrast to control conditions intense 
upregulation of HCN2 channels was seen in processes of certain reactive, polarizing astrocytes 
(Figure 24b). Anti-HCN2 labelling was present in processes of non-juxtavascular and 
juxtavascular non-proliferating astrocytes (arrows). Nevertheless, there were also anti-HCN2 
negative non-juxtavascular and juxtavascular astrocytes present (hollow arrows) suggesting a 
heterogeneous expression of HCN2 channels after a stab wound lesion. Regarding anti-Ki67 
positive proliferating astrocytes, anti-HCN2 labelling was also heterogeneous with some 
proliferating astrocytes expressing HCN2 channels whereas others were negative for anti-








Figure 24: HCN2 channels become upregulated in a subset of reactive astrocytes 5dpi 
a: Confocal maximum z-projection (all optical sections) of a control hemisphere in an adult (p51) Aldh1l1-eGFP 
mouse. From left to right the Aldh1l1-eGFP expressing astrocytes and the anti-HCN2 staining are shown. The 
right image shows an overlay of the two single channels with Aldh1l1-eGFP positive astrocytes (green) and anti-
HCN2 (red). Astrocytes showed no sign of anti-HCN2 positivity indicated by hollow arrows. Anti-HCN2 positive 
neurons were present. Scale bar 41µm. b: Maximum z-projection (optical sections 10-33) of a close up of 
astrocytes surrounding the lesion in an adult (p51) Aldh1l1-eGFP mouse at 5dpi. The four upper pictures show 
Aldh1l1-eGFP expressing astrocytes, the anti-HCN2 staining, blood vessels and activated microglia (TL 649) and 
the proliferation marker anti-Ki67. Left lower picture shows an overlay of Aldh1l1-eGFP positive astrocytes 
(green) and blood vessels and activated microglial cells (red). Right overlay shows Aldh1l1-eGFP positive 
astrocytes (green), the anti-HCN2 staining (red) and the anti-Ki67 positive proliferating nuclei (blue). Arrows 
indicate non-juxtavascular and juxtavascular non-proliferating astrocytes labelled by anti-HCN2. Proliferative 
astrocytes that are negative for anti-HCN2 are marked with an asterisk. Astrocytes that show no anti-HCN2 











The aim of this doctoral thesis was to characterize non-juxtavascular and juxtavascular 
astrocytes regarding their ion channel expression pattern and electrophysiological properties 
to analyse if there are differences present between the two astrocyte subsets that might be 
responsible for their differential reaction to traumatic events. This discussion will elaborate the 
findings in the healthy somatosensory cortex, which show that the two subgroups are not 
inherently different regarding their ion channel expression pattern. Moreover, the results 
gathered in the two astrocyte subgroups after a stab wound lesion was inflicted will be 
elaborated and compared to the healthy control brain. Astrocytes transition from mainly 
passive current response patterns, which are present in non-reactive healthy somatosensory 
cortex astrocytes, to non-passive current response patterns, when they become reactive in 
response to traumatic brain injury. Moreover, the shift in ion channel expression patterns in 
response to traumatic brain injury will be elucidated and critically examined in the context of 
proliferation. 
4.1 Passive electrophysiological properties of non-juxtavascular and 
juxtavascular astrocytes before and after a lesion 
In this study, the passive electrophysiological properties Vr (resting membrane potential), Gr 
(resting membrane conductance) and Rin (input resistance) were used to define whether there 
are differences present between non-juxtavascular and juxtavascular astrocytes. In the healthy 
brain the two astrocyte subtypes did not differ significantly regarding any of these passive 
properties (Figure 6d). However, great heterogeneity in Vr, Gr and Rin could be observed 
between single astrocytes of both groups (Figure 6d). The Vr lay between -100 mV and 
- 62 mV with the median of both subtypes being more negative than - 80mV. This suggests a 
dominant role of inwardly rectifying K+ channels of the Kir4.1 type in the majority of 
somatosensory cortex astrocytes as these channels maintain a Vr close to the K
+ equilibrium 
potential (EK) of around -80 mV. (Mishima et al., 2007; Seifert et al., 2009; Mishima & Hirase, 
2010; Dallérac et al., 2013; Verkhratsky & Nedergaard, 2015, 2018). This is well known from 
Bergman glia as well as astrocytes in the neocortex, hippocampus, the medial nucleus of the 
trapezoid body (MNTB) and the lateral superior olive (LSO) (Clark & Barbour, 1997; Matthias 





et al., 2009; Reyes-Haro et al., 2010; Uwechue et al., 2012; Stephan & Friauf, 2014). Even if 
the median Vr in somatosensory cortex astrocytes was hyperpolarised, the great heterogeneity 
between the cells is not completely in line with the very negative astrocytic Vrs that are reported 
for most astrocytes. However, in contrast to other studies, in which astrocytes with depolarised 
membrane potentials are excluded, here it was decided to include all astrocytes that showed 
stable recordings over time. This prevented the exclusion of astrocytes with a more depolarized 
Vr. McKhann et al. (1997) critically discussed studies that excluded astrocytes with a 
depolarized Vr and were able to show that cultured neocortical rat astrocytes, as well as 
astrocytes in hippocampal slices of rats showed great heterogeneity in Vr independent of 
external and developmental factors. They propose that variations in Vr stem from dynamic 
changes in cell coupling that help and facilitate spatial K+ buffering (McKhann et al., 1997). 
Studies in the rodent optic nerve also show heterogeneous and depolarized resting membrane 
potentials in mature astrocytes that seem to be caused by protein kinase A (PKA) and cAMP 
(Bolton et al., 2006).  
Gr and its inverse Rin were used as other passive electrophysiological parameters to compare 
non-juxtavascular and juxtavascular astrocytes. The same as for Vr, also Gr and Rin did not 
differ between non-juxtavascular and juxtavascular astrocytes and showed great heterogeneity 
amongst single astrocytes (Figure 6d). Both astrocyte subgroups had a very low Rin (Figure 
6d), which is in line with literature (Zhou, 2005; Kafitz et al., 2008; Seifert et al., 2009; Ma et 
al., 2014; Stephan & Friauf, 2014). The underlying cause of the high Gr and very low Rin is the 
high amount of Kir4.1 channels present in astrocytic membranes (Mishima et al., 2007; 
Mishima & Hirase, 2010; Dallérac et al., 2013). The heterogeneity observed in my study, might 
be attributed to the various functions these cells have to perform, as well as to different ion 
channel and transmitter receptor expression, a variance in morphology and the different 
cortical layers they are residing in (Matyash & Kettenmann, 2010). Furthermore, the 
heterogeneity in gap-junctional coupling between astrocytes, which leads to isopotentiality in 
astrocytic networks, has to be considered (Ma et al., 2016). It has also been shown by clonal 
Star Track analysis in mice, that the clonal identity of an astrocyte defines heterogeneity in 
cortical astrocytes. For example astrocytes of different lineage origin are arranged in specific 





astrocytes of a specific clonal origin also possess special electrophysiological features that 
delineate them from other clones.  
After a stab wound lesion, Vr, Gr and Rin did not differ significantly between non-juxtavascular 
and juxtavascular reactive astrocytes. Moreover, they were similar compared to the ones from 
healthy control conditions (Figure 18d). It has been shown that reactive astrocytes in the 
hippocampus of rats have a depolarized Vr already 3 days after an ischemic event caused by a 
downregulation of Kir4.1 ion channels in these cells (Pivonkova et al., 2010). This 
downregulation would also result in smaller Gr and higher Rin values which was not observed 
here. Another study showed that 5 weeks after global cerebral ischemia in rats, the Vr of 
astrocytes is depolarized accompanied by an increase in the cells´ Rin (Honsa et al., 2014). In 
mice that suffer from focal cerebral ischemia, Vr was also depolarized, while Rin decreased 
significantly (Honsa et al., 2014). However, it might be possible, that Kir4.1 channels are not 
the only K+ conducting channels that contribute to the negative Vr of astrocytes and that other 
ion channels are able to mask the effect of Kir4.1 loss (Ferroni et al., 2003; Kucheryavykh et 
al., 2006; Djukic et al., 2007; Kucheryavykh et al., 2009). Also, it is important to keep in mind 
that the previously discussed results stem from experiments where astrocytes become reactive 
due to an ischemic event, while here astrocyte reactivity was induced by a stab wound lesion. 
It is known that astrocytes react differently depending on the underlying cause of an injury as 
well as the severity of the insult (Sofroniew & Vinters, 2010). Moreover, scratch wound assays 
in rat spinal cord astrocyte cultures trigger proliferation of astrocytes, accompanied by a 
downregulation of Kir4.1 currents as well as an upregulation of outwardly rectifying currents 
resulting in a more depolarized Vr compared to non-proliferating astrocytes (MacFarlane & 
Sontheimer, 1997). However, spinal cord astrocytes and astrocytes in the somatosensory cortex 
might react differently. As mentioned above, astrocytes of different lineage origin are arranged 
in specific cortical domains (García-Marqués & López-Mascaraque, 2013). It has been shown 
via clonal Star Track analysis that astrocytes of different clonal origin react differently to 
mechanical cortical injury in mice. Even astrocytes with the same clonal background show 
dissimilar responses. This suggests that the astrocytic response to injury is depending on 





Most importantly, here (for electrophysiological recordings), I did not differentiate between 
proliferating and non-proliferating reactive astrocytes. Astrocytes were sorted according to 
their location towards the vasculature, meaning that reactive non-proliferating non-
juxtavascular and juxtavascular astrocytes were mixed with proliferating ones. In future 
experiments it would be of great interest to compare reactive proliferating astrocytes to their 
reactive non-proliferating counterparts. This would especially be important, because as 
previously elaborated in the introduction, a negative Vr is linked to the incapability of a cell to 
enter the cell cycle while a depolarized Vr promotes cell cycle progression and hence 
proliferation (Blackiston et al., 2009). 
4.2 Homogeneous Kir4.1 expression is lost in a subset of astrocytes that 
proliferate after a stab wound lesion 
As discussed in the previous paragraph, it might be possible that not in all of the astrocytes that 
were recorded in somatosensory cortex of Aldh1l1-eGFP mice, Kir4.1 channels are the 
dominating K+ conducting channels. This could explain why non-juxtavascular and 
juxtavascular astrocytes in the somatosensory cortex did not differ significantly regarding their 
passive properties but showed great all over heterogeneity.  
Therefore, I performed Ba2+ (200 µM) blocking experiments on both astrocyte subtypes to 
show whether Kir4.1 channels are the dominating ion channels in cortical astrocytes, as well 
as to clarify if there are differences in Kir4.1 expression between the two respective groups in 
the healthy brain (Figure 7). Ba2+ interacts with Kir4.1 channels in the deep binding site of the 
pore, where only a single ion is capable of blocking the whole channel (Standen & Stanfield, 
1978; Shieh et al., 1998). The majority of non-juxtavascular and juxtavascular astrocytes were 
sensitive to Ba2+ showing decreased Kir4.1 currents accompanied by a tendency towards a more 
positive Vr (Figure 7b) and a decrease in Gr (Figure 7c). These findings were reinforced by 
immunohistochemistry performed on healthy control somatosensory cortex slices. I found, that 
mature astrocytes in somatosensory cortex express the inwardly rectifying Kir4.1 ion channel 
homogenously independent of their somal position towards blood vessels and across all 
cortical layers (Figure 8 and 9). This is in accordance with literature, where it has been shown 
that Kir4.1 ion channels are the dominating channel type defining the membrane conductance 





rodents (Steinhäuser et al., 1992; Müller et al., 1994; Chvátal et al., 1995; Pastor et al., 1995; 
Olsen et al., 2007; Seifert et al., 2009). Moreover, especially astrocytic processes are 
excessively labelled by anti-Kir4.1 showing that non-juxtavascular and juxtavascular astrocytes 
analysed here represent mature astrocytes. It is known that there is a developmentally regulated 
shift from somatic expression of said ion channel towards the processes between postnatal day 
0 to 60 in rats (Moroni et al., 2015), which is also accompanied by an increase in Kir4.1 channel 
density in mice (Seifert et al., 2009). However, other studies also suggest important roles of 
two-pore-domain potassium channels of the TWIK-1 and TREK-1 subtype for the passive 
conductance of mature astrocytes at least in the hippocampus of rodents (Seifert et al., 2009; 
Zhou et al., 2009). Kir4.1 channel expression is known to be positively correlated with end-
differentiated cells and therefore seems to influence the proliferative potential (Sontheimer et 
al., 1989; Barres et al., 1990; MacFarlane & Sontheimer, 1997, 2000; Olsen & Sontheimer, 
2004). The results discussed above clearly indicate that if a difference in Kir4.1 expression 
between non-juxtavascular and juxtavascular astrocytes would be involved in their distinct 
proliferative behaviour after brain injury, this must occur after the traumatic event has 
happened. 
Five days after a stab wound lesion was introduced into the brain the homogeneous expression 
of Kir4.1 channels, present under control conditions, was disrupted. 36 % of all proliferating 
reactive astrocytes completely downregulated Kir4.1 channel expression (Figure 21b and 
Figure 25b, c). Only 17 % of proliferating non-juxtavascular astrocytes lost their Kir4.1 
positivity while 47 % of proliferating juxtavascular astrocytes completely lacked Kir4.1 (Figure 
21b). In rat spinal cord cultures proliferating BrdU+ astrocytes are known to show a reduction 
in Vr, Gr as well as an increase in Rin attributed to Kir4.1 downregulation, suggesting that this 
change is crucial for cell proliferation (MacFarlane & Sontheimer, 1997). The results in my 
study are in line with these findings leading to the conclusion that also in cortical astrocytes 
the reduction of Kir4.1 seems to be essential for cell proliferation (Figure 25). Also other studies 
have previously described a downregulation of Kir4.1 ion channels in reactive astrocytes. 
Seven days after crush spinal cord injury in adult rats, Kir4.1 protein expression was found to 
be downregulated by up to 80 % in reactive astrocytes surrounding the lesion site; a change 
that persists up to four weeks post injury (Olsen et al., 2010). Additionally, RT-PCR and 





channels were downregulated as a function of time after injury (Gupta & Prasad, 2013). In 
both studies, in addition to a decrease in Kir4.1 expression, a downregulation of the glutamate 
transporter GLT-1 was found (Olsen et al., 2010; Gupta & Prasad, 2013). As Kir4.1 ion 
channels and the GLT-1 transporter are known to work together to prevent excitotoxicity in 
the CNS, the authors suggested that this downregulation would have detrimental effects after 
a lesion. It has also been reported that already 3 days after an ischemic event reactive astrocytes 
in the hippocampus of rats downregulated Kir4.1 channels accompanied by depolarisation in 
these cells (Pivonkova et al., 2010). 
Proliferating astrocytes that still expressed Kir4.1 in their membrane, varied strongly in their 
intensity for anti- Kir4.1 positivity (Figure 21a and Figure 25). One might speculate that these 
astrocytes were in a different phase of the cell cycle, where Kir4.1 downregulation was still in 
progress. While cells are known to still be hyperpolarised at the transition from G1- into the S-
phase, depolarisation is crucial during the S-phase and the transition from S-phase to the G2-
phase (Blackiston et al., 2009; Urrego et al., 2014). As Ki67 labels all active phases of the cell 
cycle (G1-, S- and G2-phase) (Kim et al., 2017; Gerdes et al., 2018), Kir4.1 positive cells might 
be in the early phases of the cell cycle and hence at the start of Kir4.1 downregulation. Thus, it 
would be of interest for follow up experiments, to use proliferation markers that label later 
stages of the cell cycle in which the membrane is known to be depolarised the most (Blackiston 
et al., 2009; Urrego et al., 2014). This could help to determine whether all proliferative 
astrocytes completely downregulate their Kir4.1 expression at some point. One candidate 
marker would be anti-PHH3 (phospho-histone 3) that labels the mitosis phase (Kim et al., 
2017). Also cyclins and their primary CDK partners would be a good target. Cyclin A, which 
activates its partner CDK2 as well as CDC2 to initiate the transition from the S- to G2-phase 
and peaks during the G2- an M-phase, would be a promising candidate. Moreover, cyclin B1 
also activates CDC2 and initiates the transition from the G2- into M-phase while peaking 
during the late G2- and early M-phase, and thus would be an appropriate marker 
(Darzynkiewicz et al., 1996).  
As Kir4.1
-/- mouse models exist and have been used to prove the importance of Kir4.1 channels 
in mature, non-reactive astrocytes it would be of interest to use Kir4.1 deficient mice for further 





one would be able to determine whether non-reactive astrocytes in the CNS of these animals 
already proliferate without an injury, just due to a depolarized Vr and the lack of Kir4.1 
channels. Second, it would be interesting to resolve whether proliferation of reactive astrocytes 
in these animals would be enhanced in response to traumatic injury.  
This could be of great importance, as it has been shown that enhanced proliferation of 
astrocytes surrounding a lesion initiated by a lack of monocyte invasion led to a decrease in 
astrocyte reactivity accompanied by a reduction of the glia scar with less extracellular matrix 
deposition. This resulted in higher neuronal coverage surrounding the smaller lesion site (Frik 
et al., 2018). Thus, one might speculate that if proliferation could be enhanced by blocking or 
knocking down astrocytic Kir4.1 channel functions, regeneration and protection of the tissue 
surrounding the lesion could be enhanced. Hence, astrocytic Kir4.1 channels might be a target 












4.3 Astrocyte reactivity results in a shift towards non-passive current 
responses especially in juxtavascular astrocytes 
I found two different types (non-passive and passive) of current responses in mature 
somatosensory astrocytes in Aldh1l1-eGFP mice. Typical Ohmic passive current patterns 
(Figure 14a) with linear IV-curves (Figure 14b) were dominant in the healthy brain. 
Nevertheless, 26 % of astrocytes show non-passive current response patterns (Figure 14a, c) 
with non-linear IV-relationships (Figure 14b). Astrocytes in the barrel cortex, the brainstem 
and the hippocampus of rodents are known to transition during development from mainly non-
passive outwardly rectifying astrocytes to mainly passive ones, whose currents are 
predominantly carried by inwardly rectifying ion channels (Zhou, 2005; Houades et al., 2008; 
Kafitz et al., 2008; Stephan & Friauf, 2014). Additionally, many other K+ channels are known 
to be present in astrocytic membranes which together with the Kir4.1 ion channels are the 
underlying cause for mainly passive current patterns that result in linear IV-relationships 
(Pastor et al., 1995; Isokawa & McKhann, 2005; Fazel et al., 2006; Djukic et al., 2007; 
Adermark & Lovinger, 2008; Du et al., 2015). 
The presence of non-passive current patterns in astrocytes of healthy animals that were seen in 
this study might be explained by their age (postnatal day 24 to 48). It has been shown that in 
rodent astrocytes there is a continuous increase in Kir4.1 expression until postnatal day 60 
(Zhou, 2005; Houades et al., 2008; Kafitz et al., 2008; Seifert et al., 2009; Stephan & Friauf, 
Figure 25: Kir4.1 channels become downregulated in a subset of proliferating astrocytes after TBI 
a: 74 control astrocytes (43 non-juxtavascular and 31 juxtavascular astrocytes) and 33 reactive astrocytes (19 
non-juxtavascular and 14 juxtavascular) from lesioned brains were sorted according to their current pattern. Under 
control conditions, only 30 % of non-juxtavascular and 19 % of juxtavascular astrocytes display non-passive 
current patterns. In the lesioned brains 53 % of non-juxtavascular and 64 % of juxtavascular astrocytes have non-
passive current patterns. A Chi-square test shows that the subgroups are significantly different (p < 0.0001). b: 
Proliferating anti-Ki67 positive non-juxtavascular and juxtavascular astrocytes were counted in two adult lesioned 
Aldh1l1-eGFP mice 5dpi. Out of the 80 proliferative cells 64 % were positive for anti-Kir4.1 c: Confocal 
maximum z-projection (optical sections 1-27) of an adult (p51) Aldh1l1-eGFP transgenic mouse lesioned 
hemisphere 5dpi. The upper picture shows the anti-Kir4.1 staining, the lower one the proliferation marker anti-
Ki67. Arrows indicate non-proliferating astrocytes labelled by anti-Kir4.1. Dashed double arrows point to 
astrocytes double positive for anit-Kir4.1 and anti-Ki67. Astrocytes that show no Kir4.1 labelling but are 
proliferative are marked with an asterisk. The dashed circle indicates the astrocytic domain of two proliferating 
astrocytes that are negative for anti-Kir4.1. Scale bar 57µm. d: Schematic of the lesioned cortex. Reactive 
proliferating astrocytes (dark green, pink nucleus) downregulate Kir4.1 channels. Reactive non-proliferating 





2014; Moroni et al., 2015). At embryonic stage E20, Kir4.1 is nearly undetectable in astrocytes 
in the hippocampus and somatosensory cortex of rats. During development Kir4.1 is 
upregulated to the point, where it is the dominating ion channel at around p60 (Moroni et al., 
2015). In addition, electrophysiological recordings have shown that the activity of Kir4.1 
channels increases enormously over the course of the first postnatal weeks accompanied by a 
change in astrocyte morphology and passive electrophysiological properties in rats and mice 
(Bordey & Sontheimer, 1997; Seifert et al., 2009). Hence, it might have been possible that not 
in all of the somatosensory cortex astrocytes recorded in this study, Kir4.1 channels were the 
dominating K+ conducting channels. Even though I found homogeneous expression of Kir4.1 
channels in healthy somatosensory cortex astrocytes (Figure 8 and 9) it might be possible that 
in some astrocytes Kir4.1 expression was indeed present but still relatively low and hence did 
not constitute the dominating current. I obtained similar results for astrocytes in the lateral 
superior olive in Aldh1l1-eGFP mice. Passive astrocytes with non-linear IV-relationships were 
already dominating (66 %) between the ages p15-p30 (Figure 14c). Somatosensory cortex 
astrocytes differed from those in the lateral superior olive regarding their passive properties 
(Vr, Gr, Rin) (Figure 14d, e, f). However, these discrepancies might be explained by the fact 
that on average, younger animals have been used in LSO recordings than in somatosensory 
cortex ones, and hence the transition towards higher levels of Kir4.1 channel expression was 
not as advanced as in somatosensory cortex astrocytes. It also has to be considered that 
different types of ion channels, transporters and transmitter receptors might be present in LSO 
astrocytes that cater to the special needs of LSO neurons that receive excitatory as well as 
inhibitory inputs to process interaural level differences (Grothe et al., 2010). 
In young rodent astrocytes, the dominant currents are known to be delayed rectifying (Id) and 
transient (IA) currents caused by voltage-activated K
+ channel (Kv) subfamilies (Bordey & 
Sontheimer, 1997; Seifert et al., 2009). Kv channel expression and the according Id and IA 
currents are known to be associated with immature astrocytes that are either still mitotic or 
have proliferative potential, whereas Kir4.1 channel expression is strongly linked to end-
differentiated non-proliferative astrocytes (Sontheimer, 1994; Roy & Sontheimer, 1995; 
Bordey & Sontheimer, 1997; MacFarlane & Sontheimer, 1997, 2000; Higashimori & 
Sontheimer, 2007). Hence, I studied whether the non-passive current patterns already 





19 % of cortical juxtavascular astrocytes showed non-passive and 81 % passive current 
patterns while 30 % of non-juxtavascular astrocytes displayed non-passive and 70 % passive 
ones (Figure 15a). Even though I found that Kir4.1 was homogenously expressed in non-
reactive somatosensory cortex astrocytes, one might speculate, that the underlying cause for 
such dominance in passive current patterns of juxtavascular astrocytes might be due to higher 
amounts of Kir4.1 expression. Maybe the close association of juxtavascular astrocytes with the 
vasculature is linked to increased amounts of Kir4.1 channels in the membrane of these cells, 
as it has previously been shown in rats that Kir4.1 channels are preferably located on astrocytic 
endfeet, that are in contact with either blood vessels or synapses (Higashi et al., 2001). 
Analysing passive electrophysiological properties of non-juxtavascular and juxtavascular 
astrocytes when sorted according to non-passive and passive current patterns revealed a 30 nS 
higher Gr accompanied by a 13 MΩ lower Rin in non-juxtavascular passive astrocytes than in 
non-juxtavascular non-passive astrocytes (Figure 15c, d). This difference might be attributed 
to the high Gr of Kir4.1 channels (Bordey & Sontheimer, 1997; Seifert et al., 2009) that might 
be more extensively expressed in these passive cells.  
After the stab wound lesion, the ratio of non-passive to passive current patterns in reactive 
astrocytes changed drastically. 53 % of reactive non-juxtavascular astrocytes displayed non-
passive current patterns while in the control condition only around 30 % did so (Figure 25a). 
In reactive juxtavascular astrocytes even a bigger portion, namely 64 % of cells, showed a non-
passive current response pattern while under control conditions only 19 % behaved like this 
(Figure 25a). This transition from mainly passive current response patterns towards non-
passive ones in reactive astrocytes can be explained by my findings that Kir4.1 was 
downregulated in proliferating astrocytes. Also, that a higher proportion of juxtavascular 
astrocytes displayed non-passive current patterns compared to non-juxtavascular ones was in 
line with the much higher amount of proliferating juxtavascular astrocytes that completely 
lacked Kir4.1. These findings suggest, that reactive astrocytes transition from typical mature 
astrocytes with passive current responses back towards a state where they much more represent 
immature astrocytes with non-passive current patterns. As previously mentioned it is known 
from literature that non-passive current patterns present in immature astrocytes are related to a 
dominance of delayed rectifying (Id) and transient (IA) currents, caused by the presence of Kv 





Seifert et al., 2009). Hence, the shift towards non-passive current patterns would likely be 
accompanied by a more positive Vr, as well as a decrease in Gr and an increase in Rin. The 
results shown here, are only partly in line with these assumptions. As mentioned, the Vr of the 
different subgroups of reactive astrocytes did not differ (Figure 20b). Gr and Rin of non-
juxtavascular non-passive and passive astrocytes did change in comparison to control 
conditions by losing their significant dissimilarity (Figure 20c, d). Opposite to what one would 
expect, Rin decreased in reactive non-juxtavascular non-passive astrocytes accompanied by an 
increase in Gr. This discrepancy might be explained by an upregulation of other ion channels 
in these astrocytes. For example, HCN channels that are known to be expressed in reactive 
astrocytes in rodents (Rusnakova et al., 2013; Honsa et al., 2014) might influence astrocytic 
Gr and Rin and are also known to contribute to a hyperpolarised Vr. The upregulation of HCN 
channels in reactive astrocytes will be discussed in detail in paragraph 4.6. In addition, cultured 
rat astrocytes in in-vitro ischemia models are known to upregulate two-pore-domain potassium 
channels of the TREK2 subtype (Kucheryavykh et al., 2009).  
For future studies it would be of interest to segregate reactive astrocytes not only into non-
juxtavascular and juxtavascular, but also focus on whether an astrocyte is proliferative or not. 
Here also reactive astrocytes were taken into account that were clearly non-proliferative and 
as already discussed in the last paragraph, ion channel expression patterns were different in 
reactive non-proliferating astrocytes compared to proliferating ones.  
4.4 Kir6.2 channels are heterogeneously expressed in astrocytes before 
and after a lesion 
The Kir6 channel subfamily forms ATP-sensitive K
+ channels (KATP) that are involved in 
metabolic processes in many cell types (Hille, 1992). They are known to be present in rat 
astrocytes and speculated to play a role in the cells´ protection after metabolic stress as well as 
the regulation of gap-junctional permeability (Thomzig et al., 2001; Wu et al., 2011). 
Therefore, they are perfect candidates to be involved in astrocytic behaviour following an 
injury.  
In the healthy, unlesioned somatosensory cortex, immunohistochemical stainings showed, that 





expression was found. Kir6.2 labelling was detectable throughout all cortical layers in 
astrocytes, as well as in neurons. Especially astrocytic processes of a fraction of cortical 
astrocytes were intensely positive for the Kir6.2 antibody, whereas astrocytic somata were very 
sparsely labelled. I found heterogeneous expression of Kir6.2 in cortical astrocytes, however, 
heterogeneity did not relate to whether an astrocytes was non-juxtavascular or juxtavascular 
(Figure 10 and Figure 11). In agreement with my findings, Kir6.2 mRNA is known to be present 
in other astrocyte types like Müller glia in the retina, astrocytes in the cerebellar white matter 
and the corpus callosum of rats and guinea-pigs (Thomzig et al., 2001; Raap et al., 2002; Zhou 
et al., 2002). In contrast, it has been shown by means of immunohistochemistry that only the 
Kir6.1 subunit and not Kir6.2 is present in rat cortical astrocytes (Thomzig et al., 2001).  
After a stab wound lesion was introduced into the brain, the heterogeneity in Kir6.2 expression 
was maintained up to 5dpi and non-juxtavascular and juxtavascular astrocytes did still not 
differ. Also proliferation did not impact Kir6.2 expression. Interestingly, a shift from Kir6.2 
channels mainly being present on astrocytic processes under control conditions towards more 
somal regions in reactive astrocytes could be observed (Figure 22). This shift might protect 
astrocytes from metabolic stress after traumatic events. As astrocytic processes polarize 
towards a lesion and astrocytic domains are broken up after an injury this could lead to the 
reorganisation of Kir6.2 (Wilhelmsson et al., 2006; Sofroniew, 2009; Sofroniew & Vinters, 
2010). As the expression of Kir6.2 in cortical astrocytes is controversial, nothing is known 
about an up or downregulation of said ion channel in reactive astrocytes yet. Hence it might be 
of interest to verify Kir6.2 expression in somatosensory cortex astrocytes by in situ 
hybridization as well as single-cell RT-PCR to verify gene expression in single astrocytes 
(Toledo-Rodriguez & Markram, 2014) and compare them before and after a lesion.  
4.5 Kv4.3 channels are upregulated in polarized processes of reactive 
astrocytes 
In cultured rat hippocampal astrocytes, pharmacological experiments showed that 70 % of A-
type currents in these cells are generated by the Kv4 channel subfamily and the main subtype 
present is the Shal Kv4.3 channel subunit (Bekar, 2004). Kv4 channel subfamilies are also 
known to play an important role in regulation of cell proliferation and to influence cell cycle 





Here I showed by means of immunohistochemistry, that Kv4.3 labels processes of cortical 
astrocytes as well as astrocytic somata. Both non-juxtavascular and juxtavascular astrocytes 
expressed Kv4.3 heterogeneously throughout all layers of the healthy somatosensory cortex. 
One exception are non-juxtavascular astrocytes in cortical layer VI that are 100 % Kv4.3 
positive (Figure 12 and Figure 13). An explanation might be the type of progenitor cell these 
astrocytes are derived from. It is known that progenitor cells residing in the marginal zone of 
the embryonic and neonatal cortex of mice give rise to astrocytes residing in cortical layer I-
IV, while astrocytes in deeper cortical layers are generated by a different subset of progenitor 
cells (Costa et al., 2007; Breunig et al., 2012; Schitine et al., 2015). In addition, the clonal 
identity of an astrocyte, which defines heterogeneity in these cells in the cortex, and the 
subsequent arrangement of astrocytes in specific cortical domains might influence Kv4.3 
heterogeneity (García-Marqués & López-Mascaraque, 2013). The heterogeneously expressed 
Kv4.3 is probably at least one of the ion channels present in astrocytes that display non-passive 
current patterns observed in the electrophysiological experiments of this study.  
Five days after a stab wound lesion reactive non-juxtavascular and juxtavascular astrocytes 
retained their heterogeneity regarding Kv4.3 channel expression. Heterogeneous expression 
was also observed in proliferating astrocytes. Nevertheless, more intense anti-Kv4.3 labelling 
was present in hypertrophic, polarized astrocytic processes (Figure 23). A potential explanation 
might be an optical effect, as swollen processes are bigger and therefore labelling could appear 
more intense even if there is no upregulation of the ion channel in reality. However, if the more 
intense labelling of astrocytic processes would be due to swelling, this effect would have to be 
observed for all ion channel stainings performed in my study. But polarization and hypertrophy 
did not influence the intensity of the anti-Kir4.1, anti-Kir6.2 and anti-HCN2 channel labelling 
(Figure 21, 22, 24) suggesting that an upregulation of Kv4.3 was happening indeed. Astrocyte 
proliferation is often preceded by polarization of astrocytic processes towards the lesion site 
(Bardehle et al., 2013). This further reinforces the upregulation of Kv4.3 observed here. 
Because it is known that delayed rectifying (Id) and transient (IA) currents, caused by the 
presence of Kv channels, are dominant in young and immature astrocytes that are either still 
mitotic or have the potential to proliferate (Bordey & Sontheimer, 1997; Seifert et al., 2009). 
Kv4.3 upregulation on astrocytic processes might be important for subsequent proliferation of 





dominating in reactive proliferating astrocytes in rat spinal cord cultures (MacFarlane & 
Sontheimer, 1997). The upregulation of Kv4.3 channels in polarized reactive astrocytes, 
together with the downregulation of Kir4.1, might be the origin of the high increase of non-
passive current patterns observed in reactive astrocytes by means of electrophysiology (Figure 
20 and 25a).  
Even though Kv4.3 channels are present in astrocytes and upregulated in reactive ones after 
injury, I found no functional IA currents in electrophysiological recordings performed in this 
study. However, this might be explained by the small amplitude of these currents and thus they 
are masked by the much larger and dominating Kir4.1 currents in astrocytes (Bekar, 2004; 
Seifert et al., 2009). Hence for future experiments one should consider to perform 
electrophysiological recordings combined with pharmacological blocking of Kir4.1 channels 
on non-reactive and reactive, non-juxtavascular and juxtavascular astrocytes to verify the 
presence of IA currents evoked by Kv4.3. In addition, it would be interesting to see if IA current 
amplitudes are bigger in proliferating cells than in non-proliferating ones. 
4.6 HCN channel expression patterns in astrocytes are altered after a 
stab wound lesion 
It has been shown that HCN channels are involved in the cell cycle progression of embryonic 
stem cells. Blocking of these channels with ZD7288 decreased the amounts of cells in G0-state 
and G1-phase and increased the amount of embryonic stem cells in the S-phase (Lau et al., 
2011). Transcripts of HCN channels are present in primary astrocyte cultures and post-
ischemic astrocytes of rats and mice and might therefore play a role in cation influx in these 
cells (Rusnakova et al., 2013; Honsa et al., 2014). In my study, electrophysiological whole-
cell patch-clamp experiments performed on healthy somatosensory cortex astrocytes showed 
a reduction in the slope of the IV-relationship after ZD7288 application (Figure 16). It is 
important to note that the reduction in the slope of the IV-curves that was observed after HCN 
channel blocker (ZD7288) application is a linear reduction (Figure 16d). HCN current-voltage 
relationships are nearly linear quite similar to the ones for Kir channels, but their reversal 
potential lies at around -20 mV (Hille, 1992). The IV of the difference current (subtraction of 
the blocked current response pattern from the control condition) (Difference Trace; Figure 16c 





very negative (below -80 mV) and resembles the one caused by Kir4.1 channels and not HCN 
channels, which lies at around - 20mV (Hille, 1992). Moreover, the reversal potential before 
and after the application of the HCN channel blocker remained similar. This suggests no or 
only little involvement of HCN channels in the measured currents. Hence the current reduction 
I observed here might most probably be due to a run-down of Kir4.1 channels over the course 
of the recording period. Another possibility might be a slightly higher input resistance caused 
by eventual clogging of the electrode after the long recording. However, immunohistochemical 
stainings in my study showed that cortical astrocytes were positive for anti-HCN1 in the 
healthy somatosensory cortex (Figure 17), while HCN2 (Figure 24a) and HCN3 (data not 
shown) were not present at all. Moreover, the expression of HCN1 is heterogeneous but not 
linked to whether an astrocyte is non-juxtavascular or juxtavascular in nature (Figure 17). One 
explanation for the absence of functional HCN1 currents in electrophysiological recordings of 
this study might be the extremely high amount of Kir4.1 currents and their run-down that might 
mask the much smaller HCN currents. As it has been discussed in previous paragraphs Kir4.1 
current amplitudes are very high. Therefore, it might be of interest to repeat the HCN channel 
blocking experiments under the presence of the Kir4.1 channel blockers. Ba
2+ would be the best 
choice because in comparison to other Kir4.1 channel blockers like Cs
+ and Rb+, it does not 
strongly block HCN currents (Hille, 1992). However this might be difficult as Ba2+ often times 
impacts the longevity of the cell and the wash-in of the HCN channel blocker (ZD7288) takes 
time. Additionally, ZD7288 also activates and inhibits several other types of ion channels like 
low-threshold Ca2+ channels, Nav1.4 channels and NMDA-evoked currents that might also be 
present in astrocytes (Felix et al., 2003; Klar et al., 2003; Wu et al., 2012; Han et al., 2013). 
Therefore, it is possible that the application of ZD7288 simultaneously activates or inhibits 
other channels, which could mask the effect of the HCN channel blocking. The presence of 
HCN1 in cortical astrocytes observed here is only partially in line with literature. Even though 
HCN1-4 channel mRNA is present in astrocytes of the healthy rodent brain in small amounts 
(Rusnakova et al., 2013), another study has shown that HCN1 channels were only present in 
polydendrocytes but not in other glia cells in the rodent cortex (Honsa et al., 2014). However, 
the results from my study are strongly supported by the aforementioned presence of small 
amounts of HCN1 channel mRNA expression seen in single cell RT-qPCR experiments 





why no HCN currents were detectable in electrophysiological recordings in my study. This 
might be the result of to the heterogeneous expression which I found for HCN1 channels in the 
somatosensory cortex and the very minimal percentage of HCN1-4 channel transcripts known 
to be present in the healthy rodent brain (Rusnakova et al., 2013; Honsa et al., 2014). It is 
possible that the number of studied astrocytes was simply too small to have the chance of 
recording from an astrocyte with functional HCN channels. 
As already mentioned, reactive astrocytes are known to upregulate the expression of certain 
sets of HCN channels weeks after ischemia in rats and mice and transcripts of these channels 
are already upregulated earlier (Rusnakova et al., 2013; Honsa et al., 2014). After a stab wound 
lesion in the somatosensory cortex, up to 5dpi no changes in HCN1 channel expression were 
found compared to control conditions. The same was true for HCN3 channels which were not 
expressed in astrocytes in the healthy brain and still absent five days after a stab wound lesion 
was inflicted (data not shown). Nevertheless, it is possible that HCN1 and HCN3 channels 
might still upregulate at later stages which I did not study. HCN2 channels, which were absent 
in astrocytes in the healthy somatosensory cortex (Figure 24a), were extensively upregulated 
on processes of a subset of reactive polarizing astrocytes already at 5dpi (Figure 24b). The 
upregulation was independent of non-juxtavascular and juxtavascular positions of astrocytic 
somata and proliferative behaviour of these astrocytes. This is in line with the findings in the 
ischemic brain of mice and rats where reactive astrocytes are known to upregulate HCN2 
channels as well (Rusnakova et al., 2013; Honsa et al., 2014). However, after a stab wound 
lesion, the HCN2 upregulation seems to happen much faster. The earlier presence of HCN2 
channels shown in my study might be related to the severity of the injury that results in severe 
reactive astrogliosis in combination with proliferation and scar formation early on. Astrocyte 
reactivity peaks later under ischemic conditions (Anderova et al., 2011). It is known that HCN 
channels play a role in proliferation in embryonic stem cells (Lau et al., 2011). In my study, 
HCN2 channel expression was upregulated not only in proliferating but also in non-
proliferating astrocytes. This suggests that HCN2 channel upregulation might not exclusively 
play a role in the proliferation of reactive astrocytes. As the upregulation of HCN2 occurs 
mainly on hypertrophic polarized processes of reactive astrocytes, it might be important for 
the homeostasis of sodium in the lesioned brain or to prevent seizures by supporting the Na+/K+ 





Thulborn et al., 2005; Black et al., 2010; Honsa et al., 2014). Moreover, HCN2 upregulation 
might prevent glutamate excitotoxicity by influencing glutamate release at presynaptic 
terminals (Neitz et al., 2011; Honsa et al., 2014). Moreover, it might together with the 
downregulation of Kir4.1 channels and the upregulation of Kv4.3, be involved in the shift 
towards non-passive current patterns in reactive astrocytes that I observed after the stab wound 
lesion (Figure 20 and 25a). Additionally, the combination of the upregulation of HCN2 and 
Kv4.3 channels might also explain why I did not observe an overall reduction in Gr and an 
increase in Rin in reactive astrocytes after a stab wound lesion compared to the control 
condition (Figure 18). The upregulation of these channels might compensate for the reduction 






4.7 Final conclusion 
The findings of my study show that non-juxtavascular and juxtavascular astrocytes do not 
inherently differ regarding their expression patterns of major K+ channels studied here. 
Accordingly, no dissimilarities in passive electrophysiological properties were detectable 
between the two astrocyte subgroups. Most of the astrocytes in the somatosensory cortex of 
mice were typical mature astrocytes with passive current response patterns and linear IV-
relationships mainly caused by Kir4.1 activity. The stab wound lesion and the subsequently 
following reactive astrogliosis triggered a shift especially in juxtavascular astrocytes towards 
non-passive current patterns. This suggests that these reactive astrocytes might resemble 
immature astrocytes that are known to still have proliferative potential. Especially the 
downregulation of Kir4.1 in proliferating reactive astrocytes as well as the upregulation of 
Kv4.3 channels on polarized astrocytic processes seem to be the underlying causes for the 
aforementioned shift. Hence, I propose an important role of these two K+ channel subtypes in 
the astrocytes´ proliferative response to traumatic brain injury. Moreover, HCN2 channels, 
which were absent in astrocytes in the healthy somatosensory cortex were extensively 
upregulated on processes of a subset of reactive polarizing astrocytes independently of non-
juxtavascular and juxtavascular positions of astrocytic somata and proliferative behaviour of 
these astrocytes which might be important for sodium homeostasis and the prevention of 
glutamate excitotoxicity. Furthermore, the upregulation of HCN2 channels might also 
contribute to the shift towards non-passive current patterns. 
These findings might be of great interest for therapeutic approaches since there is increasing 
evidence, that astrocyte proliferation positively affects healing processes and axon 
regeneration after traumatic brain injury. Moreover, an increase in astrocyte numbers due to 
proliferation of reactive astrocytes is known to limit monocyte invasion into the brain, which 
minimizes scar formation. Therefore manipulating ion channels in astrocytes to promote 
astrocyte proliferation could be beneficial to ameliorate the patients’ outcome and 
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